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SUMMARY
The aim of this project was to assess clinical heterogeneity 
in senile dementia of the Alzheimer type, relating clinical 
features of the disorder to structural brain changes as assessed 
by Computed Tomography (CT) scan and to cognitive function. The 
study was based on 178 elderly psychiatric patients who satisfied 
criteria for Alzheimer’s disease suggested by the National 
Institute for Neurological and Communicative Disorders and Stroke 
and the Alzheimer’s disease and Related Disorders Association 
(NINCDS/ADRDA).
The mean age of the sample was 80.4 years and the mean 
duration of illness 63 months. Each patient underwent a number 
of standardised assessments. The history and course of illness, 
before the commencement of the study, were documented with the 
CAMDEX; cognitive function was measured by the CAMCOG, the 
Mini Mental State Examination and the Abbreviated Mental Test 
score; physical examination was performed using a standardised 
schedule; psychiatric symptoms were rated by the CAMDEX and 
by the Geriatric Mental State Schedule; behaviour was 
assessed by the Stockton Geriatric Rating scale; questions 
were also asked regarding behaviour associated with the 
Kluver-Bucy syndrome; a global rating of severity of dementia 
was allocated to each subject (the Clinical Dementia Rating) 
and a CT scan of head was performed. The assessments were 
repeated after twelve months and the mortality of the sample 
was recorded for 36 months from the start of the study.
The main results can be summarised under the following 
headings:
1
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Psychiatric symptoms
Since the onset of the illness, 17% of the sample had 
experienced hallucinations (10% auditory and 13% visual) and 30%
demonstrated misidentification syndromes (12% failing to
recognise other people, 4% failing to recognise their own image, 
17% believing that other people were in the house and 6%
believing that events on the television were real). 16% of the
group were deluded, the most common themes being delusions of 
suspicion and of theft. A higher proportion of males than 
females were deluded. In addition, 20% had paranoid ideation not 
held with delusional intensity. Affective disturbances were 
common - 24% of the sample appeared depressed, 39% had symptoms 
suggestive of depression and 43% were rated by their relatives as 
being depressed. In comparison, symptoms of mania were rare - 
only one subject experienced manic symptomatology and only 4% 
appeared elated and over-active.
Patients with or without hallucinations had similar 
cognitive function at entry to the study but the former group 
had greater cognitive decline over the twelve month follow-up 
period. Subjects with misidentification syndromes were younger, 
the illness had started at a younger age and they had a lower 
mortality rate than those without these syndromes. Patients 
with systematised delusions had smaller lateral ventricles and 
were more likely to have basal ganglia calcification than those 
without these delusions. Depressive symptoms complained of by 
the patient correlated with ventricular size and subjects whose 
relatives felt they were depressed had smaller third and 
lateral ventricles. Manic symptoms were significantly
2
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associated with enlargement of the interhemispheric fissure, 
while those with depressive symptoms had smaller fissures. The 
patients who appeared depressed had a higher mortality rate than 
those who did not.
Behavioural disturbance
Aggression was found in 20% of the group, excessive 
wandering behaviour in 19%, incontinence in 48% and excessive 
eating behaviour in 10%. Seven elements of the Kluver-Bucy 
syndrome were identified (binge eating, hyperorality, sexual 
disinhibition, misrecognition of others, rage behaviour, 
hypermetamorphosis and apathy). Aggression was more common in 
men and in hospitalised subjects. All behaviours except binge 
eating, rage behaviour and hypermetamorphosis were associated 
with increasing severity of dementia, both as assessed by the 
cognitive tests and on the CDR. The presence of incontinence was 
associated with an increased mortality at follow up.
Individual items of the Kluver-Bucy syndrome were common, with 
72% of the group having at least one symptom. Only one subject 
had all seven features. A factor analysis showed three factors 
in the Kluver-Bucy syndrome - one factor consisted of rage 
behaviour and hyperorality, another consisted solely of binge 
eating and the third of the remaining behaviours. Aggression was 
associated with temporal lobe atrophy, wandering with sylvian 
fissure atrophy and hyperorality with increased third ventricular 
size.
Neurological signs
These were assessed by a standard physical examination. A 
snout reflex was found in 41%, a palmomental reflex in 3% and a
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grasp reflex in 7%. Myoclonus was observed in 5% and a history 
of epileptic fits (since the onset of the dementia) was obtained 
in 3%. 15% of subjects had extrapyramidal signs, 3% of which
were considered neuroleptic induced. The grasp reflex, 
extrapyramidal signs and myoclonus were associated with a younger 
age of onset, longer duration of illness and more severe 
dementia. Non drug-induced extrapyramidal signs were associated 
with calcification in the globus pallidus and a grasp reflex was 
associated with increased frontal lobe atrophy. Patients 
developing a grasp reflex in the twelve month follow up period 
had larger ventricles while the development of a snout reflex or 
extrapyramidal signs was associated with increased mortality. 
Longitudinal change in cognition
An attempt was made to assess heterogeneity in the pattern 
of cognitive decline over twelve months. Data were available on 
105 subjects. There was a highly statistically significant 
decline in cognition over the follow up period and patients with 
a family history of dementia in their parents (but not siblings 
or second degree relatives) had a greater decline. A cluster 
analysis revealed three patterns of decline (mild, moderate and 
severe) but none of the clusters were related to other 
characteristics of the disease or to subsequent mortality. Thus, 
the decline in cognitive function was not supportive of clinical 
subtypes.
Longitudinal change in CT scans
Sixty-three subjects had two CT scans twelve months apart. 
Statistically significant deterioration occurred in all the CT 
measures but there was a wide variation in the size of the
changes - 14 of the 63 showed virtually no change in ventricular 
size whereas six showed a marked increase. These subgroups were 
not associated with any other disease characteristic or with 
subsequent mortality. An increase in ventricular size was 
associated with deterioration in cognitive function. Thus, there 
was some evidence that deterioration in CT variables was 
heterogeneous but not sufficient evidence to suggest significant 
clinical subtypes.
Factors affecting survival
Factors influencing survival were analysed using univariate 
and multivariate proportional hazards modelling. The mortality 
of the sample was 3.5 times that expected and the following 
features were predictive of decreased survival: male sex, 
advanced age, longer duration of illness, presence of physical 
illness, poor cognitive function, absence of misidentification 
syndromes and presence of observed depression. Apraxia was a 
stronger predictor of early death than either aphasia or 
amnesia.
Neuropathological findings
The ability of the NINCDS/ADRDA criteria to predict 
Alzheimer pathology at post mortem was assessed. 63% of the 
patients who died were submitted to post-mortem on whom 
detailed post mortem information is available on 48 subjects.
Of these 48 patients, 85% had sufficient Alzheimer pathology 
to merit that diagnosis. Two patients had pure vascular 
disease, three had cortical Lewy body disease and three had 
no identifiable neuropathological features. Therefore, the 
clinical criteria were satisfactory in predicting Alzheimer
5
pathology at post mortem.
This work has shown that there is considerable clinical 
heterogeneity in senile dementia of the Alzheimer type and that 
certain disease characteristics are related to the natural 
history of the condition (cognitive decline and mortality) and 
to structural brain changes (as assessed by CT scan). The 
evidence does not prove unambiguously that there are absolute 
qualitative subtypes of the disorder but does suggest that 
features of the disease are helpful in predicting decline and 
death. More research is needed and the ultimate test for 
qualitative heterogeneity depends on the discovery of the 
aetiology of Alzheimer’s disease and how that relates to 
neuropathological changes.
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ABBREVIATIONS AND TERMINOLOGY 
The following terms will be used in this thesis -
Alzheimer’s Disease (AD) - this term will be used when 
neuropathological features of Alzheimer’s Disease have been found 
at post mortem in patients suffering from a clinical syndrome of 
dementia during life.
Senile Dementia of the Alzheimer Type (SDAT) - this will 
refer to the most common clinical situation viz where a patient, 
over the age of 65, is suffering from a clinical dementia 
syndrome and other causes of dementia have been excluded. The 
presumption is made that Alzheimer changes will be found at post 
mortem but has not yet been confirmed.
Dementia of the Alzheimer Type (DAT) - is analagous to SDAT 
but refers to patients under the age of 65. This age-based 
dichotomy is purely arbitrary.
Senile Dementia and Pre-Senile Dementia - this refers to the 
clinical syndrome of dementia occurring after the age of 65 
(senile) or before 65 (pre-senile). No statement can be made as 
to the possible aetiology.
Multi-infarct Dementia (MID) - will refer to dementia 
(either presumed or proven) to be secondary to cerebrovascular 
damage resulting on one or more cerebral infarcts.
Primary Degenerative Dementia (PDD) - an American term used 
clinically to describe patients in whom other secondary causes of 
dementia have been excluded but where there is not sufficient 
confidence to predict that Alzheimer changes will be found at 
post mortem. In practical terms, this is synonymous with, and 
has been replaced by, SDAT and DAT.
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Different studies apply a variety of terms to their 
patients. When referring to other studies, for the sake of 
consistency and to ensure standardisation, I use the above 
terminology irrespective of the terms employed in the paper. In 
doing so, I make no comment on the appropriateness or otherwise 
of terminology used by others.
Standard abbreviations are used in this thesis. The first 
time an abbreviation appears in the text it will be written in 
full followed by the abbreviation. A full list of the 
abbreviations appears below.
AD - Alzheimer’s Disease
AMTS - Abbreviated Mental Test Score
BDS - Blessed Dementia Scale
CAMDEX - The Cambridge Battery (Roth et al,1986)
CAMCOG - The Cognitive Section of the CAMDEX
CAPE - Clifton Assessment Procedures in the Elderly
Chat - Choline acetyl transferase
CSF - Cerebrospinal Fluid
CT - Computed Tomography
DAT - Dementia of the Alzheimer type
DCT - Digit Copying Test (Kendrick, 1972)
EEG - Electroencephalogram
GMSS- Geriatric Mental State Schedule (Copeland et a l , 1976)
IHF - Interhemispheric Fissure
IMC - Information, Memory and Concentration Scale of Blessed 
MTS - Mental Test Score
MID - Multi-infarct Dementia
MMSE - Mini Mental State Examination (Folstein et al, 1975) 
NINCDS/ADRDA - National Institute for Neurological and
Communicative Disorders and Stroke and the 
Alzheimer's Disease and Related Disorders 
Association 
NFT - Neurofibrillary tangle 
OLT - Object Learning Test (Kendrick, 1972)
PALT - Paired Associate Learning Test (Inglis, 1958)
PDD - Primary Degenerative Dementia
SDAT - Senile Dementia of the Alzheimer Type
SP - Senile (Neuritic) Plaque
VBR - ventricular-brain Ratio
WAIS - Weschler Adult Intelligence Scale (Wechsler, 1955)
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INTRODUCTION
In 1907, Alois Alzheimer published a description of the case 
of a 51-year old woman who presented with delusions of jealousy 
towards her husband. Subsequently, her memory deteriorated 
rapidly, she got lost around her flat and had fears that someone 
was going to kill her. In hospital, she exhibited abnormal 
behaviour - loud shrieking and dragging her bedding around the 
ward. She was disorientated, had a poor short term memory, 
demonstrated paraphasias and showed signs of apraxia. There were 
no abnormal physical signs in the central nervous system. She 
died four and a half years after the onset of her illness. A 
post mortem examination was performed with these results: 1)
macroscopically, the brain showed clear evidence of cerebral 
atrophyand 2) microscopically, neurofibrillary tangles and senile 
plaques were seen.
There are two threads to the subsequent story. First, the 
relationship of the neuropathological findings in dementia to the 
clinical picture of dementia and normal ageing. Second, the 
search for heterogeneity within the primary dementias.
Kraepelin (1910) introduced the eponym "Alzheimer*s 
disease" (AD) and suggested that the neuropathology 
was pathognomonic of the clinical picture of AD. Subsequently, 
Gellerstedt (1933), Rothschild (1941) and Tomlinson et al (1968) 
found that these histopathological changes were not specific to 
AD as they were also found in mentally unimpaired elderly people. 
Thus, neuropathology perpetuated the belief that observed 
morphological changes were not specific to dementia. In the 
early 1950 *s, Roth validated a descriptive clinical
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classification (Roth and Hopkins, 1953, Roth, 1955) which showed, 
using mortality rates, that disease classification was justified 
in the elderly. This served as the blueprint for the clinical 
classification of psychiatric disorders of later life. In the 
1960’s, two developments occurred which emphasised the 
relationship between clinical and neuropathological findings. 
First, the ultra-structure of neurofibrillary tangles and senile 
plaques was defined (Terry, 1963, Kidd, 1963, Terry et a l , 1964) 
and were found not to be the relatively formless structures 
previously considered. Second, correlations between quantitative 
psychological tests and quantitative neuropathological changes 
were found (Blessed et al, 1968). It is now generally accepted 
that Alzheimer type changes in the brain are responsible for the 
clinical features of both presenile and senile dementia.
The second thread concerns the search for heterogeneity in 
Dementia of the Alzheimer type (DAT). Lauter and Meyer (1968) 
noted differing symptoms in patients with early and late onset 
disease and found that parietal lobe signs and neurological 
disturbances decreased in frequency with increasing age but that 
delusions and hallucinations increased. McDonald (1969) 
suggested a division based on age and the presence or absence of 
apraxia. Subsequent clinical studies have supported this (Hare, 
1978, Seltzer and Sherwin, 1983, Mayeux et al, 1985b) and 
neurochemical studies (Rossor et al, 1984, Perry et al, 1968) 
have revealed heterogeneity based on age at death.
Currently, scientific interest in Alzheimer’s disease and 
related conditions is high, probably for three main reasons.
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First, the vast numbers of elderly people suffering from dementia 
(6% of the over 65’s rising to 18% of the over 85*3, Bergmann, 
1985) cannot be ignored. Second, neurochemical and molecular 
biology techniques have been applied with some success to the 
condition offering the real hope of discovering the aetiology and 
pathogenesis. Third, drug trials have met with moderate success 
and there is genuine optimism that an agent may be found which 
ameliorates the symptoms (Levy, 1990).
The purpose of this thesis is to examine the evidence for 
clinical heterogeneity in Senile Dementia of the Alzheimer Type 
(SDAT). It will start with three chapters reviewing the 
relevant literature. The first chapter will outline current 
concepts of Alzheimer’s disease (AD), dementia of the Alzheimer 
Type (DAT, which includes the condition specifically relating to 
those patients over 65, Senile Dementia of the Alzheimer’s Type, 
SDAT). The second chapter will assess different features of SDAT 
which have been implicated in clinical heterogeneity while the 
third will discuss the longitudinal changes which occur.
The study itself will then be presented (Chapters 4-10).
Each chapter will deal with a specific topic and will include its 
own results, discussion and summary. Clinical features of SDAT 
will be described in detail (psychiatric symptoms, behavioural 
disturbance and neurological abnormalities) and will be related, 
not only to one another, but to the natural history of the 
disorder as assessed by survival and longitudinal changes in both 
cognitive function and CT scans.
Because clinical features of the disease are to be 
interrelated, a choice had to made at the outset as to which
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variables to examine primarily. For example, the relationship 
between age of onset and misidentification syndromes could 
be assessed either by dealing with age of onset primarily and 
including a discussion of misidentification syndromes or vice 
versa. I have chosen to describe primarily features of the 
disorder which are apparent on examination (psychiatric symptoms, 
behaviour disturbances and neurological signs) and to relate them 
to other features such as age of onset, family history of 
dementia and neuropsychological function. This order has been 
determined both by the way in which the study evolved and by 
the presence of certain features which struck me as being most 
important in the clinical setting.
The reason that age of onset has not been used as a primary 
variable is that all the patients in the study (except one) were 
over the age of 65 when first seen which reflected the population 
from which the sample was drawn (elderly patients in contact with 
a psychiatric hospital). Thus, the traditional dichotomy of 
onset above and below the age of 65 was felt to be largely 
irrelevant to the current work. Neuropsychological heterogeneity 
has been discussed in relation to dementia and the relationship 
between the differing functions of memory, language and 
visuospatial ability noted. These aspects have not been 
emphasized in the present thesis for two reasons. First, the 
majority of patients were moderately demented and so detailed and 
sophisticated psychological tests were not possible. Second, the 
neuropsychological assessment instruments used in this study are 
relatively simple and have been developed primarily for use by
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psychiatrists as screening tests to assess cognitive function 
globally and to indicate where more complex tests are necessary. 
Therefore, they provide a detailed global assessment of cognitive 
function and the relationship of individual scales to each other 
and to specific neuropsychological functions is uncertain. As 
such, I felt it inappropriate to place excessive weight on the 
results of these tests applied in a cross-sectional manner. 
However, using the results to indicate a change in cognitive 
function seemed more appropriate and so this measure has been 
used in an attempt to assess quantitative subtypes (Jorm, 1985).
Data on neuropathological findings will be presented, not 
because of a direct bearing on the heterogeneity issue, but to 
justify use of the clinical criteria used in the diagnosis 
(neuropathological heterogeneity is a separate subject and will 
not be tackled by this thesis).
The hypotheses at the start of the study were:
1) there is considerable clinical heterogeneity in SDAT and 
features of the disease will be related to cognitive decline and 
survival;
2) specifically, apraxia will be related to a poorer outcome, 
depression will carry a relatively good prognosis and Computed 
Tomography (CT) scan changes of ventricular enlargement will 
reduce survival;
3) the proportion of patients with specific psychiatric symptoms 
will be lower than in other studies because of the representative 
nature of the population examined;
17
4) specific psychiatric symptoms, behaviour disturbances and 
neurological signs will be associated with structural 
abnormalities as assessed by CT scan;
5) longitudinal changes in cognitive function and CT scan 
appearances will identify subgroups and
6) the strict application of appropriate clinical criteria will 
ensure that the majority of subjects will have histopathological 
changes of Alzheimer's disease.
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CHAPTER 1
CURRENT CONCEPTS OF ALZHEIMER*S DISEASE AND SENILE DEMENTIA OF
THE ALZHEIMER TYPE
1.1. INTRODUCTION
The purpose of this chapter is to review current diagnostic 
criteria for dementia in general and Dementia of the Alzheimer 
Type (DAT) in particular and to examine the proportion of cases 
in which a clinical diagnosis of DAT is accompanied by the 
neuropathological findings of Alzheimer*s disease. (For the sake 
of clarity in this and the following two chapters, DAT will refer 
to the clinical situation where Alzheimer*s disease is presumed 
to be responsible for the clinical picture, regardless of the age 
of the patient. In this sense, Senile Dementia of the Alzheimer 
Type (SDAT) is a subset of DAT). The clinical process involved 
in making a diagnosis of DAT comprises two parts. The first part 
is to make the diagnosis of a dementia syndrome, the second is to 
identify those patients who are likely to have the 
histopathological changes of AD. The first is essentially a 
diagnosis of inclusion while the second, until recently, was 
essentially a diagnosis of exclusion whereby other causes of 
dementia were excluded. If none were found, DAT was diagnosed. 
The most recently developed criteria, which will be discussed 
below, have made the diagnosis of DAT one of both inclusion and 
exclusion.
1.2 CRITERIA FOR THE DIAGNOSIS OF DEMENTIA
The two major diagnostic schemata for the classification of 
psychiatric disorders in use at present are the International
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Classification of Diseases, revision 10 (ICD 10) and the North 
American Diagnostic and Statistical Manual, revision of the third 
edition (DSM IIIR, APA, 1987). ICD 10 gives a simple definition 
of dementia as Ma syndrome due to disease of the brain, usually 
of a chronic or progressive nature, in which there is impairment 
of multiple higher cortical functions, including memory, 
thinking, orientation, comprehension, calculation, learning 
capacity language and judgement". It states that dementia must 
occur in the presence of clear consciousness, must be of such a 
degree as to "impair functioning in daily living" and that 
symptoms should be present for at least six months.
DSM IIIR defines dementia more fully and suggests specific 
criteria essential to the diagnosis. In summary these 
criteria are:
A. Evidence of short and long term memory impairment
B. At least one of the following:
1) impairment of abstract thinking;
2) impaired judgement;
3) evidence of higher cortical dysfunction (eg aphasia, 
apraxia or agnosia;
4) personality change.
C. That the disturbance in A and B significantly interferes 
with work or usual social activities
D. The absence of delirium.
E. The absence of an non-organic mental disorder which can 
mimic dementia.
Criteria are also provided which enable the severity of 
dementia to be rated - mild dementia (independent living is
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possible although work and social functioning are impaired); 
moderate dementia (supervision needed for independent living) and 
severe dementia (continual supervision required).
The criteria presented in DSM IIIR represent an improvement 
on those in the previous edition (DSM III). They appear largely 
to have resulted from a paper by Jorm and Henderson (1985).
These authors questioned the classification of dementia as a 
categorical entity and suggested that defined cut-offs be laid 
down so that the disorder was diagnosed as part of a continuum. 
They also criticised use of the term ’’loss of intellectual 
abilities” indicating that it was very difficult to evaluate 
’’loss” unless the previous level of functioning was known. One 
further criticism, which still holds true for DSM IIIR, was that 
in criterion B, ”.... at least one of the following must be 
present...". If only one of the four subcriteria was required, 
then it was apparent that any single criterion was not essential 
to the diagnosis but simply increased diagnostic certainty. 
Therefore, it was theoretically possible that a case of dementia 
could exist where none of the four subcriteria was present.
Thus, DSM IIIR is a significant improvement on DSM III, 
emphasising how current concepts of dementia are continually 
being refined. It is superior to its European counterpart (ICD 
10) which remains essentially a descriptive paragraph lacking 
defined guidelines. The two advantages of ICD 10 are first, that 
it suggests a time period over which symptoms should be present 
(six months) and second, that it attempts to introduce the notion 
of heterogeneity by dividing dementia associated with Alzheimer’s
21
disease into early onset (Type 2) and late onset (Type 1).
1.3 CRITERIA FOR THE DIAGNOSIS OF ALZHEIMER*S DISEASE
It is important to understand that dementia, as defined 
above, indicates the presence or absence of a particular clinical 
picture (ie a dementia syndrome). The aetiology of the syndrome 
is a separate consideration. Both ICD10 and DSM IIIR offer 
additional guidelines as to how DAT may be diagnosed. The former 
states that, in addition to the presence of dementia, the 
diagnosis of DAT requires that the condition have an insidious 
onset and that other causes of such a syndrome be excluded. It 
divides DAT into two types - early onset (beginning prior to age 
65, Type 2, presenile onset) and late onset (beginning after the 
age of 65, Type 1, senile onset).
DSM IIIR has essentially the same criteria but, in addition, 
has subcategories under the senile and presenile headings for 
dementia associated with delusions, depression, delirium and 
"uncomplicated'' categories. This recognition of phenomenological 
subtypes of DAT is of importance and will be discussed at length
later in this thesis (Chapters 2 and 6).
In DAT, there exists a yardstick against which clinical 
criteria may be measured - neuropathological examination. This 
situation does not obtain in the other major psychiatric 
conditions such as schizophrenia and depression. Whilst being an 
obvious advantage to the scientific study of the disorder, it
also has the disadvantage in that a clinical diagnosis can be
disproven, an opportunity not generally present in other branches 
of psychiatry.
22
In an attempt to refine diagnostic criteria for DAT, a work 
group was set up by the National Institute for Neurological and 
Communicative Disorders and Stroke and the Alzheimer’s Disease 
and Related Disorders Association (referred to hereafter as the 
NINCDS/ADRDA). Their remit was to establish a set of criteria, 
to be adopted by researchers studying the disorder, which would 
ensure a degree of homogeneity for the diagnosis amongst 
researchers from different centres. The published criteria 
(McKhann et al, 1984) represented a consensus from participants 
drawn from a variety of disciplines. The criteria are reproduced 
in Table 1.1. Three main subsets are defined - possible AD, 
probable AD and definite AD. Briefly, definite AD requires the 
presence of possible or probable AD with neuropathological 
confirmation of the diagnosis. Probable AD is diagnosed when a 
dementia syndrome of gradual onset is present and other causes 
excluded ie essentially the same as the definition in DSM IIIR 
and ICD10. The criteria are an improvement in that much greater 
detail is given as to how the condition should be diagnosed and 
various psychological tests and investigations are mentioned. 
Possible AD Is diagnosed when a dementia syndrome is present but 
probable AD cannot be diagnosed confidently - either due to the 
presence of a coexisting physical illness or of an atypical 
clinical picture. The criteria state that they are to be used 
for "the clinical diagnosis of Alzheimer’s disease". In other 
words, they are clinical criteria which, if applied, will predict 
which patients will have the histopathological changes of 
Alzheimer’s disease. Thus, they can be regarded as synonymous 
with clinical criteria for DAT and SDAT.
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Table 1.1 NINCDS/ADRDA CRITERIA FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
I. The criteria for the clinical diagnosis of PROBABLE Alzheimer’s 
disease include:
dementia established by clinical examination-anddocumented 
by, the Mini-Mental Test.- Blessed Dementia Scale,-1 or some 
similar examination, and confirmed by neuropsychological 
teats;
deficits in two or more areas of cognition;
progressive worsening of memory andother cognitive functions;
no disturbance of consciousness;
onset between ages 40 and 30, most often after age oo; and
absence of systemic disorders or other brain diseases that in and 
of tbemseives could account for the progressive deficits in mem­
ory and cognition.
IL The diagnosis of PROBABLE Alzheimer’s disease is supported 
by:
progressive deterioration of specific cognitive functions such as 
Language (aphasia), motor skills (apraxia), and perception (ag­
nosia):
impaired activities of daily living and altered patterns of be­
havior;
family history of similar disorders, particularly if confirmed 
neuropathologicaily; and
laboratory results ou
normal lumbar puncture’ as evaluated by standard tech­
niques.
normal pattern or nonspecific changes in EEC. such as 
increased slow-wave activity, and
evidence of cerebral atrophy on CT with progression docu­
mented by serial observation.
ILL Other clinical features consistent with the diagnosis of PROBA­
BLE Alzheimer's disease, after exclusion of causes of dementia 
other than Alzheimer's disease, inciude:
plateaus in the course of progression of the illness:
associated symptoms of depression, insomnia, incontinence, 
deiusions. illusions, hallucinations, catastrophic vernal, emo­
tional. or physical outbursts, sexual disorders, and weight loss:
other neurologic abnormalities in some patients, especially with 
more advanced disease and including motor signs such as in­
creased muscle cone, myoclonus, or gait disorder;
seizures in advanced disease: and
CT normal for age.
IV. Features that make the diagnosis of PROBABLE Alzheimer’s 
disease uncertain or uniilteiy include:
sudden, apoplectic onset;
focal neurologic findings such as hemiparesis. sensory loss, vi­
sual fieid deficits, and incoordination early in the course of the 
illness; and
seizures or gait disturbances at the onset or very early in the 
course of the illness.
V. Clinical diagnosis of POSSIBLE Alzheimer’s disease:
may be made on the basis of the dementia syndrome, in the 
absence of other neurologic, psychiatric or systemic disorders 
sumcient to cause dementia, and in the presence ofvariations in 
the onset, in the presentation, or in the ciinical course:
may be made in the presence of a second systemic or brain 
disorder sumcient to produce dementia, which is not considered 
to be the cause of the dementia; and
should be used in research studies when a single, gradually 
progressive severe cognitive deficit is identified in the absence ox- 
other identifiable cause.
VL Criteria for diagnosis of DEFINITE Alzheimer's disease are:
the clinical criteria for probable Alzheimer's disease and
histopathologic evidence obtained from a biopsy or autopsy.
VTL Classification of Alzheimer’s disease for research purposes should 
specify feature* that may differentiate subtypes of the disorder, 
such as:
familial occurrence; .
onaec before age of 65;
presence of trisomy-21: and
coexistence of ocher relevant conditions such as Parkinson’s 
disease*
from; McKhann et al. (1984). Reproduced with permission of the author and 
publisher.
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1.4 CLINICO-PATHOLOGICAL CORRELATIONS
The NINCDS/ADRDA criteria appear at face value to be the 
most sophisticated in the clinical diagnosis of AD (ie DAT). 
However, it is essential to examine those studies in which 
clinical criteria are validated against neuropathological 
findings. These studies are summarised in Table 1.2.
Todorov et al (1975) in a large study reported the results 
of 776 autopsies, performed over a 10 year period in Geneva (the 
same work was published, without reference to the previous 
publication, by Constantinidis, 1978). The clinical 
classification was based on nosology developed at the University 
of Geneva. Clinically, 273 cases could be allocated to three main 
categories:
1) senile dementia - onset around age 70, with amnesia as the 
prominent feature and little or no aphasia/apraxia;
2) "Alzheimerised" senile dementia - similar to (1) but with 
apraxia and aphasia and
3) Alzheimer presenile dementia - similar to (2) but with onset 
before age 65.
The authors also defined neuropathological criteria. Senile 
dementia was characterised by brain atrophy, numerous senile 
plaques (SP) in the neocortex and neurofibrillary tangles 
(NFT) in the hippocampus (but not in the neocortex). 
"Alzheimerised” senile dementia and Alzheimer’s presenile 
dementia were indistinguishable by their neuropathology - 
widespread brain atrophy with NFT in the hippocampus and 
neocortex.
Assuming that a clinical diagnosis of senile dementia or
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"Alzheimerised" senile dementia corresponded to a diagnosis of 
SDAT then, of 237 patients with senile dementia, only 121 (48%) 
had Alzheimer pathology at post mortem. In the younger patients, 
28 out of 36 had Alzheimer pathology (78%). It is possible that 
the clinical criteria, which did not mention ancillary 
investigations or the presence or absence of physical disease, 
were incorrectly classifying elderly patients with confusional 
states, mild memory disorders or physical illness as demented. 
Also, it is possible that younger patients were more rigorously 
investigated to exclude secondary dementias resulting in a higher 
"success rate" of correct diagnoses in this population.
Muller and Schwartz (1978) examined EEG and post-mortem 
findings in 100 elderly psychiatric patients. The patients had 
been diagnosed according to the contemporary European 
classification of the time, ICD 8, and 37 were given the 
diagnosis of SDAT. Of these, 32 had Alzheimer neuropathology (not 
operationally defined, but representing the diagnosis given by 
the pathologist on the basis of plaque and tangle formation). 
Despite the drawbacks of the study (observations made by a number 
of clinicians and pathologists over a number of years, the 
retrospective nature of the study and the relatively crude 
clinical criteria employed), the success rate of correct 
diagnoses was 86%. The main criticism which can be directed 
against the study is the lack of standardisation of the 
neuropathology examinations. There was no mention of vascular 
lesions. It is possible that AD was diagnosed in the presence of 
small numbers of SP*s or NFT’s or in the presence of vascular
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damage. Such cases would not meet current neuropathological 
definitions.
Sulkava et al (1983) reported the autopsy results of 27 
subjects suffering from primary degenerative dementia who formed 
part of a prospective series of 71 patients. The clinical 
criteria employed in the study were based on those of Roth 
(1955). Twenty-two of the 27 patients had typical Alzheimer 
changes at post mortem (defined as "abundant" NFT and SP in the 
hippocampus and "moderate to large numbers" in the neocortex). Of 
the five patients without these features, one had Parkinson’s 
Disease (neuronal loss and Lewy body formation in the substantia 
nigra), two had hippocampal cell loss and gliosis and two a non­
specific encephalopathy. Thus, Roth’s (1955) criteria were 
validated neuropathologically. It is noteworthy that these 
criteria successfully excluded all cases of vascular dementia.
Perl et al (1984) reported clinico-pathological findings in 
26 patients referred with a physician’s diagnosis of DAT. Twenty- 
one had Alzheimer features but only nine had pure AD. Of the 
others, two had evidence of cerebral infarction, two had evidence 
of cortical anoxia, one an infarct in the temporo- parietal 
region and seven had the additional pathological features of 
Parkinson’s disease. Excluding those with evidence of infarction, 
18 of the 26 had features of AD. It seems likely that these cases 
represented a biased sample in that they were referred to a brain 
bank. In this case, physicians might have referred a larger 
proportion of cases in whom a diagnosis of AD was more likely.
Molsa et al (1985) presented the results of a prospective 
study of 58 autopsies of patients with dementia, three of whom
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were under 65 years of age. They were drawn from a previously 
identified community sample. Three groups were defined 
clinically:
1) patients with a SDAT (defined as the absence of secondary 
causes of dementia and a Hachinski score (Hachinski et al , 
1975) of less than four);
2) MID (defined as present when the Hachinski score was greater 
than seven) and
3) combined MID and SDAT (defined as a Hachinski score of between 
four and seven).
Results were presented of a group described as having 
"other” dementias but these dementias were not defined 
clinically. Neuropathological criteria were specified - for a 
diagnosis of AD at least three NFT in "any neocortical field", or 
at least one NFT in more than one section, were required. SP 
counts were not quantified separately but it was stated that 
moderate or high counts "invariably" were accompanied by 
significant NFT counts. MID was diagnosed pathologically as the 
presence of "any ischaemic lesions" and in the absence of AD 
criteria being satisfied. Of 28 cases defined clinically as DAT, 
20 satisfied neuropathological criteria for AD. However, of 19 
patients diagnosed clinically as MID, six had AD at post-mortem. 
The authors concluded that the Hachinski score produced a 
moderately reliable instrument to distinguish between AD and MID 
during life.
The results of cerebral biopsies were analysed in 24 
patients by Neary et al (1986). The patients were young (mean
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age 58 years, range 43 to 69 years) and performing a cerebral 
biopsy was obviously regarded as ethically justifiable. Normal 
control material was obtained from non-demented subjects 
undergoing other neurosurgical procedures. Many
neuropsychological tests were performed on the group, all of whom 
had:
1) progressive deterioration of mental function of at least one 
year’s duration;
2 ) an absence of other causes of dementia and
3) evidence of non-focal cerebral atrophy and ventricular 
enlargement on CT scan.
AD was diagnosed neuropathologically if any SP or NFTs 
were present. 18 of the 24 patients had these features at 
biopsy. They were divided into 4 different groups on clinical 
grounds:
1) 11 patients who conformed to the typical picture of AD with 
amnesia, aphasia and apraxia;
2) three patients with no aphasia but with constructional loss 
and amnesia;
3) two patients with prominent loss of motor skills, dysarthria 
and some signs of Parkinson’s Disease and
4) two patients with pure amnesia.
The authors argued that this study confirmed the 
heterogeneity of pre-senile dementia. However, several points 
should be made in relation to the diagnosis of AD. First, the 
sample was a highly unusual one. The patients were all very 
young, they had very "neurologicalM illnesses, many of them had 
neurological signs and all were considered to be sufficient
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diagnostic "puzzles" to merit a brain biopsy. Second, the 
heterogeneity was based purely on anecdotal clinical descriptions 
and not subjected to proper statistical analysis. Third, the 
criteria for the neuropathological diagnosis of AD were rather 
unusual in that any NFTs or SPs were sufficient. Fourth, the 
drawbacks of a solitary cerebral biopsy in the diagnosis of AD 
are obvious - an area of unaffected cortex could easily have been 
biopsied. Thus, general comparisons cannot be drawn from this 
study.
Kokmen et al (1987) studied all the autopsies of patients 
within Olmsted County in Minnesota who died in 1980 and 1981. 
Autopsies had been carried out on 350 subjects (out of a total 
of 1,042 who had died). Of the 350, 32 were clinically demented 
and sufficiently detailed post-mortems had been undertaken to 
allow a re-evaluation of the cerebral sections to be made. The 
pathological diagnosis of AD was made on the basis of "abundant” 
NFTs and SPs in the hippocampus and neocortex. Of the 32 
patients, 23 had these features (72%). The remainder had 
evidence of vascular disease, subdural haematomata and 
hydrocephalus. The high proportion with AD at post mortem was 
surprising as the criteria for inclusion in the study were not 
those of DAT but of dementia in general. Twenty-six of the 32 
were in chronic care facilities which may have acted as a source 
of bias in that patients with dementia of the Alzheimer type may 
have been over represented by being more often referred for post 
mortem by their families. Also, cerebral sections were more 
likely to have been made when a diagnosis of AD was suspected
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clinically and where other causes of dementia had been ruled out 
at general macroscopic examination of the brain.
Roth's (1955) criteria (to be discussed in detail in 
Chapter 3.1) were employed by Wade et al (1987) who studied 65 
patients of whom 39 had a clinical diagnosis of DAT. Additional 
information was obtained from a Computed Tomography (CT) scan and 
the Hachinski score. The other patients consisted of those with 
diagnoses of multi infarct dementia (MID), mixed dementia and 
’’other types” of dementia. The ischaemic score was found to be 
less than four in 35 of 38 cases of neuropathologically confirmed 
AD.
Alafuzoff et al (1987) employed multivariate data analysis 
and principal component modelling to categorise histopathological 
and clinical variables in 55 demented patients. A
neuropathological score was computed to assess NFT and SP counts 
in the frontal lobe and anterior hippocampus. Combining these 
with measures of infarcts and perivascular protein deposits, 
specific histological criteria were applied. Of 32 patients 
with a clinical diagnosis of SDAT, 17 had neuropathological 
evidence of AD. Another finding of the paper was a non-linear 
relationship between the neuropathological features of mixed 
SDAT/MID and SDAT or MID. Thus, combined dementia was postulated 
to represent a distinct entity and not merely as part of a 
continuum between AD and MID. Of course, this may well have been 
an artefact of the complicated statistical analysis employed.
Homer et al (1988) reported on the results of 27 autopsies 
on a series of 400 patients with dementia admitted for 
investigation to St. George's Hospital, London. The patients were
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older than in other studies (range 70 to 94 years, mean 82 
years). The reasons for admission were not specified and it was 
not therefore clear whether the cases were atypical ie if there 
was sufficient doubt about the diagnosis the cases might not 
merit further investigation. Other possible sources of bias 
were not mentioned. A detailed list of investigations performed 
was presented in the paper. However, no criteria were given as 
to how the clinical diagnosis was reached. Of the 27 patients, 
13 were clinically diagnosed at DAT, ten as MID and four as 
"other” types of dementia. Only six of the 13 DAT patients had 
their diagnoses confirmed at post mortem. The Hachinski score 
was successful in discriminating between AD and MID in only 64% 
of cases. Likewise, the CT scan was, likewise, disappointing at 
discriminating between the two groups.
The study, because of its publication in a journal aimed at 
a general medical readership (The British Medical Journal), was 
an influential one. However, several methodological flaws must be 
discussed and have been outlined elsewhere (Burns et al, 1988). 
First, no clinical criteria were given. It was stated simply 
that, at a weekly multidisciplinary meeting, a consensus view was 
reached as to the diagnosis. From that information it is 
impossible to ascertain how a particular diagnosis was reached. 
Second, the patients represented only a tiny proportion of the 
total number of cases seen and so general conclusions cannot 
validly be drawn. Third, many of the patients had coexisting 
physical disease - some apparent clinically but some discovered 
only at post mortem. These patients would certainly not have
3b
satisfied the NINCDS/ADRDA criteria. Finally, an over- reliance 
on the Hachinski score and an idiosyncratic definition of some 
terms (such as preservation of personality defined as retention 
of insight) may have contributed to the diagnostic inaccuracy.
In a large retrospective study of 150 autopsies, Joachim et 
al (1988) examined the brains in a standardised way according to 
the pathological criteria suggested by Khachaturian (1985). The 
autopsies were referred from many sources, the only common links 
being 1) that the relatives had requested a post mortem and 2) 
that the clinical diagnosis in each case was DAT. Over 100 
physicians were responsible for the referrals. Remarkably, 87% 
of cases satisfied the neuropathological criteria for AD. In 
common with other studies reporting a relatively large number of 
patients, neuropathological findings other than those of AD were 
present. For example, patients with plaques only were included 
as AD, Lewy bodies in the substantia nigra were seen in 18% (in 
just over half of whom a separate diagnosis of Parkinson’s 
disease was justified) and amyloid angiopathy was seen in all 
cases of AD. Only 2% of the 150 cases had evidence of significant 
vascular disease, none of whom in addition fulfilled the AD 
criteria. In keeping with Homer et al (1988) and other studies, 
a small number of cases had insufficient neuropathological 
findings to account for the clinical syndrome of dementia. The 
authors concluded that:
1) physicians diagnosed AD with a high degree of accuracy;
2 ) degenerative changes in the substantia nigra and 
amyloid angiopathy were common accompaniments of AD and
3) vascular dementia was rare.
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The method of obtaining the material was not made clear in 
the paper. A comment in the discussion section suggested that 
brains were referred by other pathologists. Consequently, the 
centre must have acted as a specialist advisor for brains in 
which AD was suspected. Thus, a strong bias in favour of AD cases 
(where for example other causes of dementia had been ruled out at 
general post mortem) must have been present. Another significant 
source of bias was that relatives had specifically asked for post 
mortems in order to substantiate a clinical diagnosis of AD. Also 
the type of stain used (the Bielschowsky Silver Stain), was said 
to be more sensitive than other stains in common use. These 
sources of bias are not discussed.
Some studies have employed the same current strict clinical 
criteria for the diagnosis of DAT employed in the present study 
(McKhann et al, 1984). Morris et al (1987) reported the 
cerebral biopsy results on 11 patients who had undergone 
intraventricular bethanacol infusions. Biopsies were taken from 
the frontal lobe at the time of insertion of the canula. All 
patients satisfied the pathological criteria for AD while none of 
the nine control patients had any evidence of AD. The mean SP 
count correlated with dementia in the expected direction, with 
tests of language and on the Mini Mental State Examination (ie 
more severe impairment, more SPs). NFT counts were not included 
in the correlations as they were rated on a four point scale of 
severity rather than on actual counts. The authors concluded 
that aphasia had been confirmed as a bad prognostic feature in 
DAT, whether it was measured against histopathological severity
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or diminished survival (the latter as in the studies by Kaszniak 
et al, 1978, Berg et al, 1984). The lack of correlation between 
memory scores and neuropathology was explained by the 
universality of amnesia in DAT. Thus, a suitable range of scores 
would not be obtained. On the other hand, language disorder was 
more preserved and so a sufficient range of scores could be 
obtained. One possible conclusion to be drawn from the results 
was that the only point they had demonstrated was a relationship 
between language and pathology in the left frontal cortex. The 
paper gives three reasons against acceptance of this conclusion:
1) that a relationship between global severity as measured by the 
MMSE and SP count, was noted;
2 ) although cross region plaque counts did vary, they did so only 
in early disease and therefore would not be expected in the 
patients seen and
3) language deficits are traditionally associated with posterior 
cortical pathology.
Martin et al (1986, 1987) studied 26 patients, all of whom 
satisfied the NINCDS/ADRDA criteria. The study was particularly 
interesting in that 17 of the 26 cases had been diagnosed early 
in the course of their illness. Although all cases satisfied 
neuropathological criteria for AD, additional features were 
found. Four patients had no NFTs in the neocortex, features of 
Parkinson’s Disease (Lewy bodies) were seen in 38% and some 
degree of infarction was present in the brains of over one-third 
of the cases.
Boiler et al (1989) used a different method to assess the 
accuracy of predicting AD neuropathology. The case notes of 54
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patients in whom autopsies had been performed were subjected to 
an independent analysis by two neurologists. They used a check 
list derived from the NINCDS/ADRDA criteria to categorise 
patients as probable or possible DAT. Three groups were 
studied-the first group consisted of 12 patients assessed in an 
Alzheimer’s Disease research centre, the second of 28 patients 
seen in a geriatric or psychogeriatric setting and the third 
group of 14 patients in other institutions, not all of whom had 
been assessed by a neurologist. In each of the three groups the 
percentage of cases in which both neurologists successfully 
predicted AD neuropathology were 75%, 57% and 57% respectively. 
When at least one neurologist was correct, the "success rate" 
increased to 83%, 61% and 71%. Total agreement on the diagnosis 
of DAT was reached only in 63% of cases and partial agreement 
in 80%. The authors concluded from these findings that the 
aetiology of dementia could not be predicted accurately during 
life. However, for each observer, the "success rate" was 85% and 
95% respectively, tending to validate the NINCDS/ADRDA criteria. 
The authors pointed out that, although the group followed most 
intensively during life (group 1) had the lowest percentage of 
misdiagnoses (16%), the group about which least was known (group
3) were misdiagnosed in 21% - statistically, not a significant 
difference. This conclusion is in keeping with Muller and 
Schwartz (1978), Kokmen et al (1987) and Joachim et al (1987), 
who showed that physicians were generally accurate at predicting 
AD during life. Boiler et al (1989) suggested, rather 
contentiously, that detailed clinical and radiological
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investigations were not necessary for the improvement of routine 
clinical diagnosis.
Tierney et al (1988) specifically tested the NINCDS/ADRDA 
guidelines in a clinical pathological study. 57 cases, 22 with 
a clinical diagnosis of DAT and 35 suffering either from another 
type of dementia or with no dementia, were analysed using nine 
different neuropathological criteria. The analyses consisted of 
any combination of three inclusion criteria and three exclusion 
criteria. The inclusion criteria were:
1) one or more NFTs and SPs in the hippocampus, regardless of 
neocortical findings;
2) one or more NFTs and SPs in both the hippocampus and 
neocortex and
3) one or more NFTs or SPs in the neocortex, regardless of the 
findings in the hippocampus.
Exclusion criteria were:
1) ischaemic lesions of greater than 50 mis;
2 ) any ischaemic lesion anywhere in the brain and
3) any ischaemic lesion in the neocortex, white matter or 
hippocampus.
Combinations of the inclusion and exclusion criteria were 
tested, against the clinical diagnoses, for accuracy, sensitivity 
and specificity . Accuracy varied between 81% and 88%.
Sensitivity (ie the number of clinical AD cases classified 
pathologically as AD) varied between 64% and 86%. The best 
classification occurred with inclusion criterion 1 (NFTs and SPs 
in the hippocampus only) and exclusion criterion 1 (ischaemic 
lesions of greater than 50 mis). The specificity of the criteria
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(ie the percentage with neither a clinical diagnosis of AD nor a 
neuropathological one) was high and showed little variability 
across combinations of criteria (89% to 91%).
There was no difference in the classifications using 
inclusion criterion 2 (requiring both hippocampal and neocortical 
lesions) and inclusion criterion 3 (requiring neocortical lesions 
only) as in all cases where neocortical lesions were found, 
hippocampal lesions were also present. However, hippocampal 
lesions occurred without neocortical ones. The main conclusion 
of the paper was that the NINCDS/ADRDA criteria had been 
validated against a wide range of neuropathological features.
Jellinger et al (1989) reported on a large series of 440 
consecutive autopsies of patients clinically diagnosed as 
demented, drawn from subjects in a psychiatric hospital, a 
geriatric hospital and a general hospital. The aim of the study 
was to "validate the clinical diagnosis” made by DSM IIIR, ICD 10 
and the NINCDS/ADRDA criteria but no further information was 
given as to how this was done. Of 382 patients in whom DAT was 
diagnosed, 315 (82.6%) satisfied neuropathological criteria for 
AD. As the report was presented as an abstract, the lack of 
detail makes interpretation of the results difficult .
Ettlin et al (1989) assessed the accuracy with which SDAT 
and MID could be diagnosed during life. Thirty-two cases with 
autopsy proven AD, MID or a combination of the two were included 
in the sample. A retrospective analysis of clinical features 
during life revealed that AD was correctly predicted in 80% of 
cases - the clinical features, CT and EEG all being equally
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useful in the diagnostic process. In MID, clinical features were 
the most successful at correctly predicting neuropathological 
findings - the CT and EEG were unhelpful. Mixed cases were 
diagnosed most successfully in the same way as MID - it was not 
possible to differentiate the two ante mortem. The study can be 
criticised on two counts - (1) the sample consisted of only 32 
cases (which represented only a sample of 50 cases which came to 
post mortem) and (2) the study was dependent on the retrospective 
analysis of case notes.
Finally, Blessed (1989), reviewed the experience of the 
Newcastle group from 1963 to 1977 with regard to clinico- 
pathological correlations. A total of 50 cases in whom a 
clinical diagnosis of senile dementia, SDAT or AD was given had 
post mortem examinations. All but seven were diagnosed as AD at 
post mortem. Blessed noted that when patients with parietal lobe 
signs (apraxia, aphasia or agnosia) were assessed at post mortem, 
every case had AD. The report was not primarily concerned with 
clinico-pathological correlations but its main purpose was to put 
all the clinico-pathological studies into perspective. The main 
achievement of the work was to confirm that correlations existed 
between the clinical features of psychiatric disorders and 
neuropathological and neurochemical changes. Although correct 
prediction of subsequent pathology by the application of certain 
clinical criteria was not the main function of the studies, they 
clearly showed that Roth’s (1955) definition of SDAT was valid.
It should be noted that the neuropathological diagnosis of 
Alzheimer’s disease varies slightly from study to study. The 
basic requirements of NFT and SP in the cortex and hippocampus
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are always met but differences occur in relation to the numbers 
involved and the stains used to assess their presence. As can be 
seen from Table 1.2, the numbers of NFT and SP required for the 
diagnosis varies from "any" (Neary et al, 1986) to "extensive" 
(Perl et al, 1984). All studies mention histological changes in 
the neocortex as being a prerequisite for the diagnosis (although 
one report confined this to the frontal lobe, Alafuzoff et al, 
1987) but not all include changes in the hippocampus as being 
essential.
Some authors have attempted to formalise neuropathological 
criteria eg Khachaturian (1985), Ball et al (1987). Others have 
simply described their methodology which has later been taken up 
by others eg Blessed et al (1968), Tierney et al (1988). 
Wisniewski et al (1989) surveyed the diagnostic practices of 
neuropathologists in the USA and Canada. The majority reported 
that they used quantitative (or semi-quantitative) methods of 
analysis. However, wide variation occured in relation to the 
stains used with half using Bielschowsky or thioflavin S staining 
while the others concentrated on amyloid or silver stains. As 
the former are generally more sensitive to the presence of 
lesions, any quantitative judgement of neuropathology must take 
into account the stain employed. (A detailed description of the 
neuropathology of Alzheimer’s disease is outwith the scope of 
this thesis but is mentioned here for the sake of completeness 
and to add a note of caution to the interpretation of clinico- 
pathological studies.)
1.5 SUMMARY
The correct diagnosis of Alzheimer’s disease is a two stage 
process - first, the diagnosis of a dementia syndrome and second, 
the selection of cases in whom Alzheimer’s disease is likely to 
be histologically proven. Strictly speaking, Alzheimer’s disease 
is a neuropathological diagnosis, the clinical equivalent of 
which is Dementia of the Alzheimer type or, when dealing 
specifically with an elderly population, Senile Dementia of the 
Alzheimer type. The most rigorous clinical criteria for the 
clinical diagnosis of Alzheimer’s disease are those of the 
National Institute for Neurological and Communicative Disorders 
and Stroke and the Alzheimer’s Disease and Related Disorders 
Association (NINCDS/ADRDA). They have evolved from other 
clinical criteria and have been consistently shown to be highly 
accurate. Non adherence to such criteria leads to considerable 
diagnostic inaccuracy.
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CHAPTER 2
HETEROGENEITY IN SENILE DEMENTIA OF THE ALZHEIMER TYPE
2.1 INTRODUCTION
The purpose of this chapter is to present evidence 
(clinical, genetic and neuropathological) to support the 
hypothesis that DAT is a heterogeneous disorder. Amongst 
patients suffering from DAT, there appear to exist distinct 
subtypes of the disease, each with a different clinical 
presentation and natural history despite sharing a common 
pathology. That subtypes of DAT exist has been known for some 
time and the neuropathological differences between senile and 
presenile dementia were noted by Alzheimer (1911). Merritt 
(1955) recognised that the disease duration varied enormously -
" the duration of the disease is usually between four and 10
years, with extremes varying from less than one year to more than 
20 years”. Different clinical presentations have been observed, 
each with its own symptom complex. Karnosh and Zucker (1945) in 
their ’’Handbook of Psychiatry” describe the following 
presentations: ’’Simple deterioration, depressed/agitated, 
delirious/confused, paranoid and presbyophrenia” (excited and 
over-active). More recently, phenomenological subtypes have been 
recognised by DSM IIIR (see Chapter 1). This chapter will deal 
predominantly with results from cross sectional studies. Chapter 
3 will address longitudinal changes and will examine survival in 
more detail. (Some cross referencing across the two chapters and 
within individual sections is inevitable because of the diverse
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nature of the material with which some papers deal.)
Whether or not there are subtypes of a number of psychiatric 
disorders has been debated for some time with regard to 
depression and schizophrenia. The problem cannot be resolved 
completely because, as yet, no criteria exist which define 
unambiguously where a subtype of a particular disorder may be 
regarded as present. Theoretically, two forms of subtype may be 
defined - qualitative and quantitative (Jorm, 1985).
Qualitative subtypes can be said to exist when an 
aetiological factor acts independently on the core disorder to 
produce a subtype characterised by additional symptoms (eg 
aphasia occurring as an additional cognitive deficit in a 
dementia syndrome characterised primarily by amnesia).
Qualitative subtypes can be difficult to evaluate for three 
reasons. First, the aetiological factor must be strongly related 
to the subtype or it would have few implications for treatment or 
prevention. Second, if the primary symptom of the subtype is a 
continuous variable (and represented by, for example, a shift on 
a test for aphasia) and the aetiological factor is dichotomous 
(eg the presence or absence of a particular gene) then bimodality 
in the distribution of a test score for aphasia may be present. 
Bimodality may indicate the presence of subtypes but if two 
normal distributions (each representing a subtype) are not widely 
separated or if the sample sizes are different, then bimodality 
would not appear. Alternatively, bimodality may be present if 
another dichotomous variable (not aetiologically related to the 
subtype) such as gender bears an influence on the aphasia score.
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Third, in a progressive disorder such as DAT, cross sectional 
studies may include patients with both early and late stages of 
the disease. Thus, the aphasia may not indicate the presence of a 
true subtype.
Quantitative subtypes are present if two aetiological 
factors (such as a gene and head injury) have an additive 
influence on the disorder. Thus, if both factors were present 
the disorder would be more severe.
These subtypes are theoretical and as Jorm (1985) points 
out, no studies have been done which prove conclusively the 
existence of either category of subtype. Only when definite 
biological markers of the disease have been elucidated can this 
be done, as in the case of Duchenne and Becker Muscular 
Dystrophy. However, clinical studies are able to indicate whether 
subtypes may be present.
2.2 AGE OF ONSET
Seltzer and Sherwin (1983) examined the distinction between 
early and late onset DAT. Of their 65 male patients, all of whom 
satisfied DSM III criteria for Primary Degenerative Dementia 
(PDD, equivalent to a diagnosis of DAT), 34 were deemed to have a 
age of onset less than 65 years of age and 31 an onset older than 
65 years. They examined the prevalence of a number of clinical 
features in the two groups. The younger onset group had 
significantly poorer scores on tests of language, a higher number 
of left-handers and a shorter survival time compared to the older 
onset group. They had a tendency to be more apraxic but this did 
not reach statistical significance. No significant differences
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between the two groups were found for the proportion with 
seizures, personality change or the neurological signs of 
increased tone and primitive reflexes. The authors postulated 
that this heterogeneity was due to a genetic predisposition 
leading to an early age of onset and left hemisphere dysfunction 
- the latter resulting in language disturbance. The higher 
proportion of left handers in the younger group was regarded as 
an indication of right hemisphere damage. The authors argued 
that this did not confound their hypothesis because first, 50% of 
them would have left hemisphere dominance despite being left 
handed, and second, the higher than expected number of left 
handers suggested prior damage to the left hemisphere favouring 
development of the right hemisphere and so left handedness. This 
genetic theory, although plausible, is not supported by any 
information on family history of dementia.
Heyman et al (1987) further investigated the early/late onset 
dichotomy when reporting the results of a longitudinal study on 
92 patients with early onset DAT (mean age 62.4 years). Almost 
all were seen for at least two years and 13 were followed for six 
years. Clinical features were examined which were predictive of 
two predetermined * end points * - institutionalisation and death. 
The five year mortality rate was 2.5 times greater than would 
have been expected in the normal population. Complex statistical 
models were applied to estimate the relative contribution of 
cognitive impairment to institutionalisation and death. It was 
found, not surprisingly, that greater impairment was a 
significant factor in predicting both institutionalisation and
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death. Age had a significant modifying effect - younger patients 
were at greater risk of institutionalisation and death than older 
patients with the same degree of cognitive impairment. That many 
factors influence admission to nursing homes was recognised by 
the authors (indeed ten of the 54 patients were admitted because 
of death or serious illness in the responsible caregiver). Also, 
the young age of the sample may also have influenced reasons for 
admission. Thus, unmeasured factors may have resulted in 
institutionalisation. Death was obviously less likely to be 
influenced by social factors and represents a more robust 
biological measure of the severity of the disorder (although 
patients die from causes other than the direct effect of their 
DAT) .
Mayeux et al (1985b) examined the case records of 121 
patients satisfying DSM III criteria for PDD to determine whether 
clinical subgroups existed. Age of onset showed a bimodal 
distribution with a point of rarity at age 70 years. The young 
group was characterised by severe cognitive impairment and a 
greater proportion exhibiting myoclonus. The authors noted that, 
although they had demonstrated bimodality in age of onset, this 
factor was not definitive evidence for subgroups.
Chui et al (1985) performed a cross-sectional analysis of 
146 patients satisfying DSM III criteria for DAT in an attempt to 
define clinical subtypes. In addition to the information sought 
by Mayeux et al (1985b), they noted whether or not a family 
history of dementia was present or not and examined aphasia in 
more detail. The mean age of their sample was slightly older than 
that of Mayeux et al (1985b) - 73 years compared to 69 years. A
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family history was present in 45% of the total (families with 
inadequate information or where first degree relatives failed to 
survive to an age comparable to the patient’s age of onset were 
excluded). Aphasia was present in 60% of patients. Patients in 
whom symptoms started before age 65 had a longer duration of 
illness and more had aphasia than the late onset group. The 
authors recognised that the increased proportion with aphasia in 
the younger group may have been due to their longer duration of 
illness. However, when subsamples of young and old patients with 
comparable duration of illness were compared, aphasia remained 
more common in the younger group.
Patients with a family history of dementia did not differ 
from those without on all variables, with two important 
exceptions. First, agraphic subjects were more likely to have a 
family history of dementia (confirming earlier work by Breitner 
and Folstein, 1984). Second, there was a trend showing a 
positive relationship between the presence of aphasia and family 
history (in keeping with the work of Selzer and Sherwin, 1983). 
However, no increased prevalence of left handers in the early 
onset group was observed. Patients with extrapyramidal signs and 
myoclonus were more severely demented. This finding concurred 
with earlier work by Mayeux et al (1985). Chui et al (1985) 
tentatively concluded that there were subtypes of DAT in view of 
the association between early age of onset and aphasia. However, 
the lack of longitudinal data detracts from their conclusions.
Filley et al (1986) examined neuropsychological test 
results on 23 patients with early onset DAT (mean age 57
years) and 18 patients with late onset DAT (mean age 70 years), 
all of whom satisfied DSM III criteria for DAT. The tests were 
divided broadly into those assessing memory, language function 
and visuo-constructional ability. Although the two groups were 
similar for overall impairment of cognitive function and memory, 
significant differences existed in the other tests. Language 
impairment was significantly greater in the early onset group, 
confirming the earlier work by Chui et al (1985) and also Seltzer 
and Sherwin (1983). Visuo-constructional performance was worse 
in the late onset group. By extracting standardised scores and 
comparing relative impairments on language and visuo- 
constructional performance, the differences between the two 
groups were even greater. The authors concluded that left 
hemisphere damage characterised early onset DAT and that right 
hemisphere damage was responsible for the impairments seen in 
late onset DAT. Only one patient in each group was left handed 
and, when they were excluded from the analyses, the reults were 
unchanged. The authors argued that their results suggested 
clinical variability in early and late onset DAT but showed no 
evidence of distinct disease entities. A follow-up study would 
be required to explore the possibility that subjects progressed 
to develop additional neuropsychological deficits.
Grady et al (1987) assessed both neuropsychological function 
and regional cerebral metabolism in subjects with early and late 
onset DAT. The 34 patients (early onset N=21, late onset, N=13) 
were diagnosed according to NINCDS/ADRDA criteria and both 
’’probable" and ’’possible" cases were included. Each subject 
underwent an extensive neuropsychological battery including the
Welscher Adult Intelligence Scale (with additional assessments of 
aphasia and visuo-perceptual function) and an 18F Deoxyglucose 
Positron Emission Tomography scan. In addition, 21 were assessed 
longitudinally for an average of 19 months. There were no 
significant differences in the neuropsychological profiles 
between the early and late onset groups at entry to the study, 
the rate of decline in each being almost identical. The authors 
concluded that they did not find heterogeneity based on age of 
onset. They argued that the findings of Mayeux et al (1985b) 
could be explained in terms of differing disease severity, not 
subtypes, and that their own results were more persuasive as they 
had the benefit of longitudinal data. Although the study of 
Grady et al (1987) was well executed and the neuropsychological 
battery impressive, the numbers involved were small (N=26 for the 
follow up) and should be regarded as preliminary findings 
requiring replication.
2.3 NEUROPSYCHOLOGICAL FUNCTION
McDonald (1969) was among the first to address specifically 
the question of heterogeneity in SDAT based on neuropsychological 
tests. The study was in two parts. In the first, 51 patients 
completed five scales as a measure of cognitive function - 
memory, parietal, abstract thinking, aphasia and colour/shape 
sorting (Weigl). When the distribution of error scores was 
examined, the parietal and Weigl scores had a bimodal 
distribution. The former scale was chosen for further examination 
because the distribution was more evenly weighted between success
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and failure. The group was divided into low error scorers (up to 
one error, group B) and high error scorers (two or more errors, 
group A). The mean ages of the groups was 81 and 79 years 
respectively. The author argued that the results indicated the 
low error scorers did not simply precede high error scorers in 
the natural history of the condition.
In the second part of the study a different sample of 57 
patients was divided into two groups according to their scores on 
the same five cognitive tests. Their six month mortality was 
compared. Twenty-six percent of the high error group (mean age 76 
years) had died compared to 4% of the less impaired group (mean 
age 83 years). Thus, the group who were less impaired on the 
parietal test were older and survived longer than those more 
impaired. McDonald (1969) postulated that there were two 
different types of senile dementia, a younger group with a poor 
prognosis and an older group with a better prognosis. He argued 
that this latter group may be related to the the concept of 
"benign senescence” as described by Krai (1962). Although 
McDonald (1969) presents some evidence to support qualitative 
subtypes in SDAT, the absence of longitudinal data on cognitive 
decline makes it impossible to draw definite conclusions. If, 
for example, the less impaired group developed high error scores 
on the parietal scale over time, this would suggest the subtypes 
were quantitative rather than qualitative. The fact that those 
who were less impaired were older does not necessarily mean that 
they were qualitatively different. A differential age of onset 
could explain the differences in terms of quantitative subtypes.
Further evidence for neuropsychological heterogeneity was
52
presented by Martin et al (1986). They analysed the results of 
six neuropsychological tests (three assessing non-verbal 
abilities and three assessing verbal abilities) in 42 patients 
satisfying the NINCDS/ADRDA criteria (McKhann et a l , 1984). A 
principal components analysis revealed two separate cognitive 
profiles - one with high loadings on non-verbal tests (visual 
perception and construction) and another with high loadings on 
verbal tests (mainly word finding ability). There was no 
significant correlation between the verbal and non-verbal 
tests which confirmed that they represented discrete categories.
A cluster analysis revealed five subgroups. Three were defined 
as showing global impairment (mild, moderate and severe, N=25) 
with similar degrees of deficits between the two factors. The 
fourth group (N=9) showed word finding difficulty with relative 
preservation of visuo-constructive performance while the fifth 
(N=8) had a test profile the mirror image of the fourth group 
with more pronounced visuo-constructive deficits. There was no 
difference in the five subgroups with regard to age of onset or 
symptom duration. The graphical display of the results was very 
impressive and showed clear differences in the groups. The 
conclusion was made that qualitatively different profiles of 
cognitive impairment and cortical metabolism existed in DAT and 
thus subgroups had been demonstrated.
The authors cautioned that the evidence for subgroups was 
strong enough to cast doubt on the common practice of averaging 
data across groups of DAT or SDAT patients on the assumption that 
they shared a common diagnosis (inferred from a presumed common
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neuropathology). They warned that this was erroneous and could 
serve to hinder neuropsychological research in the field.
Freed et al (1989) investigated picture recognition in 20 
patients with DAT and assessed delayed recognition (72 hours 
after initial testing) and attentional focusing (the 
difference in reaction time between a cued and uncued stimulus).
A subgroup of patients (N=10) was found to show impaired 72 hour 
recognition and to have impaired visual selective attention.
Based on animal models, the authors associated this finding with 
lesions in the ascending noradrenergic system of the locus 
coeruleus. While the results of this study were interesting and 
provided evidence that cognitive subtypes exist, it should be 
noted that the cognitive tests used were complicated and, to a 
certain extent experimental, all of which raises questions both 
about their validity and usefulness in clinical practice.
2.4 PSYCHIATRIC SYMPTOMS
Psychiatric symptoms have received very little attention 
compared to the cognitive changes which occur in DAT. Alzheimer’s 
first case in which delusions of jealousy and hallucinations were 
prominent (Alzheimer, 1907) has already been described (Chapter 
1.1). Psychiatric symptoms are of importance in the study of DAT 
for two main reasons. First, the strain on carers is directly 
related to their presence (Rabins et al, 1982). Second, and most 
germane to the present study, is that their presence may indicate 
subtypes of the disorder.
Descriptions of psychiatric symptomatology in DAT can be 
divided into two temporal categories - those before and those
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after the mid-1970,s. Early studies relied on substantially 
anecdotal reports from clinical observers, usually in small and 
unrepresentative samples of patients (eg young patients 
referred to hospital for assessment). Later, instruments of 
proven validity and reliability were used to assess symptoms in 
more representative groups of patients.
Henderson and MacLachlan (1930) reported four female 
patients (mean age 57), only one of whom was without psychotic 
features. Of the other three, one had hallucinations (type 
unspecified), one paranoid delusions and the third had both. 
Goodman (1953) noted that in his 23 autopsy proven AD cases that 
"...hallucinations frequently occurred", visual being the 
most common type. Paranoid delusions "were fairly common early 
in the disease" and most were of a simple, unsystematised type.
Ziegler (1954) found in his sample of 40 psychiatric 
patients with idiopathic atrophy on pneumoencephalography, that 
15% were "paranoid", 15% were "depressed" and the sample 
proportion had "neurotic" symptoms". However, although quoted in 
many articles as indicative of the prevalence of psychiatric 
symptoms in DAT (eg Liston, 1979), it is uncertain how many of 
these patients were suffering from primary dementia. Sim and 
Sussman (1962) reported on 46 patients referred to a department 
of psychological medicine, 22 of whom had AD diagnosed by 
cerebral biopsy. They reported that in this group, depressive 
symptoms occurred early in the disease and tended to disappear as 
the dementia became more severe; also that "psychotic" features 
(not further defined) were a late manifestation. "Agitation" was 
present in 29% . Coblentz (1973) examined ten subjects with
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histologically confirmed AD and described five as "agitated” and 
two with psychotic features.
Gustafsson and Hagberg (1975) studied 57 patients with pre- 
senile dementia. Extensive psychiatric assessments were 
performed on the patients and 50 had cerebral blood flow assessed 
by Xenon-133. Seven factors were described based on a factor 
analysis of a standardised psychiatric interview - ixophrenia (an 
emotionally charged "clinging" attitude), depression, explosive 
temper, hypochondriasis, paranoia, psychomotor overactivity 
(euphoria and affective liability). Associations were 
described between the presence of these symptoms, regional 
cerebral blood flow and severity of dementia. Ixophrenia, 
depression and hypochondriasis were all found in subjects with 
mild dementia and relatively normal cerebral blood flow, 
although the first two were associated with slightly reduced 
flow. As such, these three symptoms were considered as 
"compensatory" (both psychologically and physiologically) for 
mild impairment of cerebral function, but also possibly related 
to pre-morbid personality characteristics. Affective lability, 
explosive temper and overactivity were associated with severe 
cognitive impairment and were designated as signs of 
disinhibition related to low frontal blood flow. Paranoia was 
said to be present at all levels of cognitive impairment - in 
mild dementia it was considered a psychological reaction to 
diminished comprehension of the environment and in the later 
stages, the result of direct brain damage. The authors stated 
that blood flow studies appeared to confirm this with high
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frontal flow in the early stages, reducing in the later stages. 
Gustafsson and Hagberg (1975) were the first to describe an 
association between blood flow and particular symptoms which went 
some way towards the elucidation of subtypes ie different 
clinical manifestations (with different symptom complexes) were 
associated with pathophysiological markers (alterations in 
regional cerebral blood flow).
More recent work has used standardised and reproducible 
measures of assessing phenomenology Three main types of 
psychiatric phenomena have been defined (Lancet, 1989) - 
disorders of thought content (delusions and paranoid ideation), 
disorders of perception (hallucinations and misidentifications) 
and disorders of affect (depression and elevated mood).
The importance of non-cognitive symptoms in dementia from a 
heuristic point of view has been discussed by Berrios (1989). He 
cites four possible explanations for the occurrence of such 
symptoms - the presence of an intercurrent delirium, cortical 
disinhibition, the pathoplastic effects of personality and the 
coexistence of two mental disorders. Berrios (1989) states that 
patients with prominent non-cognitive symptoms represent a 
subgroup of DAT subjects but he did not go as far (as would have 
seemed logical to do) as to suggest that they were representative 
of clinical subtypes of DAT.
Disorders of Thought Content
It is recognised that delusions occur in association with 
DAT. DSM IIIR has a separate category, subsumed under the main 
heading ’’Primary Degenerative Dementia of the Alzheimer Type”, 
for patients with delusions but no such subheading occurs in ICD
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10. Delusions are known to occur in patients with organic brain 
disease such as Huntington’s Disease (Dewhurst, 1969) and post­
encephalitic Parkinsonism (Fairweather, 1947). Regional 
localisation has suggested an association between delusions and 
temporal lobe damage as in temporal lobe epilepsy (Toone, 1981) 
and Herpes Encephalitis (which preferentially affects temporal 
structures, Rennick et al, 1973). Schneiderian first rank 
symptoms of schizophrenia have also been related to temporal lobe 
atrophy (Trimble 1990). Idiopathic basal ganglia calcification 
has been implicated in the genesis of delusions (Cummings and 
Benson, 1983).
Attempts have been made to subclassify delusions associated 
with organic brain damage. Cummings (1985) suggested that they 
be divided into four types - simple persecutory delusions, 
complex persecutory delusions, grandiose delusions and those 
delusions associated with specific neurological deficits. He 
identified delusion ideation in a prospective study of 20 male 
patients with organic disorders, four of whom had DAT 
(representing 15% of all DAT subjects seen in the service). 
Patients with mood congruent delusions were excluded. Simple 
delusions were confined to subjects with DAT or vascular dementia 
while the other delusions occurred in patients with a variety of 
neurological disorders such as tumours and encephalopathies. It 
was found that those with simple delusions were more cognitively 
impaired than those with any of the other three types. Cummings 
(1985) also made the practical observation that simple delusions 
were more responsive to neuroleptic medication than complex
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delusions.
Cutting (1987) followed Cummings * (1985) scheme in an 
attempt to classify delusions in 74 patients with acute organic 
psychoses, 35 of whom were deluded. He was able to classify 
only seventeen patients according to the Cummings (1985) 
classification - eight with simple persecutory delusions and nine 
with mood congruent delusions (this category replacing that of 
grandiose delusions as described by Cummings, 1985). Seventeen 
of the remaining 18 were afforded a separate category described 
as "complex, bizarre or multiple". This category was similar to 
the "complex persecutory" delusions described by Cummings (1985). 
In addition, one patient had a delusion "based on a specific 
neuropsychology deficit" (a phrase employed by Cutting to 
describe the concept suggested by Cummings).
There have been some studies specifically assessing the 
frequency with which delusions occur in DAT. Cummings et al 
(1987) defined both delusions and DAT using DSM III criteria.
They found that delusions had occurred, since the onset of 
illness, in 14 out of 30 DAT subjects (average age 70.4 years) 
and that there was a trend (not statistically significant) for 
these patients to be less cognitively impaired. Although well 
characterised, the sample had only 30 subjects who were referred 
from a variety of sources (out-patients or inpatients, geriatric, 
psychiatric or neurological) and thus cannot be considered to be 
a representative population of DAT subjects. Rubin et al (1988) 
found 31% of their sample to be deluded, the commonest type of 
delusion being that of stealing (which would have been in the 
"simple persecutory" category of Cummings, 1985). Although, in
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comparison to the sample of Cummings et al (1987), the number 
studied was large (N=110), there was no definition of delusions. 
It can be inferred from the paper that the patients were 
diagnosed by a number of investigators, thus reducing the 
reliability of the results.
Berrios and Brook (1985) reported delusions in 37% of 100 
demented patients referred to an out patient clinic. Twenty 
three of 68 patients with DAT were diagnosed as deluded. These 
subjects scored less than the non-deluded patients on the 
information, but not on the memory subscale of the Blessed 
Dementia Scale (BDS, Blessed et al, 1968). Patients with both 
vascular dementia and DAT were included and it seems likely that 
some of the subjects had an intercurrent delirium at the time of 
examination. Also, 14 of the 37 deluded subjects had an 
additional diagnosis of a functional illness. This factor raises 
the suspicion that they had a previous psychiatric disorder, 
thereby casting doubt on the diagnosis of DAT.
Common delusional themes include delusions of abandonment 
and impostering (Reisberg et al, 1987), suspicion and stealing 
(Rubin et al, 1988; Berrios and Brook, 1985; Cummings et a l , 
1987). None of these studies divided delusions in DAT into the 
subtypes described by Cummings (1985) and Cutting (1987).
Clues to the pathological substrate of delusions come from 
two lines of evidence. First, delusional ideation seems to 
require relatively intact cerebral function. Jacoby and Levy 
(1980,a) and Gustafsson and Risberg (1974) found delusions to be 
inversely related to the cerebral atrophy and to cortical
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perfusion respectively. Second, delusions have been associated 
with basal ganglia calcification (Cummings, 1985). There appears 
to be no difference in the prevalence of delusions in patients 
with vascular or degenerative dementia (Berrios and Brook, 1985; 
Cummings et al, 1987) suggesting that they are not specific to a 
particular pathological process but that they result from brain 
damage of diverse aetiology, perhaps localised to particular 
brain regions.
Paranoid ideation, held without delusional intensity, has 
not been examined specifically in DAT although Reisberg et al
(1987) described 21% of his sample as exhibiting "paranoia" (not 
further defined). Merriam et al (1988) found 42% to have 
paranoid ideation "of a relatively minor nature" and 56% to have
"more severe paranoid symptoms". It may be that the former
finding represented paranoid ideation and the latter delusions, 
but this conclusion cannot be made with certainty. The relatively 
high rates suggest that some difference in definition is present 
or that a very biased sample has been studied. No definitions of 
the symptoms were given and the sample was drawn from patients
referred to a neurology clinic and, as stated in the paper, not a
clinic dealing particularly with psychiatric or behavioural 
problems. These factors make the high proportion of patients with 
psychopathology even more surprising. Most studies lack a 
precise definition of delusions (with the exception of Cummings 
et al, 1987) so it is possible that some patients have paranoid 
ideation which has been wrongly equated with ideas held with 
delusional intensity and vice versa. The absence of operational 
criteria for the diagnosis should be borne in mind when comparing
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different studies.
Disorders of Perception
Perceptual disturbances can be divided into two types (Fish, 
1985) - sensory distortions (changes in the intensity, quality or 
spatial form of perception) and sensory deceptions (illusions and 
hallucinations). Hallucinations occur in many psychiatric 
conditions such as schizophrenia, depression and acute organic 
psychoses (Cutting, 1987). Their presence in senile dementia was 
partly responsible for the condition being classified as a senile 
psychosis. There is a considerable French literature on 
hallucinations. Lhermitte (1951) noted that hallucinations (in 
particular visual hallucinations) occurred in elderly patients 
with atherosclerosis and cerebral atrophy. Henri Ey (Ey, 1973) 
observed that clinicians had long been familiar with the tendency 
for the aged to experience hallucinations especially those 
suffering from DAT though rarely in patients with Pick’s disease. 
Both authors mention the "Charles Bonnet syndrome” as an example 
of visual hallucinosis in the elderly. This syndrome has been 
well documented (Berrios and Brook, 1984; Damas-Mora et a l ,
1982). Characteristically, the sufferers have insight into their 
experiences, generally have poor vision, are not worried by the 
hallucinosis and remain cognitively intact which makes a 
misdiagnosis of dementia unlikely.
Several studies have reported the prevalence of 
hallucinations in DAT. For example, Sjogren et al (1952) 
reported a prevalence of 15%. More recently, Cummings et al
(1987), in addition to diagnosing delusions, assessed
6 2
hallucinations in their 30 DAT patients (average age 70.4 years) 
and 15 with MID. Of the DAT patients, only one had auditory 
and none had visual hallucinations; in MID, three experienced 
visual and one auditory hallucinations. The authors required 
that only those subjects reporting "a sensory perception” would 
be regarded as suffering from hallucinations. The patients were 
interviewed directly to ascertain whether hallucinations were 
present but information was also sought from the casenotes.
Three of the four patients with these experiences had visual 
defects. The association between this type of hallucinatory 
experience and ocular pathology has been described previously 
(Berrios and Brook, 1984). Clinical subtypes of DAT based on 
visual hallucinations, which do not take ocular pathology into 
consideration, cannot therefore be posited.
Reisberg et al (1987), in describing a new behavioural 
rating scale, found that 12% of their sample of 57 out-patients 
(mean age 75.0 years) had suffered visual hallucinations.
Auditory hallucinations were not mentioned. Merriam et al (1988) 
examined 175 subjects with DAT using the Schedule for Affective 
Disorders to assess depression and reported, incidentally, that 
28% had experienced either visual or auditory hallucinations. 
Similarly, Teri et al (1988) reported that in 127 out-patients, 
21% of subjects had hallucinations (type unspecified). There was 
a tendency (not statistically significant) for the proportion 
of subjects with these perceptual phenomena to be greater as 
severity of cognitive impairment increased.
The difference in frequency rates in various studies may be 
explained in three ways. First, the sample studied. Most
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reports from North America describe populations of patients 
referred to outpatient clinics or to AD research facilities.
There may be differences in referral procedure to each centre and 
the patient group may be biased in favour of subjects suffering 
from psychiatric problems. No reports have yet described the 
rates of psychiatric symptoms for an epidemiologically 
representative population. Second, the definition and method of 
ascertainment of symptoms. For example, Cummings et al (1987) 
used a very stringent definition of hallucinations and relied 
mainly on direct interview with the patient. By contrast, 
Reisberg et al (1987) relied solely on review of medical 
casenotes. Third, the periods of time to which the given rates 
refer. In the majority of studies, it is unclear whether the 
prevalence rates refer to symptoms occurring at any time since 
the onset of the illness or if they are reserved for symptoms 
present at the time of the examination.
The other main types of perceptual disturbance seen are 
misrecognitions and misidentifications which have been virtually 
ignored as symptoms of DAT. There have been a number of case 
reports in the literature of misidentification of relatives in 
dementia (some manifesting as the Capgras Syndrome, eg Burns and 
Philpot, 1987). Misidentification of mirror image has also been 
described and "Signe du miroir" is the term used to refer to 
patients conversing with their own image (Mayer Gross et a l ,
1960). Rubin et al (1988) described three types of
misidentification - imagining that other people were in the same
house, the inability of a subject to recognise his or her own
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image in a mirror and treating events or people on the television 
as if in real three-dimensional space. Rubin et al (1988) 
reported that 23% of their 110 patients had experienced at least 
one type of misidentification (the belief that others were in the 
house being the most common). Merriam et al (1988) described 
these as "perceptual" symptoms and found that 49% of the patients 
misidentified other people and 41% misidentified places. The 
study by Merriam et al (1988) is, again, unusual in the very high 
rates of symptomatology described (eg major depression was found 
in 86% of cases, vide infra) and so the number of patients 
experiencing these disorders of perception may be falsely high 
Delusions, misidentifications and hallucinations have been 
reported as being associated with an accelerated cognitive 
decline (Drevets and Rubin, 1989) and with a decreased death 
rate. Mayeux et al (1985a) reviewed the records of 62 patients in 
a longitudinal study and found that those with "psychosis” 
(inadequately defined as persistent or recurrent thought 
disorder) deteriorated more rapidly in both cognitive and 
functional abilities over time. Stern et al (1987) reported on 
the follow up of 55 patients in the study. They reported that 
the sudden onset of psychosis was associated with a rapid decline 
in one of the "benign" group (an intermittent delirium may have 
been present but there was no mention of it). Very little has 
been recorded as to the pathological substrate of perceptual 
symptoms. However, one recent preliminary report has suggested 
that in cortical Lewy body disease, cholineacetyltransferase 
activity is lower in patients who have experienced hallucinations 
than in those who have not (Perry et al, 1990).
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Disorders of Affect
The relationship between depression and DAT is particularly 
interesting in view of the occurrence of cognitive impairment in 
depression embodied in the concept of "pseudodementia" (Kiloh, 
1961; Rabins et al, 1984; Pearlson et al, 1989). The 
documentation of mood disorders in DAT and their relationship to 
cognitive impairment is another way in which to assess this 
complex relationship.
Follow-up studies from the 1960*s suggested that there was 
no increased incidence of primary dementia in subjects with 
affective disorder (Post, 1962; Kay 1962). However, more recent 
studies have cast doubt on this finding. Krai (1983) followed 22 
patients (for an average of eight years) diagnosed as having 
depressive pseudodementia and found that 20 of them had developed 
SDAT at follow up. Reding et al (1985) reported that, of 28 
patients with depression, 16 developed dementia over a three year 
follow up. Cerebrovascular, extrapyramidal or spinocerebellar 
disease and a Hachinski score of greater than four were found to 
be particularly associated with progression to dementia. It can 
be argued that the association between depression and the later 
occurrence of primary dementia has not been proven convincingly 
by these two papers. The patients described by Krai (1983) 
obviously had some cognitive impairment initially (they were 
diagnosed as having pseudodementia) and only five of the 16 
patients described by Reding et al (1985) developed SDAT - the 
others developed Parkinson*s dementia, cerebrovascular dementia 
or other types of dementia. Thus, the contention that
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uncomplicated depression gives rise to SDAT later in life is 
unproven. Retrospectively, a history of depression in DAT is 
described in 10% of patients (Agbayewa, 1986). This observation 
has recently been extended by Henderson et al (1989) who, in a 
case control study, found an increased number of episodes of 
depression in the previous ten years (but not before then) in 
patients with DAT. Whether this represents a risk factor for DAT 
or prodromal symptoms is not yet clear. No studies have yet 
assessed non-cognitive symptoms as the possible prodromata of 
dementia (Berrios, 1989).
Cross-sectional studies of the prevalence of depression in 
DAT are common but inevitably the results differ widely because 
of variations in the population under study and in the assessment 
instruments employed. In a recent comprehensive review, Wragg 
and Jeste (1989) reviewed 14 studies. These 14 studies plus an 
additional six papers (published after the literature search 
commissioned by Wragg and Jeste) are presented in Table 2.1.
Wragg and Jeste (1989) concluded that depression was more 
prevalent in DAT patients drawn from acute care facilities 
(compared to research clinics) and that depressive '’symptoms" 
were more common than depressive "disorders".
The prevalence of depression in DAT varies from between 0% 
(Knesevich et al, 1983; Cummings et al, 1987) and 86% (Merriam 
et al, 1988). The majority of studies have described a 
prevalence rate of between 20% and 40% (Liston 1979, Ron et al 
1979; Ballinger et al, 1982; Burke et a l , 1988). The method by 
which DAT was diagnosed was either by clinical impression (eg 
Bucht and Adolfsson, 1983) or adherence to standardised criteria
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(eg those of the NINCDS/ADRDA, McKhann et al, 1984, utilised by 
Rubin and Kinscherf, 1989 and McKenzie et al, 1989). In two 
studies, there was neuropathological confirmation of the 
diagnosis (Sim and Sussman 1962; Birkett 1972). Similarly, the 
diagnosis of depression was often clinically based (eg Nott and 
Fleminger, 1975) or adhered to one of the recognised diagnostic 
schemata (eg DSM III or Feighner criteria - employed by Reding et 
al, 1985 and Burke et al, 1988, respectively). Standardised 
depression rating skills were commonly used (eg the Hamilton and 
Zung Rating Scales - Knesevich et al, 1983 and Lazarus et a l , 
1987). Two recent studies have compared depressive 
symptomatology complained of by the patient to that observed by a 
relative or interviewer (McKenzie et al, 1989; Rubin and 
Kinscherf, 1989). Both found that observed depression was greater 
than reported depression.
Reifler et al (1982) noted that depression was more common 
in women and became less apparent as cognitive impairment 
increased. Cummings et al (1987) reported that major depression 
occurred in patients with an Mini Mental State Examination 
(MMSE, Folstein et al, 1975) score of 17 or above but not below 
this level. These authors suggested that although behavioural 
manifestations of depression (appetite loss, sleeplessness, 
crying) could be discerned in advanced dementia, symptoms such as 
anxiety and guilt could not be assessed so easily. This factor 
may explain the low rates of depression found in patients with 
advanced disease. However, Knesevich et al (1983) confined their 
studies to patients with early DAT and found no cases of
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depression. Lazarus et al (1987) assessed individual items on the 
Hamilton Depression Rating Scale. They found that patients with 
primary dementia scored higher on items assessing intrapsychic as 
opposed to vegetative symptoms. At first sight, this finding 
appears to contradict the view of Cummings et al (1987) but may 
be explained in terms of the sample studied by Lazarus et al
(1987). The latter authors compared the depressive phenomenology 
of demented patients with normal (ie non-depressed, non-demented) 
controls. Hence, no statement could be made regarding depressive 
symptomatology at different stages of DAT. In agreement with 
Reifler et al (1982), Lazarus et al (1987) found depression to be 
more common in women but reported no correlation between 
cognitive impairment and degree of depression.
The significance which individual authors place on 
particular symptom complexes is also variable. For example, 
Merriam et al (1988) reported the frequency of depression in 175 
community residents with DAT. They employed DSM III criteria to 
diagnose both depression and dementia and found that 87% of 
demented patients satisfied either criterion A (dysphoria) or 
criterion B (four out of eight symptoms which include biological 
features of depression, agitation, worthlessness and suicidal 
ideation) for major depressive disorder. 86% satisfied both 
criteria A and B (the unusually high proportion of patients 
affected with symptoms in this study has already been mentioned). 
Cummings et al (1987) applied these same criteria to diagnose 
depression but found no cases in their DAT sample. Thus, although 
some differences in prevalence of depression may be due to the 
population studied and assessment instruments employed, it is
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possible that individual interpretation by the authors of 
criteria (such as those in DSM III) is responsible for some of 
the differences seen.
A point which has never been discussed in the literature is 
that in DSM III (and DSM IIIR), a diagnosis of primary 
degenerative dementia of the Alzheimer type and major depressive 
disorder are mutually exclusive. In DSM IIIR, criterion E2 for 
primary dementia states that one can only assume that an organic 
factor is present in dementia if the disorder "...cannot be 
accounted for by any non-organic mental disorder, eg major 
depression". In the criteria for major depressive episode, 
criterion B1 states that the diagnosis of major depressive 
episode may be made if "...it cannot be established that an 
organic factor initiated and maintained the disturbance". 
Alternatively, "major depressive syndrome" may be diagnosed 
instead of major depressive episode (the former involves the 
presence of defined depressive symptomatology and makes no 
inference as to their origin). The point may seem like hair 
splitting but is an important one in that it perpetuates the 
confusion surrounding the association between depression and 
dementia. DSM IIIR does not allow the diagnoses of major 
depressive episode and of primary dementia of the Alzheimer type 
to be made together and yet it concedes that depressive symptoms 
occur in DAT by having a sub-category under the latter for 
patients with depression. However, no guidance is given as to how 
depression should be diagnosed in DAT.
Two recent studies have assessed neuropathological changes
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in depressed and non-depressed AD patients. Zweig et al (1988) 
found that subjects with AD and major depression had more 
neuronal cell loss at the mid-level of the locus coeruleus than 
the non-depressed. There was a tendency towards greater loss of 
neurones at all levels of the locus coeruleus and dorsal raphe 
nucleus in depressed patients. Zubenko and Moossy (1988) found 
that patients with major depression and primary dementia had more 
degenerative features in the locus coeruleus and substantia nigra 
than non-depressives with dementia. These findings are 
intriguing and represent one of the definitive tests for the 
possible existence of subgroups of AD - that based on 
neuropathology. In addition, they may shed light on the organic 
substrate of functional illnesses such as depression.
In contrast to depression, elevated mood has been reported 
less often as an accompaniment to DAT. Rothschild (1941) 
reported that one out of 31 cases of DAT presented "a manic like 
picture”. Sim and Sussman (1952) described one out of 22 patients 
with histologically proven AD as being euphoric and Bucht and 
Adolfsson (1982) found three out of 20 patients with "elated 
mood". Berrios (1985) reviewed the concept presbyophrenia which 
was used at the beginning of the century to categorise a subtype 
of dementia with features of elevated mood and hyperactivity. He 
described 15 cases and found elevated mood to be present in nine 
arguing that presbyophrenia may represent a true subtype of 
dementia. As with depression, definite cerebral organic changes 
have been demonstrated in patients presenting with manic 
illnesses in old age (Shulman and Post, 1980; Broadhead and 
Jacoby, 1990).
73
2.5 BEHAVIOURAL DISTURBANCE
Behavioural disturbances, like psychiatric symptoms, have 
received very little attention when compared to the large 
literature on cognitive changes in DAT. Abnormal behaviours are, 
however, very important as they impose a significant burden on 
carers (Rabins et al, 1982) and because their presence or absence 
may indicate clinical heterogeneity in DAT. While behavioural 
problems may be related to previous personality traits, they may 
also be a manifestation of underlying structural brain damage 
(Fairburn and Hope, 1988a). Behaviours are considered separate 
to psychiatric symptoms and can be defined as acts observed by 
and which affect others. Aggression, incontinence, binge eating 
and wandering are examples. I believe that it is necessary to 
make this distinction from psychiatric symptoms although I 
recognise that the two may often be associated (eg a 
hallucinating patient responding to his or her experiences by 
becoming aggressive). Many authors do not make such a distinction 
with the result that some studies assess aggression and 
hallucinations in the same way, seemingly unaware of such an 
important potential distinction (eg Swearer et al, 1988; Teri et 
al, 1989).
Sanford (1975) was among the first to highlight the 
difficulties experienced by carers because of behavioural 
disturbance. Fifty carers of elderly subjects admitted to a 
geriatric ward for "social reasons" were interviewed. Behaviours 
particularly disruptive and a cause for admission to hospital 
were nocturnal wandering, incontinence of urine or faeces and
physical aggression. Although no detailed information regarding 
diagnosis was given, it was stated that these behaviours were 
specifically related to senile dementia.
Rabins et al (1982) highlighted the difficulties which were 
experienced by caregivers. The families of 55 demented patients 
were interviewed and behaviours regarded by them as a "problem" 
were recorded. Of the seven items of behaviour cited as causing 
serious problems, only one (memory disturbance) could be related 
to cognitive function. The others (physical violence, hitting, 
incontinence, catastrophic reactions, suspiciousness and 
accusatory behaviour) appeared to be unrelated to cognitive 
def icits.
Greene et al (1982) extended simple behavioural observation 
by administering two scales to the relatives of 38 patients with 
senile dementia who were attending a day hospital. One assessed 
the patients* behaviour and the other measured relatives* 
distress. Using factor analysis, it was found that relatives* 
personal distress was related to patients* apathy and withdrawal 
while negative feelings towards to the patient were associated 
with disturbances in the patients* mood. This well conducted 
study also showed that relatives’ distress was unrelated to the 
degree of cognitive impairment.
Several recent studies have highlighted behavioural 
disturbances in more detail. Swearer et al (1988) evaluated 126 
demented patients (56 with DAT) who attended an AD Research 
Centre. "Angry outbursts" occurred in over 50% of the sample and 
"violent behaviour" was present in 21%. "Dietary change" (not 
further specified) was present in 46% of subjects and violent or
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bizarre behaviour and incontinence became proportionally more 
common as the severity of the dementia increased. Teri et al
(1988), in 127 out-patients with DAT, found wandering behaviour 
in 26%, agitation in 24% and restlessness in 45%. The lack of 
definition of terms and the conversational tone of the 
study detract a great deal from the scientific validity of the 
study. In a subsequent publication, the same group (Teri et al, 
1989) presented more detailed results on 56 subjects. They 
stated categorically in the Methods section that they did not 
refer to the same group described by the authors previously (Teri 
et al, 1988), but were drawn from the same clinical source. There 
were differences in the proportion of patients exhibiting certain 
behaviours, eg in the 1988 sample, 26% demonstrated wandering 
compared to 5% in the 1989 sample; 21% in the earlier study had 
hallucinations but only 6% in the later study. Such differences 
in the proportion of individuals with a particular behaviour 
requires explanation but none is given. One of the main reasons 
was probably that the 1989 study involved the presentation of a 
new scale for assessing behaviour. This new scale may have been 
more rigorous in its assessment of behaviours rather than relying 
on the individual assumptions of various clinicians, which may 
have been the case in the previous sample.
In a community study of aggression (Ryden et al 1988) found 
65% of the 183 subjects to be aggressive. However, dementias of 
any aetiology were included in this sample and some of the 
definitions of aggression appeared idiosyncratic (eg sexual 
aggression included the behaviours of kissing, hugging and
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sexual intercourse).
A particular syndrome encompassing behavioural changes in 
dementia is of interest - the "Kluver-Bucy Syndrome". This
syndrome was originally described following bitemporal lobectomy
in monkeys (Kluver and Bucy 1937). The following striking 
behavioural changes were described:
1) visual agnosia;
2) strong oral tendencies with hyperphagia;
3) hypermetamorphosis (an excessive tendency to attend to
and react to every visual stimulus;
4) increased sexual behaviour and
5) emotional changes, both withdrawal and apathy but also
loss of fear and "rage" reactions.
In man, the syndrome has been described following bilateral 
removal of the temporal lobes (Terzain and Ore, 1955), in DAT
(Sourander and Sjogren, 1970) and in Pick’s Disease (Cummings and
Duchen, 1981) .
Sourander and Sjogren (1970) reported a detailed analysis of 
the features of the Kluver-Bucy syndrome in 60 patients with DAT. 
Over 70% of cases had features of the syndrome, with the 
exception of hypersexuality which occurred in only ten subjects. 
They confirmed that temporal and plaque counts were higher in 
subjects who had features of the syndrome during life. However, 
damage to other parts of the brain appear to be required. It is 
unusual for all the features of the syndrome to occur in man as 
it seems to be specific to primates (Pilleri, 1966). Sourander 
and Sjogren (1970) emphasized, however, that individual symptoms 
were common.
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Probably the most widely recognised feature of the syndrome 
seen in DAT is increased eating (often associated with 
hyperorality for other objects). Hope et al (1989) described four 
cases of increased food intake in DAT patients and suggested five 
reasons why it occurred - as a result of the patient forgetting 
they had eaten, release from previous dieting habits, a 
behavioural stereotypy, a response to malabsorption or occurring 
as a direct result of brain damage. The authors favoured the 
last explanation and backed up their contention with data from 
animal experiments. Their conclusions were, however, premature 
as no direct clinical evidence was presented to support the 
theory. Their material was based on four anecdotal case reports 
and it appeared that it was mainly a rejection of the other 
hypotheses that led to their conclusions.
Morris et al (1989) studied the eating habits of 33 patients 
with dementia. Both decreased and increased food intake were 
described. Twenty-six percent noted excess oral behaviour with 
eating of inedible and inappropriate objects. The sample 
consisted of elderly patients (27 with DAT, four with MID and two
with mixed DAT/MID). The paper described a wide range of eating
behaviours and their possible mechanisms which was helpful in 
drawing attention to these abnormal behaviours.
2.6 NEUROLOGICAL SIGNS
Neurological phenomena such as primitive reflexes, 
extrapyramidal signs and myoclonus have all been described in
DAT. Traditionally, they are considered to be late
manifestations of the disorder and are regarded as the
78
consequence of advanced cerebral damage (Lishman, 1987).
Roller et al (1982) found a snout reflex in 54% of 52 
patients with DAT (mean age 68.3 years) and in exactly the same 
proportion of 48 elderly age matched non-demented controls. The 
proportion with this reflex increased with age. A glabellar tap 
was found in 23% of DAT subjects but in only 8% of controls (a 
difference which was statistically significant). Tweedy et al 
(1982) found that a glabellar tap was the most common primitive 
reflex (79%) in 32 subjects with DAT, a palmomental reflex was 
present in 47%, a snout reflex in 19% and a grasp reflex in 17%. 
Snout and grasp reflexes were associated with cognitive 
impairment while a glabellar tap and palmomental reflexes were 
not. Neurological signs were strongly associated with CT evidence 
of ventricular enlargement but not with cortical atrophy. Huff 
and Growdon (1986) found comparatively smaller proportions of 165
DAT subjects with primitive reflexes - a snout reflex in 18% and
a grasp and palmomental reflex in 10%. The palmomental reflex was 
unrelated to degree of dementia but the other two were 
significantly more common as severity of dementia increased.
The presence of myoclonus in DAT has often led to an 
erroneous diagnosis of Creutzfeld-Jakob disease in which 
myoclonus occurs frequently (Fadden and Townsend, 1976). Cases 
of myoclonus in association with DAT have been reported (eg
Barratt, 1913) and some are hereditary (Jacob, 1970). More
recent studies have described the prevalence of myoclonus in 
large populations of DAT subjects (eg Mayeux et al, 1985b; Chui 
et al, 1985).
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Mayeux et al (1985b) found that 28% of 121 patients had 
extrapyramidal signs - bradykinesia and rigidity most frequently 
observed with tremor being rare (an additional 10% were described 
as having extrapyramidal signs due to neuroleptic medication). 
Patients with extrapyramidal signs had poorer cognitive function 
(as assessed by a modification of the MMSE), poorer functional 
capacity (assessed by the BDS) and were more likely to have 
delusions and hallucinations. Subjects with drug-induced 
extrapyramidal signs were the most impaired on the cognitive and 
functional scales. No differences were observed between the 
groups with regard to age, age of onset of dementia or family 
history of dementia. Ten per cent of the sample had myoclonus. 
These patients had a younger age of onset and more cognitive 
impairment than subjects without myoclonus. Fifty patients were 
followed longitudinally from between six months and four years 
after initial evaluation. Extrapyramidal signs developed in 10% 
and these signs were accompanied by cognitive and functional 
impairment greater than in those patients who did not develop the 
signs. 18% developed myoclonus during the follow-up period. They 
were characterised by poorer performance on the modified MMSE but 
functional capacity was not diminished.
In agreement with other studies, eg Berg et al (1987), a 
subgroup of patients (seven out of 50) had mild impairment of 
intellectual function and did not deteriorate throughout the 
follow-up period. The authors claimed to have delineated four 
subgroups of DAT - extrapyramidal (sporadic and drug-induced), 
typical, myoclonic and benign. They had the benefit of 
longitudinal analyses to test the stability of their subgroups
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and as such satisfy many of the criteria for the existence of 
subgroups as outlined by Jorm (1985). Quite correctly, they do 
not suggest that the bimodality seen in the age of onset is 
suggestive of subgroups but do not present the longitudinal data 
in different age groups. Most of their findings could be 
explained in terms of quantitative subgroups, eg the differences 
in modified MMSE and functional ratings at the beginning of the 
survey being a function of disease duration. The development of 
extrapyramidal signs and myoclonus in 10% and 18% of the patients 
respectively may also indicate a progression to a common type.
Chui et al (1985) found that 34% of 146 patients had 
extrapyramidal signs while 6% had myoclonus. Patients with these 
signs were more demented than those without, in agreement with 
the findings of Mayeux et al (1985b). Therefore, the presence or 
absence of certain neurological signs may indicate subtypes of 
DAT.
2.7 GENETIC HETEROGENEITY
Larsson et al (1963) were pioneers of the genetics of DAT.
In a large investigation (Larsson et al, 1963), 719 subjects with 
SDAT were studied comprehensively and information gathered 
regarding familial factors. The conclusion was that there was a 
significant genetic component and the favoured mode of 
transmission was autosomal dominant. Around the same time, 
Constantinidis (later summarised in Constantinidis, 1968) 
reported, in a study of 229 probands, that presenile dementia was 
inherited as an autosomal dominant and senile dementia as an 
autosomal recessive condition.
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Two papers dealing with the issue of familial DAT can be 
considered together (Folstein and Breitner, 1981; Breitner and 
Folstein, 1984). In the first of these studies, two important 
observations were made. Of 39 subjects with DAT, 41% had a first 
degree relative affected. This percentage was significantly 
greater than in patients with vascular dementia or other types of 
dementia. Within the DAT group, those who could not write a 
sentence (defined as being agraphic) had a significantly 
increased chance of having a family member affected (54% compared 
to 20%). The authors* conclusion was that the classic features 
of DAT (aphasia and agraphia) identify specifically a familial 
form of DAT. They quoted from existing pedigree studies which 
suggested that the inheritance was by an autosomal dominant gene 
which led them to conclude that the lifetime risk to first degree 
relatives of patients with aphasia and agraphia would be about 
50%. Their next paper examined this in greater detail.
Breitner and Folstein (1984) drew their sample from 15 
nursing homes in Baltimore, Maryland. They had strict exclusion 
criteria (approximating to NINCDS-ADRDA criteria) but no physical 
investigations were performed on the subjects. Of 3,500 subjects 
screened, 62 patients (all were white females) were selected for 
further investigation. Subjects were assigned to categories on 
the basis of the presence or absence of agraphia (assessed by the 
ability to write a sentence spontaneously) and aphasia/apraxia 
(assessed by an interview with caregivers). A very high 
association between the two categories was found and, because the 
cases split conveniently into two using the agraphic/non-agraphic
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distinction, the analyses were based on this distinction. Using 
information obtained from interviews with relatives, the 
prevalence of cases of dementia in the families was estimated. 
There was an increase risk of cases of dementia in both male and 
female relatives of agraphic DAT subjects. 10.5% of first degree 
relatives (N=181) of agraphic DAT patients were demented compared 
to 3.8% (N=79) of non-agraphic subjects. The prevalence in first 
degree relatives of non-demented control subjects was 2.5% 
(N=157). Using the Weinberg Morbidity table, the authors 
estimated that the cumulative risk to relatives of agraphic 
probands was greater than 50%. Their conclusion was that agraphic 
DAT was inherited by an autosomal dominant gene with age- 
dependent penetrance.
Several aspects of the paper merit comment. The cases 
represented a biased sample in that all the patients were in 
nursing homes and therefore their dementia syndrome could be 
considered severe. Language disordered subjects may have been 
overrepresented in this group. Although the inclusion/exclusion 
criteria were carefully specified, no physical investigations 
were performed and this omission may well have led to erroneous 
diagnoses. The presence or absence of aphasia/agraphia was 
ascertained by historical information taken from relatives by 
non-medically qualified interviewers. Despite these 
reservations, the results of the paper are so significant that 
they cannot be easily ignored. The authors concluded that further 
studies were required to replicate their findings. Although such 
investigations might be used as evidence for the existence of 
qualitative subtypes of DAT, the possibility remains that the
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language disorder described in familial DAT is merely a late 
manifestation and that it would develop in all cases with 
sufficient time. Breitner and Folstein (1984) recognised this and 
excluded eight cases who did not have aphasia, apraxia or 
agraphia and who had been ill for less than four years. They did 
so on the assumption that the patients may have developed these 
signs later in their illness.
Knesevich et al (1985) presented details on the longitudinal 
course of SDAT (discussed in detail in Chapter 3.3). In addition, 
they reported information on the family history of the disorder. 
It was found that subjects with aphasia had a more rapidly 
progressive form of the disorder. Calculating the risk of 
dementia in relatives of the probands (up to age 79) showed that 
the relative risk was (in aphasic and non-aphasic probands 
respectively) 7.5% and 26.3% for siblings and 17.7% and 34.5% for 
parents. The authors concluded that SDAT was a heterogeneous 
condition with aphasia early in the illness signifying a non- 
familial rapidly progressive subtype. The association between 
aphasia and rapid progression was predictable while the lower 
familial risk was not. One possible explanation for this result 
was that aetiological heterogeneity exists and that aphasia 
(independent of genetic risk) in some way lowers the threshold 
for the development of the clinical disorder.
The development of the techniques of molecular genetics 
has been useful in the genetic investigation of DAT. Recent 
developments began when three articles appeared in the same issue 
of "Science” (St. George-Hyslop et al, 1987; Goldgaber et a l ,
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1987; Tanzi et al, 1987). The first reported genetic linkage of 
the disorder to chromosome 21 (the same gene duplicated in Down’s 
syndrome, sufferers from which universally develop AD brain 
changes). The other two articles showed that the gene coding for 
B-amyloid (an integral part of the neuritic plaque) was also on 
chromosome 21. Two subsequent publications (Van Broeckhoven et 
al, 1987; Tanzi et al, 1987) found that, using restriction 
fragment length polymorphisms, recombination events occurred 
between the gene for familial DAT and that for amyloid protein, 
proving that the genes were not one and the same.
The findings of St. George-Hyslop et al (1987) have been 
replicated by Goate et al (1989) but refuted by Roses et al
(1988) and Schellenberg et al (1988). Analogies may be drawn 
between the search for the familial DAT gene and that for 
muscular dystrophy. In the latter, genetic heterogeneity has 
been found (ie two loci) resulting in the description of two 
types of muscular dystrophy - Becker and Duchenne. If genetic 
heterogeneity were present in DAT, then at least two loci would 
occur which would not even necessarily be on the same chromosome 
as suggested by Roses et al (1988) and Schellenberg et al (1988). 
If this was so, the task of identifying the gene for DAT 
would be much more difficult. However, as Goate et al (1989) 
argued, the negative results of these two studies may be 
explained in terms of the populations examined - Roses et al
(1988) examined late onset cases and Schellenberg et al (1988) 
studied the Volga Germans, a genetically inbred and therefore 
unusual sample. Even if genetic homogeneity (ie only one mutant 
gene) were present, the phenotype might have variable expression
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as in the case of Sickle Cell Disease.
2.8 NEUROPATHOLOGICAL AND NEUROCHEMICAL HETEROGENEITY
The main drawback to clinical studies of DAT is that the 
diagnosis cannot be made with absolute certainty before death. 
Thus, even although the most rigorous diagnostic criteria 
classify correctly 80-90% of cases, 10-20% will still be 
diagnosed wrongly. This fact would seem to cast doubt on the 
validity of clinical studies. The advantage of neuropathological 
studies is that a neuropathological diagnosis can be made at the 
same time as a search for subtypes. Ideally, both clinical and 
neuropathological information is required.
Hubbard and Anderson (1981) examined the brains of 20 
severely demented patients and 18 non-demented age-matched 
controls. Cerebral volume was estimated in relation to cranial 
capacity making a correction for shrinkage of the brain during 
formalin fixation. The clinical diagnoses of the demented 
patients were all of SDAT - 15 were confirmed as AD at necropsy. 
None of the non-demented control group had neuropathological 
evidence of AD. The demented group were divided according to age 
at death - eight over 80 years of age, seven less than 80 years. 
Compared to controls, the younger patients had significantly more 
atrophy throughout all regions of the cerebral cortex (average 
14%). In contrast, the older patients did not show this 
significant atrophy when compared to controls with the exception 
of the temporal lobes (which had on average 21% less tissue).
The cerebral cortex was primarily affected - atrophy in this 
region was more pronounced than in the white matter. No atrophy
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was demonstrated in the hind brain. Cerebral ventricular size was 
significantly greater in the younger patients compared to 
controls while older AD patients had similar sized ventricles to 
controls. The authors postulated the existence of two groups of 
AD patients with a genetic predisposition differentially 
expressed in young and old. The lack of clinical information 
detracts from their results - details about disease duration and 
family history of dementia would have added to the strength of 
the findings. Although showing differences between young and old 
AD patients, the paper falls short of showing distinct 
subtypes. This point was made by the authors.
Neuronal counts have been described in two studies and 
claims for heterogeneity made on the basis of the results. 
Bondareff et al (1981) performed neuronal counts in the locus 
coeruleus of 20 patients with AD and compared them to counts in 
ten non-demented control subjects. A histogram of total cell 
counts showed a definite bimodality in distribution. Subjects 
with low counts (group 1) were younger at death and were more 
demented (as measured by the BDS) than subjects with high counts 
(group 2). Brain weights were the same in both samples. The 
control group had similar brain weights to the two demented 
groups and similar neuronal counts to group 2.
Bondareff et al (1982) examined adrenergic cell counts in 
the nucleus locus coeruleus in 20 patients (average age 78 years) 
diagnosed as SDAT during life. Nineteen of these patients had AD 
confirmed at autopsy. Neurones were counted using an image 
analyser in a standardised section of the nucleus. The authors
87
reported that this area was ideally suited to such analysis as 
the cells could be visualised easily as a result of their 
intracytoplasmic melanin. The results were quite striking, 
showing as clear bimodal distribution of neuronal counts with a 
point of rarity at between 5,000 and 7,000 neurones. They 
assigned the label AD-1 to that group with the lower counts and 
AD-2 to the group with the higher counts. A significant overlap 
existed between the counts in AD-2 and normal controls. AD-1 
were significantly younger at death and were more demented than 
AD-2. The latter result became non-significant when women only 
were included. The authors argued that they had demonstrated 
subgroups of female SDAT patients and had localised one of the 
principal deficits to the noradrenergic system. The study can 
be criticised on three grounds. First, the inclusion of a 
patient in the analysis suffering from dementia, but without 
cerebral pathology, was probably a mistake. Second, the 
conclusions drawn are out of proportion to the number of cases 
involved. Third, the results could be explained entirely in 
terms of quantitative rather than qualitative subtypes.
Tagliavini and Pilleri (1983) produced similar results with 
neuronal counts in the basal nucleus of Meynert. The counts 
from nine patients with AD (average age 70 years) were compared 
with those of three patients with "simple senile dementia" 
(average age 93 years) and with five controls. In the AD group, 
a linear relationship was found between neuronal loss and age at 
death showing that the greatest neuronal fall-out was in the 
younger patients. No difference was found in the neuronal counts 
of the "simple senile dementia" group and the controls. Wilcock
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and Esiri (1983) quote their own work to demonstrate a decrease 
in cell counts in the nucleus basalis in eight patients with AD 
but no decrease in normal ageing. They made the point that the 
findings in the group described by Bondareff et al (1981), of 
late onset with relatively intact neuronal counts, do not support 
the hypothesis that this type of AD is age related.
Similar criticisms can be levelled at the work of Bondareff 
et al (1981) and Tagliavini and Pilleri (1983). First, the 
numbers of subjects involved are too small to make any meaningful 
statements on the presence of subtypes. Bimodal distributions 
may result from small numbers (Everitt, 1981). Second, and more 
fundamental, is the danger of interpreting quantitative 
differences as evidence of qualitative subtypes (Jorm, 1985). 
Bondareff (1983) brought together evidence from a number of 
sources (mainly neuropathological but also clinical and 
neuroradiological) to propose two types of AD. He proposed that 
AD-1 was characterised by onset in old age, a more insidious 
course, fewer parietal lobe signs, less ventricular enlargement 
and less severe neuropathological and neurochemical changes. AD- 
2 was described as having an onset in middle age, a more rapid 
course, more parietal lobe signs, greater ventricular enlargement 
and more severe neuropathological and neurochemical changes than 
AD-1. The evidence he cites, while empirically supporting the 
differentiation of AD, does not justify its categorisation into 
this rigid dichotomy.
These observations were extended by Bondareff et al (1987) 
in a further examination of the histopathological evidence for
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heterogeneity in AD. Neuronal counts in the locus coeruleus were 
studied in relation to a number of other variables including 
additional neuropathological and biochemical data and age at 
death. The results (on 46 patients which presumably included 
the 20 in the original study) did not confirm a significant 
difference in age between AD-1 and AD-2. The authors went on to 
perform three discriminant analyses (on the 27 patients in whom 
adequate data were available) in an attempt to separate the two 
groups further. First, the patients were separated into those 
with more than, or those with less than, 65 neurones per section 
in the nucleus coeruleus. Noradrenaline concentration along with 
tangle and plaque counts were successful in discriminating 
between the groups, and 74% of cases were successfully 
categorised. Second, the groups were divided into age at death 
(greater or less than 79 years). In this way, 87% of cases were 
classified correctly using the same variables, with the addition 
of choline acetyl transferase activity in Brodmann’s area 24. A 
third analysis was performed excluding patients who died between 
the ages of 76 and 82 in an attempt to provide better separation 
of the groups. Using this result, group membership was 
predicted successfully in 100% of cases using plaque and tangle 
counts, cholineacetyltransferase (ChAT) activity (in Brodmann’s 
area 21) and the number of neurones in the nucleus locus 
coeruleus. The authors cited other work to emphasise the 
paradox of more severe neurochemical and neuropathological 
changes occurring in younger AD patients. They admitted (as 
indicated previously) that the measures employed may simply have 
reflected differences in severity at extremes of a continuum.
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Thus, their description is of quantitative rather than 
qualitative subtypes. Two findings confound this. First, there 
was no correlation between the degree of dementia during life and 
any of the variables used. Second, neither duration of dementia 
nor the dementia score improved the differentiation of the groups 
when added to the discriminant analyses. Their argument was thus 
strengthened that they had demonstrated both quantitative and 
qualitative differences.
The results of neurochemical studies also lend support to 
the evidence for heterogeneity. The first to do this were 
Rossor et al (1981). The ChAT levels of 25 cases of 
histologically confirmed AD were compared to 26 normal controls. 
The AD cases were divided into young and old groups (age of death 
less than or greater than 79 years). Both groups had 
significantly lower activities of the enzyme in the temporal 
cortex but only the younger group had significant decrements in 
the frontal cortex. Enzyme activity increased with age in the AD 
group whilst decreasing with age in the control group. Two 
possible inferences could be made from these findings. First, 
that the relative preservation of enzyme activity with increasing 
age reflected the relative absence of cerebral atrophy seen in 
this group (Hubbard and Anderson, 1981). Second, that the older 
group represented a discrete subtype.
In an extension of their earlier work, Rossor et al (1984) 
reported the levels of neurochemical activity in 49 patients with 
AD and 54 non demented controls. The findings of the earlier 
study were confirmed showing a decrease in ChAT activity which
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was more widespread in younger patients. Similarly, aminobutyric 
acid, somatostatin and noradrenaline levels were decreased in 
younger patients compared to normal controls while the only 
significant difference between the older group and normal 
controls was a decrease in somatostatin in the temporal lobe. 
Although the existence of subtypes might be inferred from the 
data, the authors suggested that the older group might be dying 
earlier due to intercurrent illness and therefore have a less 
severe form of the disease. However, the dementia scores were 
similar in the two groups but unfortunately no information on 
duration of illness was provided.
Bird et al (1983) presented a full account of ChAT activity 
in 16 patients with AD and correlated the findings with clinical 
features. The control group consisted of 32 non demented 
patients and 17 patients with Huntington’s Disease. The five 
areas examined were the frontal and temporal cortices, 
hippocampus, putamen and cerebellum. The findings of this 
important paper can be summarised thus:
1) the AD group had a 40% decrease in ChAT in the frontal and 
temporal cortices, hippocampus and cerebellum when 
compared to the control group;
2) patients with early onset AD (onset less than 65 years, 
N=8) had lower Chat levels only in the temporal cortex 
compared to late onset patients (N=8). Compared to 
controls, the early onset group had lower levels in all 
areas except the putamen while the late onset group had 
lower levels only in the hippocampus;
3) patients with myoclonus (N=4) had lower levels of ChAT in
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all areas except the putamen compared to those AD patients 
without myoclonus and
4) there was a tendency for patients with a family history of 
dementia to have lower ChAT levels but these levels were 
not significantly different from those patients without a 
family history of dementia.
The duration of dementia was the same in the early and late 
onset groups which disproved the idea put forward by Rossor et al
(1984) that older patients were simply dying earlier in the 
course of their illness.
While most neurochemical studies are based on post­
mortem material, some biological markers can be measured 
in vivo. Platelet membrane fluidity (PMF), which reflects cell 
membrane structure and function, is one such marker which has 
been investigated in SDAT. Zubenko et al (1988a) found increased 
PMF in 50% of DAT subjects attending an AD Research Centre all of 
whom met NINCDS/ADRDA criteria. Those with increased PMF had 
more evidence of left parietal dysfunction (based on 
psychological test results) than patients with normal PMF. The 
authors concluded that they had discovered a biological subtype 
of DAT. Other evidence from the same group to supports this 
hypothesis.
DAT patients with the abnormality have an earlier age of 
onset and deteriorate more rapidly than those without (Zubenko et 
al, 1987a). Zubenko and Teply (1988) assessed PMF in 15 patients 
and ten controls over a 12 month period. No significant changes 
took place in individual subjects suggesting that it was a stable
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biological marker. This result is somewhat contradictory to an 
earlier finding (Zubenko et al, 1987b) where a correlation was 
found between dementia severity and increased PMF. Zubenko and 
Teply*s (1988) explanation of this fact was that increased PMF 
represents a subtype of the disorder with a more rapidly 
progressive course. Zubenko et al (1988b) showed that the number 
of relatives with dementia was the same in patients with or 
without increased PMF. However, the age of onset of the disorder 
in affected relatives was earlier in the group with the 
abnormality. This evidence suggests strongly that PMF may be a 
biological marker for a subgroup of the disease. The evidence 
is, however, less convincing that this subgroup is characterised 
by anything other than increased PMF, apart from age of onset.
The more rapid deterioration and the psychological test results 
of parietal dysfunction could be explained by the earlier age of 
onset. This in itself may be simply a manifestation of 
quantitative subtypes. Zubenko et al (1988b) discussed the 
inheritance of both DAT and the PMF trait, suggesting that either 
two genes give rise to DAT (one of them also resulting in 
increased PMF) or that increased PMF may modify the clinical 
picture of DAT (ie by causing an earlier age of onset). The work 
on PMF is interesting but, so far, falls short of proving 
biological subtypes of DAT.
Two recent studies provided interesting and additional 
neurochemical support for the clinical observations of Chui et al
(1985) and Mayeux et al (1985b) with regard to myoclonic and 
extrapyramidal subtypes of SDAT. Kaye et al (1988,a) studied 
CSF neurochemistry in 32 patients with SDAT - eight with
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myoclonus and 24 without. All patients satisfied NINCDS-ADRDA 
criteria. Patients with myoclonus were more severely demented (as 
assessed by the MMSE) and had larger lateral and third ventricles 
than those without myoclonus. Duration of dementia did not 
differ significantly between the groups, but the myoclonic 
subgroup had a younger age of onset (54.0 years compared to 63.4 
years). The following biochemical measures in CSF were 
significantly lower in the myoclonic subgroup - homovanillic 
acid, biopterin and 5 hydroxyindole acetic acid. To take into 
account severity of dementia, the authors examined two subgroups 
matched for cognitive impairment (N=7 in each group). The groups 
became matched for age, age of onset, and lateral ventricular 
size. However, the significance of the neurochemical differences 
remained.
In another study, the same group (Kaye et al, 1988b) 
examined two groups of patients with SDAT - one with 
extrapyramidal signs and one without. Lumber punctures were 
performed in 27 SDAT subjects without extrapyramidal signs, ten 
SDAT subjects with extrapyramidal signs and 14 age-matched 
controls. The following neurotransmitters were measured - 
homovanillic acid (HVA), biopterin, 5-hydroxyindole acetic acid 
(5 HIAA) and 3 methoxyl 4 hydroxy phenetheyleneglycol (MHPG).
In addition, plasma MHPG was measured to obtain a corrected value 
which was said to reflect more accurately the CNS contribution of 
total MHPG. Taking the SDAT group as a whole, only CSF 
Homovanillic acid was significantly lower when compared to the 
age-matched controls. A separate analysis showed no difference
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between levels of CSF HVA in patients without extrapyramidal 
signs and controls suggesting that the difference seen in the 
group as a whole was entirely due to SDAT patients with 
extrapyramidal signs. This latter group was more demented (as 
assessed by the MMSE). To counteract this factor, the authors 
matched, for degree of cognitive impairment, nine subjects who 
had extrapyramidal signs with ten subjects free from 
extrapyramidal signs. The decrease in CSF HVA remained 
significant but in addition CSF biopterin and 5 HIAA were 
significantly lower in the group with extrapyramidal signs. An 
analysis of the patients CT scans showed that this difference was 
not due to a difference in cerebral atrophy.
The authors argued that these results strongly suggested 
that a subgroup of SDAT patients with extrapyramidal signs 
existed, characterised by more severe disease, more rapid 
deterioration (although no evidence was presented in support) and 
a distinct neurochemical profile. The results of two post­
mortems on patients with extrapyramidal signs were given. One had 
changes of AD and Parkinson’s Disease and the other had 
multisystem atrophy. Thus, the heterogeneity of patients within 
the subgroup showing extrapyramidal signs was emphasised. One 
methodological flaw existed in the study. Although CSF was 
extracted using a very thorough protocol, the possibility of 
concomitant drug effects was not properly taken into account. 
Although patients were drug free for two weeks before the 
examination, no mention was made of drug treatment prior to that 
time. As the patients with extrapyramidal signs were more 
demented, it is possible that they were on drugs to control
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behavioural problems (such as phenothiazines). Since these drugs 
remain in the body for weeks or months, a washout period of two 
weeks might be inadequate. However, this cannot be overcome 
easily and does not detract significantly from the findings.
Jorm (1985) made two important points regarding 
heterogeneity defined by neuropathological and neurochemical 
data. First, differences in severity of a variety of 
characteristics does not necessarily mean that qualitative 
subtypes exist. Quantitative differences would explain most of 
the observations in the studies described in this section. 
Quantitative subtypes may exist but no data have yet been 
published to make a definitive judgement on this. Whilst some 
authors (eg Rossor et al, 1984) have argued that late onset cases 
may appear less severe because they are dying at a later stage, 
data such as those presented by Bird et al (1983) dispute this 
conclusion. Jorm (1985) suggested that another way to answer this 
question would be to examine early onset cases dying early in the 
disease (from causes other than AD) and to compare them to late 
onset cases. Second, all the studies (with the exception of that 
by Mayeux et al, 1985b) have examined cross sectional data. While 
it is possible to perform longitudinal studies on 
neuropsychological examinations, such studies on pathological 
data are impossible. However, neuroimaging techniques lend 
themselves to investigation of the results of neuropathological 
processes and can be repeated over time to follow the course of 
the disease.
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2.9 NEURORADIOLQGICAL HETEROGENEITY
Naguib and Levy (1982a) followed 40 patients diagnosed as 
having senile dementia. CT scans were repeated between 18 to 36 
months after the initial assessment. Two subgroups emerged - one 
showed increasing ventricular brain ratios over time while the 
other did not (this paper will be dealt with in more detail in 
Chapter 3.3).
Burns et al (1989) using Single Photon Emission Tomography 
(SPET) and hexamethylpropyleneamineoxime (HMPAO) have shown 
differences within a group of 20 patients with DAT. Subjects 
with aphasia and apraxia (N=12) had lower cerebral blood flow 
bilaterally in the lateral temporal and posterior parietal 
cortices than patients without these features. The two groups 
were of the same age and had similar duration of dementia, 
suggesting that the differences were not merely a manifestation 
of severity of illness. The status of these subtypes with regard 
to longitudinal course has yet to be fully defined.
Martin et al (1986) reported the results of Positron 
Emission Tomography (PET) in 19 of the subjects who underwent 
neuropsychological assessment described in Section 2.3. The 
profiles were strikingly different in the groups. Those with 
global impairments showed no significant left/right 
differences in either frontal, temporal or parietal lobe 
metabolism. Subjects with word finding difficulty, but relative 
preservation of visuo constructive performance, had lower left 
temporal lobe metabolism and those with visuo- constructive 
impairment had lower metabolism in the right temporal and 
parietal regions.
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Grady et al (1987) assessed 18F Deoxyglucose PET in 34 
patients with DAT, 21 of whom had early onset disease. Right 
parietal lobe metabolism was significantly lower in the early 
onset group. This finding, along with the lack of difference 
found in the psychological test results (see Chapter 2.3) led 
the authors to postulate that early onset DAT had more cortical 
reserve ie despite metabolic deficits, cognitive function was 
intact.
2.10 SUMMARY
Clinical heterogeneity in DAT can be considered in terms of 
qualitative and quantitative subtypes, the former representing 
true clinical subtypes and the latter differences along a 
continuum from mild to severe disease. There is compelling 
evidence from a variety of clinical and other sources that 
considerable heterogeneity exists in DAT. The traditional 
dichotomy between age of onset below and above the age of 65 has 
shown that younger subjects have more aphasia and a shorter 
survival time than older patients. Detailed neuropsychological 
testing has revealed possible left hemisphere damage in younger 
patients and right hemisphere damage in the older group. Younger 
patients have also been shown to have right parietal 
hypometabolism compared to elderly subjects. Even when studies 
concentrate on either young or elderly patients alone, 
neuropsychological heterogeneity has been demonstrated with 
specific subgroups characterised by language, visuo- 
constructional and attentional focusing deficits.
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Psychiatric symptoms are also important in suggesting 
clinical heterogeneity - the presence or absence of symptoms such 
as hallucinations, delusions, misidentifications or disorders of 
affect clearly distinguish clinical groups. Each is associated 
with a particular clinical profile and some have been found to 
have prognostic implications. Depressed DAT patients who come to 
post mortem have been found to have a neuropathology different 
from non-depressed subjects. Behavioural disturbances are 
traditionally associated with advanced dementia and are probably 
more indicative of quantitative subtypes. The Kluver-Bucy 
syndrome may indicate specific damage to the temporal lobes and 
so may be a clinical manifestation of a neuropathological 
subtype.
Although certain neurological signs (eg primitive reflexes) 
are common in both normal ageing and DAT, abnormalities such as 
myoclonus and extrapyramidal signs are associated with advanced 
dementia and with rapidly progressive disease. Low CSF levels of 
biopterin and homovanillic acid have been found in patients 
with extrapyramidal signs and myoclonus.
There is considerable genetic heterogeneity in DAT as 
evidenced by an association between agraphia and a positive 
family history of dementia (and in one study a negative 
association between a family history of dementia and aphasia).
The new genetics offer the possibility of determining the gene 
(or genes) responsible for the clinical syndrome and thus the 
discovery of true heterogeneity.
Neuropathological and neurochemical studies support 
the hypothesis that DAT is a heterogeneous condition.
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Neuronal counts in both the locus coeruleus and the basal 
nucleus of Meynert suggest that patients dying younger have 
a more severe loss. Neurochemical studies of
cholineacetyltransferase (ChAT) and other neurotransmitters show 
similar results and ChAT levels have been shown to be lower in 
patients with a family history of dementia and with myoclonus. 
Platelet membrane fluidity appears to be a peripheral biological 
marker for a subgroup of DAT patients associated with an earlier 
age of onset (both in the probands and their affected relatives) 
and with a more rapid course. However, all neuropathological and 
neurochemical studies may be explained in terms of quantitative 
subtypes. Neuroradiological investigations show that 
neuropsychological profiles are associated with changes in 
regional cerebral glucose metabolism.
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CHAPTER 3
THE NATURAL HISTORY OF SENILE DEMENTIA OF THE ALZHEIMER TYPE 
3.1 INTRODUCTION
A review of the natural history of any psychiatric illness 
in the elderly must start with the pioneering work of Roth 
(1955). A satisfactory classification of mental disorders in the 
elderly was made and an assessment of their natural history 
performed. This reappraisal was deemed necessary in view of the 
increasing size of the problem and the fact that the success of 
the new treatments was challenging long held beliefs (eg those of 
Kraepelin) that psychiatric illness in old age was the inevitable 
consequence of underlying cerebral pathology. The case notes of 
450 patients over 60 years of age admitted to Graylingwell 
Hospital in West Sussex during the years 1934, 1936, 1948 and 
1949 were examined. Each case was assigned to one of five 
categories - affective psychosis, senile psychosis (approximately 
equivalent to Senile Dementia of the Alzheimer Type, SDAT), 
paraphrenia, acute confusion and arteriosclerotic psychosis 
(equivalent to vascular dementia). A follow-up study determined 
the status of the patients at six months and again at two years 
after admission (the two year follow up was performed only on the 
1948/49 sample). Clear differences in prognosis were seen in the 
five groups. At six months, patients with a diagnosis of senile 
psychosis had the highest mortality of all - 58% were dead. After 
two years, the patterns were broadly similar to those at six 
months with the exception that, in the arteriosclerotic psychosis
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category, the death rate had risen dramatically to 93% (the 
highest of the five groups). The mortality rate in senile 
psychosis had risen to 82%. It was found that women had a 
significantly lower mortality across all diagnostic groups 
(except confusional states). However, this finding was of 
statistical significance only in senile psychosis.
The study concentrated exclusively on hospital inpatients 
and no attempt was made to take into account cases seen as 
out-patients or on home visits. This selection tended to bias 
the results towards more severely affected patients. Also, little 
detail was given concerning the method of classifying cases. No 
mention was made of interrater reliability nor is it certain 
whether the rules for classifying the patients were set down 
beforehand. If they were not, knowledge of the outcome in a 
particular case may have introduced a significant source of bias. 
Despite these criticisms, the work is unique as it was the first 
to give a satisfactory classification of mental disorders 
affecting the elderly and as such its importance cannot be 
overemphasised.
The natural history of SDAT can be studied from two vantage 
points - survival studies giving information on mortality and 
thence the natural history and longitudinal studies following 
individual patients over time and assessing specific changes (eg 
in cognitive function or Computed Tomography (CT) scan 
appearances).
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3.2 SURVIVAL
There have been many studies over the past 40 years 
examining the survival of elderly patients. Inevitably, 
questions of comparability arise due mainly to the different 
methods employed and to the different populations under 
investigation. Survival in dementia has been the subject of two 
recent excellent reviews (Christie, 1985, 1987). A summary of 
the relevant papers appears in Table 3.1.
One of the earliest inquiries into the fate of elderly 
hospitalised patients was by Camargo and Preston (1945). Six 
hundred and eighty-three first admissions to all the State Mental 
Hospitals in Maryland, USA, in the years 1938 to 1940 were 
followed up for three years. The main part of the paper 
concentrated on demographic characteristics (age, sex and race) 
but some information was provided about diagnosis. Forty-eight 
percent were said to suffer from senile psychosis - 70.7% of 
these were dying within three years. A higher death rate was 
observed in males. In view of the lack of diagnostic 
information, the work is of limited value to the present 
investigation. However, it was the first study to demonstrate 
the very high mortality in patients with senile dementia.
Post (1951) examined new admissions to an observation ward 
in four consecutive months during 1946. Of 214 patients, all 
over 60 years of age, 56 (26%) had functional disorders and 158 
(74%) suffered from organic conditions. The latter group was not 
subdivided into different types of dementia. At the time of 
follow up, 42 months later, 61% of the organic cases had died. 
Death was more likely in patients with ’schizoid symptoms’ than
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in those with ’simple* dementia. It is possible that organic 
cases with a better prognosis (eg acute confusional states) were 
included, resulting in a mortality rate less than expected had 
only ’senile dementia’ cases been assessed.
Roth and Morissey (1952) examined the case-records of 150 
patients admitted to Graylingwell Hospital (in West Sussex) 
during 1948. A diagnosis was made retrospectively on information 
in the case-records (not necessarily corresponding to the 
diagnosis of the consultant in charge). Follow up was performed 
either by letter or by a visit from a psychiatric social worker. 
24% of the sample were diagnosed as having senile psychosis. Six 
months after admission, 53% of these were dead (compared to 22% 
of the whole sample) and two years after admission 73% were dead 
(compared to 37% of the whole sample). Increased mortality was 
seen in males with senile psychosis - six months after admission, 
75% were dead (compared to 46% of females) and after two years, 
88% were dead (compared to 75% of females). This paper was 
clearly the forerunner of the later work (Roth, 1955) which put 
the nosology of mental illness in the elderly on a firm footing. 
There was no information on how a particular diagnosis was 
reached and it was stated that psychometric testing was available 
only on a small number of the patients.
Kay (1962) studied patients who had been admitted to the 
Psychiatric Hospital, Stockholm during the years 1931-1937. 
Patients were divided into 5 groups: - senile dementia, 
arteriosclerotic dementia, late paraphrenia and two groups of 
patients with affective disorder (onset before and after the age
107
of 60 years). This division was made on the basis of psychiatric 
symptomatology. Comparing the mortality rates with figures for 
the standard population (mortality rate 1.0), Kay showed that 
survival in senile dementia was 0.23 men and 0.33 for women. The 
mean survival time from admission to death was 2.6 years for men 
and 2.3 years for women. Patients admitted over the age of 70 had 
a higher life expectancy than those admitted between the ages of 
60 and 70. Non-demented psychiatrically ill patients had a life 
expectancy only marginally less than the general population. 
Although the main aim of the paper was to examine the part played 
by organic cerebral disease in the genesis of mental disorder, 
the study demonstrated effectively the very significant decreased 
life expectancy in subjects with senile dementia. Although the 
two year mortality rate was smaller (68% compared to 82%), the 
rest of the reults confirmed Roth’s (1955) work.
Kay and Bergmann (1966) reported a four year follow up study 
of a group of elderly patients living at home. The main aim of 
the paper was to examine the relationship between physical and 
mental health in old age. Twenty-nine patients (10% of the 
total) had been given a diagnosis of ’organic brain syndrome’, 
which included both acute and chronic conditions. However, for 
practical purposes, the cases can be regarded as due to chronic 
conditions (Bergmann, personal communication). Follow-up revealed 
that 69% of the sample had died (79% of the men and 60% of the 
women). It was found that both organic and functional illnesses 
in men were associated with a mortality rate higher than normal 
control subjects. The study was important because it was one of 
the few community samples dealing with mortality. The death rate
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was very similar to that in other reports. Goldfarb (1969) 
performed a seven year prospective study of 1280 subjects over 
the age of 64 in institutions (old age homes, nursing homes and 
state hospitals) in New York in 1957 and 1958. Those patients 
with ’chronic brain syndrome’ (diagnostic criteria not defined) 
were divided into ’moderate’ and ’severe’ (determined by a 
psychiatrist but not operationally defined). Patients with 
’moderate’ brain syndrome had a mortality rate of 23% and 88% at 
one and seven years respectively. Of those with ’severe’ brain 
syndrome, 37% were dead after one year and 94% after seven years. 
From the late 1960’s onwards, there was growing speculation that 
elderly demented patients were living longer than previously. 
Several authors addressed this question specifically. Shah et al 
(1969) reported on 38 patients with senile dementia admitted in 
the five years between 1955 and 1960 to Saxondale Hospital, 
Nottingham. The findings were not significantly different from 
Roth (1955), although the mortality rate was slightly less (at 
six months, 42% compared to 58%; at two years, 71% compared to 
82%). As in other studies, it was found that women survived 
longer than men. These differences were most marked six months 
after admission (71% of women surviving compared to 20% of men). 
Two years after admission the gap had narrowed, the additional 
deaths being all female (32% of women surviving, 20% of men 
surviving).
Gruenberg (1978), in reviewing the epidemiology of senile 
dementia, quoted his own work concerning the Lundby study in 
Southern Sweden. He looked at two cohorts of demented patients,
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1947-57 and 1957-67. Although the number of cases was small (14 
and 27 respectively) the differences were quite striking. All 
the cases in the 1947-57 cohort were dead after six years but 
nearly 20% of the 1957-67 cohort were alive after ten years. The 
author emphasised that this apparent increase in survival could 
not be explained in terms of an increase in survival of the 
general population or in a change of diagnostic criteria. The 
increased prevalence rate of senile dementia observed in the 
1957-67 cohort could be explained entirely in terms of increased 
survival, not of increased incidence. The main drawbacks to the 
study were the small numbers involved and the lack of diagnostic 
information given on the groups.
Kaszniak et al (1978) presented data on 47 hospitalised 
patients and their mortality one year after hospitalisation.
While the title of the paper suggested that it dealt with 
subjects suffering from pre-senile and senile dementia, it 
included patients with hypertension, an abrupt onset and a 
fluctuating course. In this way, patients with significant 
vascular disease were involved. In view of these drawbacks and 
the fact that the follow up was incomplete (over one-quarter were 
lost to follow up after one year), the contribution of the study 
was limited. However, two findings of interest emerged. First, 
mortality was associated with EEG abnormalities but not with 
cerebral atrophy as assessed by CT scan, and second, some 
cognitive deficits, in particular expressive aphasia, were 
associated with increased mortality.
The question of increased survival in SDAT was addressed by 
Thompson and Eastwood (1981) who examined data from a home for
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the aged over a ten year period from 1969 to 1978. Patients were 
categorised according to their diagnosis on admission or 
discharge and those categorised as "senile", "senile dementia", 
"pre-senile" or "Alzheimer’s Disease" were examined. The 
percentage mortality rate in four time periods (0-6 months, 6 
months-2 years, 2-4 years and over 4 years) following admission 
to the home was calculated for each year. There were large 
variations (eg 5% dying within 6 months in 1971 compared to 43% 
dying within 6 months in 1978) . However, none of the
findings were significant and no particular trend emerged over 
the years. The authors noted no apparent increase in survival 
time. They recognised that other factors might have influenced 
their results. They examined the age and sex composition of the 
residents and ascertained whether any change in admission policy 
had taken place. Although there had been no significant changes 
during the period, the study may have missed more subtle 
variations. The authors recognised this and other limitations 
of the study, not least the accuracy of the diagnoses given. They 
were appropriately cautious in their conclusions.
Duckworth et al (1979) examined 100 patients admitted to 
hospitals in Toronto, of whom 23 were diagnosed as having senile 
dementia. Carefully excluded were patients in whom physical 
illness had been erroneously diagnosed as mental illness. The 
authors compared the mortality rate to that described by Roth 
(1955). After six months, only 13% were dead (compared to Roth’s 
61%) and the two year mortality was 48% (compared to Roth’s 84%). 
Statistically, both differences were highly significant.
Mortality figures for ’demented’ patients (including those with 
vascular dementia) were given for three and four year mortality 
and so cannot be compared directly to the group at six months and 
two years for senile dementia only. Median life span for the 
demented group as a whole was three years and five months, 
while for the group with senile dementia, it was just over two 
years. This finding confirmed the better prognosis for patients 
with vascular dementia who were included in the group. The paper 
did not explain why the prognosis had improved so markedly 
compared to Roth’s (1955) work but concluded that ’treatment 
facilities’ had improved for the organic conditions. Although a 
genuine reduction in mortality may have been demonstrated, the 
two studies were incomparable in several respects. The Canadian 
work was prospective, used different diagnostic instruments, 
specifically excluded patients with severe physical illness and 
took place in a different country, two decades after Roth’s work. 
However, other workers have sought to replicate Roth’s findings 
using more comparable methods.
Blessed and Wilson (1982) applied Roth’s (1955) criteria to 
320 patients aged 65 and over admitted to St. Nicholas Hospital 
in Newcastle in 1976. 90% were successfully allocated to one of
the original five categories. 30% of the cases were diagnosed as 
having senile dementia (equivalent to the original ’senile 
psychoses’ in Roth, 1955). The mortality at six months was 31%, 
half that of Roth’s (1955) study. This change was highly 
significant. Mortality at two years had risen to 68% compared to 
Roth’s 82%, not a significant difference. There was an increase 
in the overall numbers of patients admitted - notably elderly
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women with senile dementia. The highly significant difference in 
mortality at six months with a non significant difference at two 
years suggested that treatment available immediately on admission 
to hospital (eg antibiotics) improved short term prognosis but 
had little effect in the long term. Also, the fact that patients 
in Blessed*s study were older (16% over 80 years compared to 5.5% 
in Roth’s study) may have been a contributory factor to increased 
mortality, leading to a narrowing of the gap at the two year 
follow-up.
Christie (1982) took great care to ensure comparability 
between his study of admissions to Crichton Royal in 1974-1976 
and that of Roth’s (1955) Graylingwell sample. It was necessary, 
in view of current practice, to examine those over 65 in the 
Crichton Royal sample. Roth gave figures by age only in ten year 
cohorts. Therefore, in order to obtain directly comparable 
groups, Christie looked at patients 70 years and over and 
extrapolated the equivalent sample from Roth’s data. In 
addition, as noted previously, two year follow up was performed 
only on Roth’s 1948-1949 group. The net effect was that only 143 
of the original 450 Graylingwell subjects were used as a 
comparison group. The death rate at six months and two years for 
the Crichton admissions was 15% and 50% respectively. The 
corresponding figures for the Graylingwell admissions were 63% 
and 88%. Table 3.2 summarises the data from Christie (1982), 
comparing mortality rates in senile dementia to that of Roth 
(1955) - the significance levels have been calculated as they do 
not appear in the original paper. They show, quite strikingly,
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the improvement in survival between the two studies. Christie
argued cogently that the studies were comparable though separated 
by 25 years during which time significant social, medical and 
demographic changes had taken place. Evidence was presented to 
show that the two hospitals were similar in their admission 
policy, diagnosis and outcome which further strengthened his 
argument. Christie (1982) therefore seemed justified in claiming 
that the differences were due to a genuine change in the natural 
history of mental disorder.
TABLE 3.2
PROGNOSIS OF SENILE DEMENTIA - COMPARISON OF MORTALITY AFTER SIX 
MONTHS AND TWO YEARS BETWEEN ROTH (1955) AND CHRISTIE (1982)
NUMBER OF PATIENTS DEAD AFTER SIX MONTHS
DEAD ALIVE
GRAYLINGWELL 
(1948-1949, 
ROTH,1955)
40 24
CRICHTON 
(1974-1976, 
CHRISTIE,1982)
15 85 Chi-Square X=39.5
df=l, pCO.OOl
NUMBER OF PATIENTS DEAD AFTER TWO YEARS
DEAD ALIVE
GRAYLINGWELL 
(1948-1949, 
ROTH,1955)
56 8
CRICHTON 
(1974-1976, 
CHRISTIE,1982)
50 50 Chi-Square X=24.0
df = 1, p<0.001
1
Whitehead and Hunt (1982) followed 45 cases of Jchronic 
brain syndrome’ (not further defined) for a period of five years 
after admission. The death rate in the first year for those aged 
75 and over was 42%, and for those aged 64-75 the rate was 24%. 
The combined death rate for all ages was 35% after one year and 
77% after five years.
The drawbacks of assessing survival on hospital based 
populations have been noted (Christie, 1987). These subjects 
represent a biased sample. It is possible that mortality is 
overestimated when data are obtained from this population. Molsa 
et al (1986) followed 218 patients with DAT from a community 
sample - all subjects alive on a particular prevalence day were 
traced six years later. Survival in DAT was 21.1% compared to 
the expected rate of 48.5%. The mean duration of illness was 5.7 
years. Mortality was independent of age but was greater with 
increased severity of dementia. The study confirmed, in a 
representative community sample, that DAT was a malignant 
condition.
This "malignant” aspect of DAT has been addressed 
specifically by two authors. Katzman (1976) emphasised the poor 
prognosis and made the point that as DAT was often not stated on 
the death certificate, both its prevalence and its contribution 
to the death rate were being seriously underestimated. Go et al 
(1978) entitled their study "The malignancy of dementias". A 
large group of patients (N=982) had all undergone post mortem 
examinations in the University Hospital in Geneva over a ten year 
period. Survival time for those with AD (proven at post mortem) 
was one third that of the normal population and was 10% of that
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expected from the time of admission to hospital. The presence of 
neurofibrillary tangles in the neocortex was associated with a 
longer survival time.
More recent studies on survival have taken a slightly 
different approach. Instead of reporting comparative 
survival rates, some have used more sophisticated statistical 
tests in an attempt to identify specific factors within groups 
which are predictive of survival.
An early contribution to this field was by Naguib and Levy 
(1982a). Forty patients with SDAT who had been studied in an 
earlier CT project (Jacoby and Levy, 1980a) were followed up for 
a mean of 29 months. One patient could not be traced, 27 had 
died and 12 survived. The deceased group had performed worse on 
a scale of parieto-temporal dysfunction, suggesting that parietal 
lobe changes were an indicator of a poor prognosis (thus 
confirming the earlier work of McDonald, (1969) and Hare, (1978, 
see Chapter 2.3). The work of Constantinidis (1978) suggested 
that subjects with parietal lobe signs had a better prognosis 
than those who did not show the signs. However, the younger age 
of onset of the former group and the failure to take age into 
account in the analysis means that their conclusion could not be 
validly drawn.
Barclay et al (1985,a) used life table analyses to compare 
survival times over five years in patients with three types of 
dementia - DAT (N=199), MID (N=69) and 43 patients with "mixed" 
DAT/MID. Fifty per cent survival for the groups was 3.4 years 
for DAT, 2.6 years for MID and 2.5 years for the mixed category.
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These results confirmed (using a powerful statistical technique) 
the poor prognosis in DAT compared to normals but also emphasized 
the even worse prognosis in vascular dementia. It is 
interesting to note that patients with mixed dementia had a 
prognosis almost identical to that of the pure vascular group.
In an accompanying paper (Barclay et al, 1985b), the same 
group presented a more detailed analysis of the DAT population. 
They were divided into subgroups, depending on the presence or 
absence of a particular characteristic. Lowered survival was 
associated with being male, having an age of onset of less than 
65 years and having a high rating on a behavioural abnormality 
scale. Duration of illness, cognitive function and the presence 
of vascular disease had no influence on survival. This study 
confirmed the work of Seltzer and Sherwin (1983) by showing that 
an early age of onset had a significant negative effect on 
survival but, surprisingly, found that impaired cognition had no 
such effect. The authors postulated that this result was due to 
the relative insensitivity of the instrument used (The Kahn- 
Goldfarb Mental Status Questionaire, Kahn, 1960).
McLaren et al (1986) used two cognitive tests (the Paired 
Associate Learning Test (PALT, Inglis, 1958) and the cognitive 
section of the Clifton Assessment Procedures in the Elderly,
CAPE) and one behavioural test (the behavioural section of the 
CAPE) to predict outcome in 107 elderly demented patients. The 
non-survivors had worse scores only the ’’easy” tests of the PALT 
and the CAPE; in the other tests there were no differences 
between those patients who died and those who survived. The 
population under study included subjects with both vascular and
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degenerative dementia and served to emphasise the poor prognostic 
significance of cognitive impairment.
Heyman et al (1987) confined their investigations to early 
onset DAT and assessed predictive features of
institutionalisation and death. The study had the advantages of 
being prospective with 100% follow up and also that all the 
patients satisfied the NINCDS/ADRDA criteria for DAT. Death was 
predicted by poor cognitive function (particularly language 
dysfunction) and overall dementia ratings. Age had a significant 
modifying effect - the younger the patient, the greater the risk 
of death for the same degree of cognitive impairment. The Cox 
proportional hazards model and the Kaplan-Meier technique were 
used to show that aphasia was associated with
institutionalisation for younger subjects but not for older ones.
Christie and Wood (1988) described the course of the illness 
in two groups of SDAT subjects - those aged 65 to 74 years and 
those 85 years old and above at the time of their terminal 
admission to hospital. The two groups were significantly 
different with regard to survival. The older group had a more 
benign course, surviving for at least 70% of their disease 
outside the hospital. Once admitted, however, survival time was 
short. In contrast, the younger group spent about 50% of their 
time in hospital and survived longer than the older group after 
admission. A behaviour rating scale correlated with survival in 
the young group but not in the older subjects. Christie and Wood 
(1988) presented compelling evidence of the differences in 
survival between young and old SDAT patients. The differences did
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not appear to be due to social factors - the reasons for 
hospitalisation and the social characteristics of the two groups 
were similar, suggesting that the elderly group lived at home for 
a shorter time. The correlation of the behaviour scale with 
subsequent mortality may simply reflect the presence of items on 
the scale which measure more accurately disease characteristics 
associated with dementia in the young but not in the elderly 
(possibly due the confounding effect of more physical illness in 
the latter group).
Knopman et al (1988) reviewed the survival of 101 DAT 
subjects between two and four years after their assessment in a 
dementia clinic. Using the Kaplan-Meier technique, it was found 
that 92% of subjects with mild dementia were alive after three 
years compared to 69% with advanced dementia (severity of 
dementia was defined as a score of above or below 16 on the 
Information, Memory and Concentration scale (IMC), Blessed et a l , 
1968). Being male and rated as irritable or exhibiting nocturnal 
disruptive behaviour were associated with significantly higher 
mortality. The study confirmed clinical sense and suggested that 
disruptive behaviours may be specifically identified which are 
predictive of death. One explanation is that behaviours such as 
"nocturnal wandering" and "irritability" may be indicative of 
confusional states, and therefore underlying physical illness, 
leading to a higher mortality.
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2.3 LONGITUDINAL CHANGES IN COGNITION
Recognition of the decline in cognitive function associated 
with the progression of SDAT is so widely accepted that it is 
included as a defining characteristic in the major diagnostic 
schemata (McKhann et al, 1984; DSM IIIR, 1987). The rate of the 
decline depends on the population under investigation and on the 
assessment instruments employed. A summary of studies looking 
at longitudinal change in cognitive function appears in Table 
3.3. Some assess cognitive change over a short period of only of 
a few weeks. These results cannot be considered real evidence in 
support of an investigation into the natural history of SDAT.
They are mentioned briefly for the sake of completeness and 
because they raise interesting issues concerning the assessments 
used and methods employed. Studies in which the diagnostic 
criteria suggest that a significant number of subjects, without 
SDAT, have been included will not be discussed.
One of the earliest investigations into change in cognitive 
function was by Walton (1958). Walton reanalysed the results 
obtained two years previously on the Wechsler Memory Scale for 
patients in the placebo group of a six week trial of 
Parenterovite. All suffered from memory impairment, but the 
group included patients with both functional and organic 
diagnoses. The memory deficit in the former group was attributed 
to either a *pseudodementia* (apparent dementia resulting from 
depression) or to the effects of prolonged hospitalisation. 
However, the author re-examined the case notes two years later in 
order to substantiate the diagnosis. Of 14 patients thought 
initially to have an organic dementia, three had changed
120
H ^  tr1 ^  CP / - n  7$ ^  2 ; n-v. O S3 COJ P* P- P  p . !-* P P  P i—* P jy P  O P P rt
P vo rt VO CO vo p VO 00 VO O' H* vo s; P P CI—1 oo rt co rt 00 CD 00 c 00 P rt 'O p P* rt P.
O' P* Ul o Ui CD tO H* 4> P P U l p M O UJ
P v.  ^ n> N-' o w  < v O' N-/ (0 P* P P
P m P - P P I—1 P PP- P o v_x fu P P rt t r
rt P p* P rt P . I-1
O P Cu P <■—\ VO
M P D- p P ✓“s i-1 P Ui
e 1-* rt r* l—1 p VO oo
p o (D VO -uCu o p <J •—1 to 1—1
3 I-1 I-* UJ — 1 N -'
P CD s _ / P
P P
OQ C
P 0)
P Pi p: Pi Pi pi pi P Pi XJo o < o P >  P > o P Ort - rt X3cCO CO p
rt rt p
P P rt
rt r t P
P P O
P- P. P
p
•xi
C/3 21c CCO to P -> I-1 p I-1 to CO p o' 0-P* OV CO U> o 00 Ul oo 00 to (-1.
port
co
O*PM
o
Ml
CO
p
P -•;p .
I-1 4> U) to to p CO Ov Ov C/3 O
CO
1
Ov 00 o ■O- ■0 to
0 « c
rt
C
c
M
4> 0 0 0 0 0 0 o P p CL. Pto O O o o O o p P p UJ rt
0
P P p p P p rt ?r 5* Prt rt rt rt rt rt or CO CO O
O P* CT P* P* pr P* CO PP CO CO CO co CO CO
rt o
P* Mi
CO
oMl
j.
0 as 2! 25 25 a cc no pc o 2! o Oo o O O o P CD J> rt M o
P p P P p 0 P pr XJ O pp p P P p P C p P c rtP Ou M X) M
rt O O__.. _ P  1 H-*
P
?rp cd hC xJ Pi W O s 3 /-^  00 X CP s: 3us a >  > P a  cp p s CO P> C3 p pCO tr* r* P CO to p CO P rt f P p p.o H  H M rt pi P P H pr CO
< P P CO CO Cp i i M H* rt rt CO P M
M O P co CP tr* P c PH* 1-t xi P* P X o P M pP p p P P rt O H p O
P TO M O CO v-/ Mi * 3 rt MlMi P p rt P H*V P P CC P CO 0 O prt P P CO O p o P O
P P 0 p 00 p M OQ
C3u P P o P CL u; P
P M P p H*
Mi Ml rt P rt M CO It
O O P P p P*
M M P < OQ p <3
0 0 P P I-1 PCO CO p
P Ml r t
P P P
M* P P
P P r t
r t
P r t
O P
P CO
rt
P p o CO
O o Ml P -
rt rt
o
OQ
P
CO 25 CO 25
+ H- +
2! p* P*
X) CO i f X) CO St- St- CO +  - p Mi
p p p P -
p p st- it- OQ P
H- p* P P
Ml Ml P
P* P - P
P P P
Cu Qu
ro
lo
St" + rti O rd a *1 fflI-*a a !> a MI 1 H a F* H t tH I
02 02 i t t 0 0
ffl ffl 1 0 fflp00 00 nj 0 Cu p O *-<!
P P P i-* X) ffl rt CO
ffl ffl O ffl p 00 rt X) O
ft) rt> ro P ffl ffl O ffl O
ffl H> \ ffl rt rt t—1 rt P
O O a O ro CO P rt
P P p P cu P 1—1P
P P p ffl O 53 ffl
ft rt Cu >  a ffl ffl Pcu CO ■o ft p
cu CU rt ro CO H" P* X3 CO
ro ffl ro 0 0 P p p
0 rti CO ro 0 00 r-h rt ffl
i-1rt) rt p ffl P ffl <_u
ffl ro • rt P rt P ro ro
p rt ffl ft ro O P 0
ro ro P ro co rt rt rt
p rt ffl CO CO
ffl 0 rt ffl O >*
p ro P ro P £
CO ft p J* P ffl ffl
rt ffl rt ro I-1 > ft
P* ffl P P P ffl
ro P 00 ffl Cu ffl 1«+ P rt I-1 cu
cu 0 00 fflI-1ffl ro
ro a W O P O 0
0 p cd H ro CO ro
ro p 02 rov^1CO X) P
p 00 CO CO ffl rt
rt ro i rt rt ffl
ro CO V 02 P P
cu W a a ffl
o' ffl H O
00 ro ro 1 P rt
rt rt CO 02 t cu ffl
O S CO PI : P :\0- ro
P ro ro 02 O fflrt
a ro cu t *<5 rt CO• P p 0 CO rt
rt
fl>
CU
ro
0ro
p
rt
ro
cu
p
pCu
o
o
p
rt
rt
O
ffl
OQrt
O
P
a
CU
ro
0ro
p
rtffl
P
02
O
O 
p
ffl 0
3: 
ro 
P 
rt 
p
p
o p
P P
CO 
' >ffl .
ro rt a  n
p n  o ?  rt o ro
P I—1 I H*
ff l CO @
P P ffl ro
M 02 00 0 rt
ro ft CO —
p rt ffl CO
rt ro ffl
02 ro CO rt cu
ffl rt P ffl
S Cd M CO
02 * ro
*0 P -—O- P •
0 ro P CO
1 fflP rt ro
P cu ffl •
02 P rt P
ffl rt ffl rt
0 ffl 0 ffl
rt O ?r rort P 'w' P• rt
ffl CO
O <•
rt
rt <5
P
a
S
ro
P
rt
p
02
rt
P
rt
Pco
O
Pro
CO
rt
ffl
O
P
P
Pffl
rt
ro
<oI-*
p
p
rt
rorort
CO
ffl
p
cu
ro
0ro
p
rt
a
rtO
OQ
rt
P
0
0ro
^  0 /'-N cd S N Cd Cd a /-n cd 02 H
ffl rt ffl ro ffl P ro ro p ffl 0 rt P
vo rt VO 0 VO rt rt rt rt) vo rt P cd
00 0 00 00 N 00 00 r-t) CO t , Cu ffl
VO 1-t) 00 ro 00 0 O) H* ro'—✓ "ffl rt v-/ P ro ro ro s-/ p
p P rt rt rt ffl u>
p ro O •
CU rt ro P P P LO
rt ffl ffl ffl
0 P ro
rt ffl P /—\ /—n rt O
ffl ffl ffl ffl O
CO vo vo VO P P
rt 00 00 00 ffl rt
P 00 '•J ''J —ffl cu
-g
U1
•P-
NJ
0O
Prt
aco
a
o
Pro
a
a
02
p
o
rt
co
a
ro
O
ro
cu
to
cd
to
0o
p
rt
P*
CO
02
a
a
a
02
+
Sf-
25 PJ
CP
O
to
CD
0O
P
rt
a
co
3
o
pro
.0us
<T>
CD
0
O
P
rt
p*
co
+
*
to
O '
u>
o
0o
p
rt
P*
co
0 ffl Cd O a
0 p p a a
p 1-t) rt pd a
0 0 rt - <•ro rt ro
p 3 rt a a
rt P ^ a a
rt rt - 02 a
P ffl S0 a
rt O rti O
ffl P a  02
O w h a
P s a
02 aH ro O H
ro 0 V
CO 0
rt rt P
a/■t a
rt) P p
rt P COO cu ffl
0 p
Cda
02
+
St"
•o
OJ
0
o
p
rt
a
CO
a
o
pro
Cd
O
02
00
•P*
00
0o
p
rt
a
CO
r-h
P
P
O
rt
ffl
o
P
rd
O
a
Pffl
P
rtffl
O
P
a a
P p
a 0
c_i. aro ro
0  ■ rt
rt
CO 0
rt)
O Oa rt 0O P
P rt
a rt
O
ffl
^  I-* K
CO CD ro
ro p
ro rt CO
ro P
rt co rd rt
ro rt P ro
X CO P
a O 0
s-' 0 rt rt)
rt) ffl
0 O
0 P O
O 0000 P
P ffl
ffl rt
rt ffl
ffl <
< ro
p 0 a
0 rt) ffl
rt 00O P
co + a ffl
a p rt)
ro st" p ffl
0 00 Offl ro P
rt) P
ffl O
ro ro
CU
sufficiently to be rediagnosed as having functional disorders.
One patient considered to have senile dementia had become 
depressed. The reanalysis confined itself to the 12 patients 
diagnosed as having a definite organic disorder two years after 
the trial. Scores on the Wechsler Memory Scale did not 
deteriorate significantly in the organic group over the six week 
trial. When compared to the functional group, it was found that 
the difference in change was significant between the two groups. 
Although the diagnostic criteria used are open to criticism, the 
follow up was a clever way of validating the diagnosis. In that 
sense, it is similar to the work of Roth (1955).
Kendrick (1972), in a paper discussing the theoretical 
assumptions behind the Kendrick Battery of tests, examined 38 
demented patients with the Digit Copying Test (DCT) and the 
Synonym Learning Test (SLT). The main aim of the paper was to 
assess different cognitive deficits in three groups of patients - 
demented, depressed and those with pseudodementia and to compare 
them with normal elderly controls. It was found that the DCT (a 
test of sensorimotor performance) was significantly decreased 
compared to controls only in the demented group. The SLT (a 
test of intermediate memory) was similarly lowered in subjects 
with pseudodementia compared to the normals and the depressed.
The demented group had the lowest scores. Over a six week test- 
retest period, some improvement was noted in cognitive function 
of the group with pseudodementia but no change in the others. The 
short duration of the study (six weeks) and the insensitivity of 
the assessment (ie a grading of ’organic* or ’non-organic*)
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detracted from the importance of this conclusion. The non­
significant change cannot be assumed to be a true finding and may 
have reflected inappropriate methods. However, one may infer from 
the results that these tests showed a consistency when 
administered to patients over a period of weeks, emphasising 
their test-retest reliability.
Cowan et al (1975) presented psychometric data from the 
US/UK Diagnostic Project from Queens County, New York and from 
Camberwell, London. Patients were assessed using the PALT, the 
Digit Copying Test (DCT, Kendrick, 1965) and the Bender-Gestalt 
Test (BG, Shapiro, 1956). In an attempt to compare diagnostic 
practice between the two countries and to validate the Geriatric 
Mental State Schedule (Copeland et a l , 1976) as an instrument
capable of differentiating depression and dementia, the three 
psychological tests were administered one week, one month and 
three months after admission to hospital. A comparison using 
nonparametric statistics showed no significant change in the 
demented group over the three month period for either country. As 
age and baseline score differed in patients with dementia and 
affective disorder, these two variables were used as covariates 
in a multivariate analysis of covariance. It was found that in 
all three tests, there was significant differential change in 
patients with dementia and affective disorder, the former showing 
significantly less improvement than the latter.
These early studies (Walton, 1958; Kendrick, 1972; Cowan et 
al, 1975) suffer from similar drawbacks which diminish their 
ability to support the hypothesis that cognitive function 
declines in SDAT. First, in common with many other studies on
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dementia, the diagnostic criteria are not provided. It is 
therefore probable that patients with dementia due to causes 
other than SDAT were included. Second, the duration of the 
follow up period is too short to assess change adequately.
Third, duration of dementia is not given and so it is difficult 
to judge whether patients are in an early or late stage of the 
illness where ceiling and floor effects may be anticipated. These 
criticisms cannot be levelled with the same force at subsequent 
investigations.
Whitehead (1977) reported follow-up data on 15 patients with 
chronic brain syndrome who had been assessed on two occasions, 
one year apart. Many different ratings were made of behaviour, 
mobility and self-care skills as well as cognitive function. 
Performance on the following cognitive tests showed a significant 
decline over the test period: an overall clinical rating of
intellectual impairment; WAIS vocabulary; digits forward; general 
orientation; general events; total learning score and a parietal 
scale. Verbal fluency showed no change. This report was one of 
the first studies to show a well documented decline in cognitive 
function in SDAT over time. However, it was possible that 
patients other than those with degenerative dementia were 
included. Also, data were available on only a small number of the 
total, hence there may be a degree of sample bias. One further 
criticism was that some of the tests used had no proven 
reliability or validity.
From the 1980Js onwards, more rigorous clinical criteria for 
SDAT were employed and follow up periods tended to be longer.
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Rabins et al (1984) followed patients with dementia, pseudo 
dementia and depression for two years. They demonstrated that 
using the MMSE (Folstein et al , 1975) patients with dementia 
deteriorated significantly over time (mean initial MMSE 11.2, 
mean after two years, 4.2). Patients with pseudodementia 
improved on the MMSE but depressed patients remained the same. 
This sophisticated study was the first demonstration of the 
validity of the MMSE as a measure of cognitive decline in 
dementia.
Naguib and Levy (1982,a) investigated 10 of the 12 
survivors of an earlier study (Jacoby and Levy, 1980a) and 
performed repeat psychological tests, using the Mental Test Score 
(MTS, Hodkinson, 1973) and CT scans after two years. All patients 
satisfied strict criteria for SDAT. A summary of the MTS results 
is shown in Table 3.4.
TABLE 3.4
SUMMARY OF FINDINGS ON MENTAL TEST SCORE IN NAGUIB AND LEVY 
(1982,a).
Initial Final Difference Significance
MTS MTS in MTS of change
Mean(SD) Mean(SD) in MTS *
Group 1 14.4(3.6) 13.6(3.0) -0.8 £ p=0.345
(N=5)
Group 2
(N=5) 14.0(2.7) 4.6(3.3) -9.4 £ p=0.043
Total
(N=10) 14.2(3.0) 9.1(5.6) -5.1 p=0.016
Key: MTS- Mental Test Score.
* - assessed by Wilcoxon matched-pairs signed-ranks test.
£ - significance of difference in MTS between group 1 and 2, 
p=0.008 (Mann-Whitney U test, two tailed).
126
Two subgroups emerged - one with no deterioration in MTS and a 
small increase in Ventricular Brain Ratio (VBR, Group 1) and a 
second group with a significant deterioration in MTS and increase 
in VBR (Group 2). The number of subjects was small and may be a 
biased sample in that they represented survivors who had a milder 
form of illness than those who died (Naguib and Levy, 1982b). 
Despite the small sample, this study raised the exciting 
possibility of two subtypes of SDAT - one showing significant 
cognitive decline over time, the other showing no decline.
Berg et al (1984) classified 43 SDAT subjects as having mild 
dementia using the CDR (Hughes et al, 1982). They followed the 
sample over 12 months to assess who would progress to moderate or 
severe dementia. Twenty-one patients did deteriorate and while 
EEG and CT measures were not helpful in predicting which 
patients would deteriorate, the Digit Symbol Substitution Test of 
the WAIS and an aphasia test predicted correctly the subsequent 
stage of dementia in 95% of cases. These results essentially 
replicated the work of Naguib and Levy (1982b) in showing the 
poorer prognosis in subjects with aphasia.
Using a new rating scale for DAT (the Alzheimer’s* Disease 
Assessment Scale, ADAS), Rosen et al (1984) retested ten subjects 
over a period of one year. The criteria were stated in the 
paper and approximated to DSM IIIR criteria for degenerative 
dementia. On the cognitive subscale of the ADAS, the ten DAT 
subjects deteriorated significantly over one year. In contrast, 
normal elderly subjects showed no decline over the year.
Knesevich et al (1985) described 43 patients with DAT
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diagnosed in accordance with the NINCDS/ADRDA criteria (McKhann 
et al, 1984). The patients were divided into those with, and 
without, aphasia and were followed up for 30 months. All 
patients were described as ’mild* (category 1) on the CDR (Hughes 
et al, 1985), at the start of the study. For ease of reference, 
the results are summarised in Table 3.5.
TABLE 3.5
SUMMARY OF FINDINGS OF KNESEVICH ET AL (1985)
AD patients- 
with aphasia
AD patients- 
without aphasia
Number (N) 24
Errors on BDAE 9.55
Errors on BDS 5.30
At 30 month follow up:
N progressed to
CDR 2 23
N developing 
aphasia
Progression in BDS 16
N dead at follow up 5
% risk of developing 
dementia to age 79:
Siblings of probands 7.5
Parents of probands 17.7
19
1.08
4.61
11
2
7
4
26.3
34.5
p<0.001
NS
p<0.005
NS
p=0.001 
p=0.001
Key: BDAE - Boston Diagnostic Aphasia Examination 
BDS - Blessed Dementia Scale 
CDR - Clinical Dementia Rating 
NS - not significant at p<0.05.
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After 30 months, 80% of the sample had progressed to 
moderate dementia (CDR 2). 96% of those with, and 58% of those 
without, aphasia had progressed (statistically significant at p 
<0.001). A deterioration in cognitive performance, as measured 
by the BDS, had occurred in both groups, with a tendency (not 
statistically significant) to greater impairment in the aphasic 
group. The work was important in that it documented progressive 
cognitive decline in a rigorously selected sample of DAT 
patients. It also showed clear differences in patients with and 
without aphasia. However, there was incomplete information given 
on the two cognitive scales used, possibly as not every subject 
was tested. The method of evaluating non-progression on the BDS 
was to define an error score regardless of initial score which 
may have masked a true decline.
An uncontrolled descriptive study of the decline in 13 
patients with DAT was presented by Dastoor and Cole (1985). The 
Heirarchic Dementia Scale (HDS, Cole et al, 1983) was used to 
trace the natural history of the patients over four years. There 
was wide inter-subject variation in the rates of decline, all but
one subject showing a decrease over time. While there was a
trend for younger subjects to decline more rapidly, there were 
many exceptions. This descriptive study was useful in that it 
emphasised the variability of cognitive decline. However, the 
small numbers involved and the relatively unknown scale employed 
makes it difficult to draw definite conclusions.
The early studies described in this section (Walton,
1958; Kendrick, 1972; Cowan et al, 1975) showed no decline in 
patients with SDAT over a number of weeks. Although no decline
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was shown, there was a significant absence of a ’practice effect’ 
in demented patients. This aspect was examined in detail by 
Little et al (1986) using two different subtests of the PALT 
(Inglis, 1958). Memory was assessed using both a repeated and 
parallel form of the PALT in 26 subjects fulfilling strict 
criteria for SDAT. If new learning were possible in SDAT, 
performance on the former (where the same material was repeated) 
would have shown a different pattern to that on the latter (where 
different material was repeated). Five test sessions over six 
months did show that, where items were changed (the parallel 
form), there was a progressive deterioration in performance. In 
the repeated form, scores remained the same. Thus, this ’masking 
of deterioration’ using the repeated form suggested that, at 
least to some extent, new learning was shown in SDAT patients. 
This observation has important implications for repeated 
neuropsychological assessment in SDAT subjects.
Botwinick et al (1986) studied 18 DAT patients extensively 
using 16 cognitive tests annually over four years (although 
curiously these were referred to as ’behavioural tests’). All 18 
were rated as CDR 1 (ie mild dementia) at the start of the study. 
The neuropsychological battery consisted of the Wechsler Memory 
Scale (mental control and logical memory), digit span backwards 
and forwards, associate learning, word fluency, Boston naming, 
visual retention (recall and copying), Bender Gestalt, four 
subscales of the Wechsler Adult Intelligence Scale (information, 
comprehension, digit symbol and block design), the Trailmaking 
test (Part A) and Crossing-Off. All tests showed significant
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decline in the DAT patents over the four years, the greatest 
decline being in logical memory (79%) and the smallest in digit 
span forward (51%). The control group showed no significant 
decline. A subgroup of five SDAT patients declined only on the 
Bender Gestalt test, with no significant deterioration in the 
other measures. They did, however, show more decline than normal 
controls in three other tests. Four possible explanations for 
the results in this subgroup were put forward:
1) that decline in SDAT has a normal distribution and the 
group was simply at one end of the distribution;
2) that the group had milder disease (although the same CDR 
rating) at the start of the study. This theory was partly 
supported by an analysis of the initial scores;
3) that although they had the same CDR rating, their disease 
was of shorter duration than the others, and therefore, in 
time, they would * catch up* on their deterioration. The 
results did not, however, support this and
4) that they represented a clinical subgroup of SDAT patients.
Reisberg et al (1982) applied the Global Deterioration Scale
(GDS) to 106 community residents and studied them prospectively 
for three years. Although "dementia of the Alzheimer type" was 
discussed, no specific information (other than a description of 
the exclusion criteria) was given. Thus, it was not possible to 
be certain of the precise diagnostic criteria employed. The main 
finding was an increased risk of death and institutionalisation 
in those subjects rated as ’deteriorated* on the GDS.
The most recent five papers to be described in this section 
represent a new level of enquiry into the longitudinal assessment
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of SDAT. Patients were diagnosed using the most stringent 
criteria for the clinical diagnosis of DAT (McKhann et a l , 1984). 
Determination of decline was no longer based on simple 
descriptive statistics comparing an initial score and a final 
score on a particular cognitive test. Complicated statistical 
methods were employed to calculate the predictive value for 
decline of various cognitive tests and numerical values obtained 
to quantify rates of decline. Three of these papers present 
results which are part of large and well organised longitudinal 
studies into the natural history of SDAT.
Huff et al (1987) challenged the traditional view that early 
onset DAT progressed more rapidly than late onset disease. Data 
were collected on 165 consecutive out-patients attending a 
memory clinic. The authors found a bimodal distribution of age 
at onset of dementia, with one peak around 56-60 years and 
another around 68-70 with a relative trough occurring at 65.
This led them to the conclusion that two discrete populations 
existed. Progression of the disease was assessed by the BDS, 
repeated at intervals of three months on 77 of the sample (the 
exact number of follow ups and their timing was not stated).
There was no correlation between rate of progression and age of 
onset, chronological age or duration of dementia in the senile 
onset group compared to the presenile group. Also, although the 
two groups were of equal severity at the first examination, the 
senile onset subgroup had a significantly shorter duration of 
illness than the presenile subgroup. The report seemed to be at 
odds with traditional teaching (although agreed with a study
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published in the same year by Grady et al (1987), discussed in 
Chapter 2.2) yet did not explore the possible explanations for 
the results. Information about the samples was inadequate and it 
was not clear if both the dementia scale and the IMC test of the 
BDS were performed. If both of these tests had been carried 
out, the functional and cognitive subscales should have been 
analysed separately. Also, fewer than half the patients received 
follow-up examinations. Consequently, the sample was not 
sufficiently representative. Despite these drawbacks, the paper 
contributed important information about age and rate of 
progression of early and late onset DAT.
Berg et al (1987) evaluated three scales in 43 patients with 
DAT over a period of 30 months. Only 26 patients completed the 
tests. The tests consisted of the BDS (the observed behaviour 
scale only, not the IMC scale), Pfeiffer’s Short Portable Mental 
Status Questionnaire (SPMSQ, an 11 item scale testing mostly 
memory but having one item on concentration, Pfeiffer, 1975) and 
the Face Hand Test (FHT, Zarit et al, 1978). The CDR was used as 
a rating of severity of dementia throughout the study, all 
subjects starting with a rating of I (ie mild dementia). From 
the initial values on the three rating scales, it was not 
possible to predict how severely demented the patients would be 
at the end of the study. Indeed, the agreement between the CDR 
rating and the scores on the three questionnaires at the end of 
the study was far from convincing. Differential progression was 
found in the group - of the patients completing the study, five 
remained mildly demented, ten had progressed to moderate dementia 
and 13 had progressed to severe dementia. (The figures provided
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in the paper did not tally, possibly because not every patient 
performed all of the tests). The authors claimed that their 
results provided evidence for heterogeneity within the SDAT 
group. This assumption seemed premature as the CDR is not a 
widely validated instrument. In addition, the findings were 
similar to those of Botwinick et al (1986). This similarity was 
not surprising as the samples were drawn from the same group of 
patients.
The same sample was described again by Berg et al (1988).
On this occasion, the results were given of five brief 
questionnaires - the BDS (both the dementia scale and the IMC 
subscale), the SPMSQ, an aphasia battery and the FHT. In 
addition, the results of the "sum of boxes" was produced, thus 
giving a composite score ("sum") on each of six cognitive 
categories ("boxes"). This forms the basis of the CDR score.
The natural history of the disorder was measured by the 
deterioration on the cognitive scores, age at death and age at 
placement in a nursing home. The method employed by Berg et al 
(1988) to indicate the deterioration in cognitive function was to 
report the results as percentiles, ie the percentage of the 
sample scoring above a certain level. In the majority of the 
tests, the ceiling level was reached by 50 months indicating that 
the disease had progressed to an advanced stage. Correlations 
between the various tests were low and this result led the 
authors to the conclusion that they each represented discrete 
cognitive defects. It is interesting to note that the correlation 
coefficients increased dramatically as the study progressed.
13k
Four of the tests showed similar patterns of decline {the 
"sum of boxes", the BDS {both functional and cognitive 
components and the aphasia battery). The FHT showed great 
variability in the scores (ie even some mildly demented patients 
did badly on it) and the SPMSQ reached its ceiling very early on. 
Consequently, these two tests were considered unsuitable for the 
longitudinal assessment of SDAT. The authors main conclusion 
from the paper was that the "sum of boxes" was the most 
informative measure to assess the natural history of SDAT. This 
conclusion did not seem justified as it was based on a relatively 
crude and insensitive scale such as the CDR. Some criticisms 
may be levelled at this paper, on the basis of the instruments 
used. The "sum of boxes" which was claimed to be the best 
instrument represents a clinician’s rating of the degree of 
disability. As to be expected, the clinicians’ rating showed 
deterioration as the disease progressed. The authors quoted 
reliability statistics for the CDR (which is derived from the 
"sum of boxes") but to claim that reliability statistics may be 
interchanged in this way seems presumptuous. The authors 
included tests which were dependent on the patient’s performance 
in a test setting as well as scales relying on observer rating. 
The "sum of boxes" is a mixture of cognitive abilities (memory 
and orientation) and functional status. Although the various 
cognitive measures decline with time, the authors correlated this 
with the CDR which they employed as their "gold standard".
Despite the complicated and involved method of its rating, the 
CDR is simply a severity scale of mild, moderate and severe. 
Within the limitations indicated, the paper was valuable in that
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it addressed the issue of which tests are most appropriate for 
use in the longitudinal assessment of SDAT.
Katzman et al (1988) presented results from one of the 
largest investigations into the natural history of SDAT. The 
annual rate of change in the IMC was assessed in 161 patients 
with either DAT or autopsy proven AD. Four different groups 
were studied - patients in a nursing home, patients attending a 
private practice out-patients service and two groups of 
volunteers involved in an ageing study and an AD Research Centre. 
All subjects were followed for at least one year. The IMC showed 
a ceiling effect on error scores of 24 and above. When subjects 
with these scores were excluded (leaving 142 subjects), two 
interesting results emerged. First, rate of change in the IMC 
score (an average of 4.4 additional errors per year) was not 
significantly different in the four sites. Second, the rate of 
change was independent of sex, education and most importantly, 
age. Thus, there was no evidence to support the hypothesis that 
a difference existed between early and late onset DAT (the age 
range of the sample was 52 to 96 years).
Two minor criticisms may be made of this important paper. 
First, the changes were calculated for the groups as a whole and 
no attempt was made to assess the significance of individual 
differences (eg by using a paired non-parametric statistic). 
Individual assessments would have provided important information 
about the differences in individual patients. Second, a case 
vignette was provided of a patient whose IMC score improved by 
five points throughout the year. The improvement was attributed
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to the patient’s habituation to the effects of large doses of 
Clonidine with which the patient’s hypertension had been treated. 
This subject would not, in my view, have fulfilled the NINCDS- 
ADRDA criteria although the authors claimed that all their 
patients did so.
Ortof and Crystal (1989) reported the rate of cognitive 
decline over 12 months, as assessed by the IMC, in 54 patients 
with DAT. The average rate of increase was 4.1 Blessed points 
per year and showed a normal distribution. Age of onset, 
duration of illness and family history of dementia had no 
influence on the rate of progression. The absence of an effect 
on progression by age of onset agrees with earlier work (Grady et 
al, 1987; Huff et al, 1987) but the lack of an influence on 
progression by duration of illness disagrees with the study of 
(Thai and Grundman, 1986).
Recently, an interesting study has measured decline in 
cognitive function over time and has related it to a biochemical 
marker. Urakami et al (1989) studied 26 patients with SDAT and 
divided them into three groups, depending on their decline as 
measured by the Functional Assessment Staging method of Reisberg 
et al (1985). Eleven patients had a rapid decline, six an 
intermediate decline and nine a slow deterioration. CSF 
concentrations of acetylcholinesterase and somatostatin were 
measured in each of the three groups and compared to the levels 
in both younger patients with DAT and age matched controls. 
Activity of both neurotransmitters was decreased in the younger 
patients and in the SDAT subgroup who deteriorated rapidly. There 
was no difference in the CSF activity between the other SDAT
137
groups and the age matched controls. The CSF examination had 
been performed at entry to the study. This, coupled with the 
fact that CSF acetylcholinesterase is known to be relatively 
stable over time and independent of dementia severity, makes the 
findings most important and raises the exciting possibility of a 
biological marker to indicate subsequent course of the disease. 
The study requires replication on a larger sample.
3.4 LONGITUDINAL CHANGES IN COMPUTED TOMOGRAPHY SCANS
Very few studies have been done which have looked at 
longitudinal changes in CT scans over time. While a single CT 
scan is of limited diagnostic use, serial scans on individual 
patients have been performed in an attempt to improve diagnostic 
accuracy and to follow the course of the disease. Studies which 
have involved the longitudinal assessment of CT scans are 
summarised in Table 3.6.
Naguib and Levy (1982a) were the first to perform serial 
scans of patients with SDAT. Their findings (in ten patients) 
suggested that there were two subgroups of patients - one with 
relatively stable ventricular size and little deterioration of 
cognitive function over time, and the second with a marked 
increase in ventricular size associated with significant 
cognitive decline. Gado et al (1983) scanned 45 DAT patients one 
year apart. They found that a significant degree of ventricular 
enlargement occured over that time but was not present in non­
demented controls. They observed that computer-assisted 
volumetric measures of CSF space were a more sensitive indicator 
of change than linear measures. Brinkman et al (1984) showed, in
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five patients with DAT, that the increase in ventricular size 
was significantly greater than in normal ageing. Bird et al 
(1986), in a unique study, re-scanned 27 subjects who four years 
earlier, had been part of the control group in another CT study 
(Jacoby et al 1980). A reduction in the MTS of more than three 
points was associated with an increase in VBR and lower 
attenuation numbers in the left thalamic region at follow-up. 
Luxenberg et al (1987) re-scanned 18 patients with DAT and 12 
healthy controls from between six months to five years after the 
first scan. The increase in size of the lateral ventricles in 
male DAT patients was such that it completely separated the male 
group from the control group. Finally, de Leon et al (1989) found 
an annual increase in ventricular size of 9% in DAT patients 
compared with 2% in normal controls.
3.5 SUMMARY
It has been known for some time that elderly psychiatric 
patients have a much reduced survival time when compared to 
healthy age matched controls. Survival has been used to validate 
disease classification in old age psychiatry and patients with 
vascular or degenerative dementia, delirium or functional 
psychoses have demonstrated differing survival patterns. It is 
therefore reasonable to postulate the presence of subtypes of 
SDAT on the basis of different survival times. DAT has been 
described as a "malignant’' condition and survival studies confirm 
that view, although there is some evidence to suggest that DAT 
patients are living longer than they did 20 years ago. Factors 
found to be associated with reduced survival include male sex,
younger age of onset, longer duration of illness and increased 
cognitive impairment and behavioural disturbance.
A progressive deterioration in cognitive function over time 
is one of the hallmarks of dementia and is a defining 
characteristic in most of the major diagnostic schemata.
Cognitive function does not deteriorate significantly over a 
matter of weeks and testing at least three months apart is 
necessary to demonstrate significant differences. There is wide 
variation in the degree of cognitive decline. Several studies 
have reported a subgroup of patients in whom progression of 
cognitive impairment is very slow. Global ratings of dementia 
(which include measures both of cognitive and functional 
impairment) appear to be more effective at demonstrating decline 
than detailed psychological tests. CSF neurochemical profiles 
have been shown to be different in patients with differing 
patterns of decline.
Changes in CT scan appearances also take place over time. 
Subgroups have been found with some subjects who have virtually 
no longitudinal change in CT indices, but the majority of studies 
report significant increases in ventricular size (both in the 
third and lateral ventricles) and in CSF spaces over 12 months. 
The increase in third ventricular size has been shown to 
separate completely male DAT subjects from controls. Thus, a
CHAPTER 4 
METHODS OF THE CURRENT STUDY
4.1 PATIENTS 
Recruitment
All patients were resident in the Camberwell Health 
Authority area in south east London (comprising the London 
boroughs of East Lambeth and South Southwark). All had been in 
contact with the psychiatric services based at the only two 
psychiatric hospitals in the area, the Bethlem Royal and Maudsley 
Hospitals (known as the Joint Hospital) and Dulwich Hospital. The 
patients recruited might be divided into two broad categories - 
those already in contact with the hospital services in October 
1986 and those who had their first hospital contact between 
October 1986 and September 1988. Patients were recruited from 
the following sources -
Inpatients - patients admitted for assessment to the old age 
psychiatry wards at the Joint Hospital and Dulwich Hospital.
After assessment, patients were discharged to their own homes, to 
private nursing homes or to Part III homes (local authority 
residential homes). A number continued in long stay hospital care 
either at Dulwich Hospital or at Cane Hill Hospital in Surrey 
(about 15 miles south of the catchment area). At the beginning 
of the study all those in hospital were included, resulting in a 
sizeable "backlog" of patients already in long-stay care, many of 
whom had been there for some years.
Day-patients - as an alternative to hospital admission some 
patients were seen on a day basis at the two hospitals. Such 
patients were generally less severely demented and disturbed than
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inpatients. After assessment, they were discharged to either 
their own or residential homes. Contact was maintained through 
two local authority day centres where day care was provided 
(Holmhurst Day Centre for South Southwark and Stockwell Day 
Centre for East Lambeth).
Domiciliary Visits - a number of patients were visited at 
home at the request of their general practitioners. A regular 
review of domiciliary reports was performed to include these 
patients. However, the majority of these were normally referred 
as either inpatients or day-patients and only a minority 
circumvented the hospital system {eg occasionally a patient was 
seen on a domiciliary visit and referred directly to a Part III 
home).
Out-patients - a few patients were referred directly 
to out-patients and these were included.
Other sources of referral - contact was made with the local 
departments of geriatric medicine and neurology and referrals of 
patients for the study were requested. Two cases, one unknown to 
the psychiatric or medical services, were first degree relatives 
of patients in the study and were found following contact with 
the probands.
The referral of patients was often at the instigation of the 
consultant in charge of the case. The author had the advantage 
of personal acquaintance with the consultants responsible for the 
care of the elderly and all were keen to involve their patients 
in the research. It is considered, therefore, that the 
population examined was free of any significant sampling bias and
that virtually all patients in contact with the hospital services 
were included. It should be noted, however, that many patients 
with senile dementia are unknown to the hospital services and so 
this study does not claim to be representative of all elderly 
demented subjects.
Inclusion Criteria
Information, gathered from the source of referral concerning 
the history and clinical findings was used to assess whether or 
not the patient was suffering from senile dementia of the 
Alzheimer type (SDAT). If there was evidence to suggest that the 
patient, although demented, was unlikely to have SDAT (eg a clear 
history of cerebrovascular accident), the case was excluded. All 
other cases were considered. Initially, a letter of introduction 
was sent to the next of kin outlining the study and asking 
permission to visit and gather additional information. An 
interview was then arranged and the history evaluated. Following 
this, the patient was interviewed and examined physically.
The criteria employed in this study have been fully outlined 
previously (Chapter 1.3) and are those of the NINCDS/ADRDA 
(McKhann et al, 1984). A decision whether or not to include a 
case in the study was taken only after the relatives had been 
interviewed. If blood tests had not been performed as part of the 
patient’s initial investigation, they were done at this stage.
The justification for the use of these criteria is twofold.
First, as has been demonstrated in Chapter 1.3, they are the best 
available and predict Alzheimer pathology at post mortem in 80% 
to 100% of cases. Second, as a measure of internal audit, the 
results of post mortem examinations of subjects in the current
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study will be presented in Chapter 10.
The application of these criteria requires explanation on 
two points. First, it is stated that these are criteria for 
AD and purists would argue that these are not the same as 
criteria which should be used to diagnose Dementia (or Senile 
Dementia) of the Alzheimer Type. However, they are clinical 
criteria and as such define a clinical syndrome - Dementia of the 
Alzheimer type. I shall therefore use these criteria to define a 
syndrome in which one might expect to find Alzheimer pathology at 
post mortem. Second, one has to accept that attempts to predict 
pathology during life are often wrong. This uncertainty is 
present in every branch of medicine and is not unique to 
psychiatry. Thus, a clinical diagnosis of Dementia (or Senile 
Dementia) of the Alzheimer type accurately defines a clinical 
syndrome - whether or,not Alzheimer pathology is found in all 
cases at post mortem is a separate issue.
4.2 ASSESSMENTS
The assessment procedure can be broken down into several 
sections-
Cognitive assessment - the main instrument used was the CAMCOG, 
which forms part of a larger assessment battery for the detection 
of dementia in the elderly, the CAMDEX (Roth et al, 1986). The 
CAMDEX (Cambridge Mental Disorders of the Elderly Examination) 
was developed to provide, in one assessment schedule, an approach 
to three related issues in the diagnosis and assessment of 
dementia - to give an accurate diagnosis, to provide a valid and 
reliable measure of the central feature of dementia ie cognitive
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impairment and to devise a reliable rating scale of behaviour and 
adaptation in everyday life. The instrument consists of eight 
sections: an interview with the patient; a cognitive 
examination (the CAMCOG); interviewers’ observations; physical 
examination; results of laboratory tests; record of medication 
taken; a section for additional information and a structured 
interview with an informant (the history schedule).
Roth et al (1986) presented details of the reliability and 
sensitivity/specificity of the CAMDEX. Interrater reliability (on 
40 subjects) was between 0.83 and 0.94 for the sections. Using a 
total CAMCOG score of 79/80 out of 107, the sensitivity of 
correctly diagnosing an organic mental disorder was 92% and the 
specificity was 96% (sensitivity refers to the number of true 
postives ie 92% of cases scoring 79 or less were clinically 
diagnosed as having an organic mental disorder and specificity 
refers to the number of true negatives ie 96% of cases scoring 80 
or above had been diagnosed as functionally ill). Actual figures 
for test retest reliability were not given but were described as 
"good".
The CAMCOG consists of 72 questions and is divided into 
several subsections, each testing one aspect of cognitive 
function. These are: orientation; language (comprehension and 
expression); memory (recall, recognition, retrieval of recent and 
remote information); attention and concentration; praxis 
(copying, ideational and ideomotor); perception; calculation and 
abstract thinking. The total score possible is 107. Additional 
questions are included to allow the Mini Mental State Examination
(MMSE, Folstein et al, 1975) and Abbreviated Mental Test Score 
(AMTS, Thompson and Blessed, 1987) to be computed. The MMSE is 
reproduced in Appendix 1 and the AMTS in Appendix 2.
The use of the CAMCOG in the present study was based on the 
second issue addressed by its developers - a valid and reliable 
measure of cognitive impairment. All the subjects involved in 
the study had already been clinically diagnosed as suffering from 
SDAT and all met the NINCDS/ADRDA criteria. Thus, the CAMCOG was 
not used as a diagnostic instrument but as a rating of the degree 
of dementia. The range of cognitive functions assessed made it 
superior to the other shorter tests available (the MMSE and 
AMTS). As the population under study was already moderately to 
severely demented, other more sophisticated psychological tests 
such as the Welscher Adult Intelligence Scale or the Wisconsin 
Card Sorting Test were clearly inappropriate.
It is reasonable to ask why the CAMDEX was not used in its 
entirety in the assessment of the population. The instrument was 
very recently developed and had, in fact, not been published at 
the start of this study. Subsequent work has consolidated the 
use of the CAMDEX as an effective assessment schedule in the 
elderly. Thus, it was reasonable at the start of the study to be 
slightly cautious about the implementation of the CAMDEX. Also, 
existing schedules were utilised where they demonstrated an 
obvious advantage over the CAMDEX. For example, in the 
assessment of psychiatric symptoms, a great deal of information 
was available about the Geriatric Mental State Schedule (GMSS, 
vide infra) and it was well known in the Department in which this 
study was undertaken. With regard to the behaviour rating scale,
1^7
many of the patients were in hospital and there was a need for a 
rating scale to assess behaviours associated with more advanced 
dementia. The Stockton Geriatric Rating Scale was therefore 
employed. Basic demographic data, the findings on physical 
examination and medication history were recorded on sheets 
specifically designed for this study. The history schedule of 
the CAMDEX was used. The History and Aetiology Schedule 
developed in conjunction with the GMSS, was considered 
inappropriate for this study as it did not focus particularly on 
the history of a demented person.
Psychiatric Symptoms - these were assessed using the Geriatric 
Mental State Schedule (GMSS, Copeland et al, 1976; Gurland et al, 
1976). The GMSS is a standardised interview for assessing 
psychopathology in patients over the age of 65 and was adapted 
from the Present State Examination (PSE, Wing et al, 1967). It 
contains 436 items and a factor analysis revealed 21 independent 
factors assessing individual symptom complexes (Gurland et al, 
1976). The factors used in this study were - depression, 
anxiety, paranoid delusions, visual and auditory hallucinations, 
reported belligerence, observed belligerence, anxiety, insight, 
non-social speech, hypomania, somatic concerns and 
incomprehensibility. The factors disregarded were mainly 
concerned with cognitive function (eg impaired memory, 
disorientation) and were regarded as superfluous as cognitive 
function was more fully assessed by the CAMCOG. In addition to 
their assessment in the GMSS, certain psychiatric symptoms were 
assessed by the history schedule of the CAMDEX. This was done in
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order to record symptomatology which had been present at some 
point during the illness but not necessarily at the time of the 
clinical interview. These symptoms will now be separately 
def ined.
Delusions were defined according to Fish (1985) and Cummings 
(1985). Their presence required that the ideas be firmly held 
and impervious to evidence to the contrary. Delusions were 
recorded as present (a) if they had occurred "at any time” since 
the onset of the illness and (b) if they had occurred within the 
twelve months prior to entry to the study (this time period was 
used as it corresponded to the time period of follow-up). Thus, 
(b) represented a subset of (a). To avoid erroneously 
attributing symptoms to an acute delirium, delusions had to be 
present for at least seven days. They were divided into three 
categories - delusions of theft, delusions of suspicion (eg 
believing the spouse was being unfaithful or believing 
him/herself to be watched) or (3) ’other* delusions which could 
not be assigned to categories (1) or (2). Thus, delusions of 
theft and suspicion correspond to the simple persecutory 
delusions of Cummings (1987) whereas ’other* delusions correspond 
to "complex, bizarre or multiple" described by Cutting (1987). In 
two of the six patients with "other" delusions, they could also 
be categorised as delusions based on specific neurological 
deficits as described by Cummings (1987).
Persecutory ideation was defined as ideas of persecution, 
not held with delusional intensity and present for at least 
seven days.
Auditory hallucinations were regarded as present if the
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subject reported hearing voices in the absence of an external 
stimulus or if he or she had been observed clearly engaging in a 
dialogue while no one else was present. Visual hallucinations 
were regarded as present if a subject reported seeing something 
or someone in the absence of an external stimulus or if he or she 
had been observed to interact clearly with a non-existent person 
or object.
Three misidentification syndromes were identified following 
the definitions used by Rubin et al (1988):
1) people in the house - this is a variant of the "phantom
boarder syndrome" and consisted of the belief, based on
misrecognition, that others were living in the house;
2) misidentification of mirror image - evidence of this was 
gleaned from the history of an inability to recognise the 
subject’s own reflection or a statement such as "someone else 
is in the mirror" and
3) misidentification of television - this was usually apparent 
with the story of the patient talking to the television or 
being fearful that an event on the screen (eg a fight or 
fire) was taking place in the room.
To these three syndromes, described by Rubin et al (1988), I 
have added a fourth:
4) misidentification of people - this was recorded if a subject 
mistook a relative or friend for another eg mistaking a 
spouse for a daughter or brother.
In order to exclude symptoms associated with an intercurrent 
delirium, hallucinations and misidentifications were required to
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last for at least seven days. As with delusions, hallucinations 
and misidentifications were recorded (a) "at any time" since the 
onset of illness and (b) in the twelve months prior to entry into 
the study. Thus, (b) was a subset of (a).
History of the illness - this was taken using the appropriate 
section of the CAMDEX (Roth et al, 1986). Details were taken of 
memory loss, personality change, functional activity (from which 
the Blessed Dementia Scale could be obtained), depression, 
history of stroke, episodes of confusion, paranoid symptoms and 
visual and auditory hallucinations. The duration of each 
symptom and the nature of its onset (gradual or sudden) was 
recorded. In addition, details of past history, family members 
and a family history of dementia, Down’s syndrome, 
cerebrovascular disease and other mental illness was noted. For
the purposes of this study, a family history of DAT was defined 
with three degrees of certainty - definite, probable or possible. 
A family history was considered definite if I was able to see the 
patient personally, if a post mortem had been performed with AD 
as the diagnosis or if the death certificate mentioned "Senile 
Dementia" or "Alzheimer’s Disease". A probable family history 
was recorded if I had spoken to a relative who knew the patient 
in question and was able to give a clear account of the illness 
suggesting it was AD. A possible family history was defined as a 
history from a relative that another member of the family had 
been demented but there was no clear account of the illness 
available.
Physical examination - this was performed in the standard way, 
the details of which appear in Appendix 3.
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Hachinski score - (Hachinski et al, 1975) each patient was 
assigned a score on the basis of the history and examination as a 
measure of possible vascular dementia.
Behaviour rating - the Stockton Geriatric Rating Scale (Meer and 
Baker, 1966) was used. This is a 33 item scale originally tested 
on 1,081 patients in Stockton, California. Although described as 
a ’'geriatric” rating scale, the population on which it was 
validated consisted of elderly patients in a psychiatric 
hospital, of whom approximately half had ’’chronic brain 
syndromes” and half functional psychoses. The scale has both 
internal consistency and interrater reliability (0.94 and 0.87 
respectively). The predictive validity of the scale (ie the 
association of scores with subsequent discharge from hospital or 
death) is excellent. A factor analysis of the items revealed 
four factors - physical disability, communication failure, 
socially irritating behaviour and apathy. The physical disability 
subscale encompasses features such as incontinence and the 
inability to eat, dress or bathe unaided. The apathy subscale 
describes patients who do not help others and who do not interact 
with others and communication failure refers to the inability of 
patients to understand others or to be understood. Thus, one 
would expect subjects with advanced dementia to score highly on 
these subscales. Socially irritating behaviour refers to patients 
making accusations against others, threatening harm to others and 
being objectionable.
Particular characteristics of dementia which have hitherto 
remained unmeasured are those of the ”Kluver-Bucy Syndrome”
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(Kluver and Bucy, 1937). In view of this, seven additional 
questions were devised in an attempt to rate these behaviours and 
they were added to the end of the Stockton Geriatric Rating Scale 
using the same three point format. The seven additional 
questions are in Appendix 5. In a separate reliability study 
(based on 480 individual observations), 24 hour testing retest 
reliability and interrater reliability achieved Kappa values of 
0.74 and 0.72 respectively (a factor analysis and measures of 
internal consistency and validity of this scale are discussed in 
Chapter 6.1). In addition to the above, one question was added 
concerning wandering behaviour (see Appendix 5). Each behaviour 
rating scale was completed by the author in a semi-structured 
interview to ensure correct understanding of the questions. 
Severity of dementia - a global rating was made using the 
Clinical Dementia Rating (CDR, Hughes et al,1982). This rating 
is a simple measure of the severity of dementia (mild, moderate 
and severe or CDR I, II, III). The rating was based on 
assessments of six areas - memory, orientation, judgement and 
problem solving, community affairs, home/hobbies and personal 
care. Inter-rater reliability of the scale was 0.89 and validity 
was suggested by highly significant correlations between the CDR 
and other cognitive and behavioural assessments. The scale was 
updated by Berg et al (1984).
Computed Tomography (CT) scan of the head - this was performed in 
the Department of Neuroradiology at the Maudsley Hospital using 
the GE 9800 whole body CT scanner. The patient lay supine on a 
movable examination table with the head supported in a head-rest, 
stabilisation straps being used to immobilise the head during the
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examination. Positioning in the gantry of the CT scanner was 
achieved using two lazer cross lights - one through the medial 
saggital plane and one along the interorbital line. The height 
of the patient was determined by a third cross light positioned 
over the external auditory meatus. Using a scout view of the 
skull, the gantry was angled parallel to the floor of the 
anterior cranial fossa to avoid irradiating the orbits.
Ten millimetre contiguous slices were taken from the floor 
of the anterior cranial fossa to the top of the head. The dose 
of radiation was approximately 50 mSv (millisieverts) and was 
comparable to that in a set of standard skull X-rays. No 
contrast enhancement was used. Each slice took about four 
seconds to scan but could be reduced to two seconds with an unco­
operative patient. The total scanning time was about five 
minutes. The output was displayed in a 256 x 256 matrix and 
interpolated on to a 512 x 512 screen.
Images were transferred to a computer tape and later 
analysed using an independent viewing console attached to the 
main computer. The scans were analysed in two ways - visual 
ratings and computer-assisted ratings. Visual ratings were 
performed comparing the scans to standards of predetermined 
severity (selected from a population not in the study). Seven 
regions were assessed on a four point scale of atrophy or 
widening: none; mild; moderate or severe. The regions assessed 
were the frontal, parietal, temporal and occipital lobes, right 
and left sylvian fissures and the interhemispheric fissure (IHF, 
which was rated on a 3 point scale). The scores from these
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individual regions were summated to give a "total cortical 
score” . White matter changes (periventricular lucencies) were 
also recorded using a four point scale. Basal ganglia 
calcification was assessed bilaterally in the caudate, globus 
pallidus and putamen. The presence or absence of infarcts was 
also noted. All scans were rated independently by two raters. 
The following Kappa scores were computed for each region - 
frontal 0.84, parietal 0.75, temporal 0.74, occipital 0.88, IHF 
0.76, sylvian fissure (right) 0.75, (left) 0.72, white matter 
changes 0.85, basal ganglia calcification 0.85 and cerebral 
infarcts 0.85.
For the computer-assisted ratings, the numerical data from 
the scans were transferred using magnetic tapes and analysed on 
an independent viewing console. Using a movable cursor, regions 
of interest were outlined and then the area within the region 
which fell within predetermined Hounsfield Units (HU) densities 
was measured. The following regions were assessed - third 
ventricle (0-25 HU), right and left sylvian fissures (0-30 HU), 
ventricular size was assessed on the two slices where the bodies 
of the lateral ventricles were seen best (0-25 HU). Ventricular 
brain ratio (VBR) was calculated by dividing the area of the 
brain slice to the inner table of the skull by ventricular size 
and expressing the result as a percentage. The average of two 
slices was taken. These particular HU densities were chosen 
because of previous reports (eg Reveley, 1985) and because they 
corresponded best to the visual impression of the scan. A total 
of 127 regions were assessed by two raters and the Pearson 
Correlation Coefficient between the ratings was 0.99. A test-
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retest reliability measure was made by analysing 60 scans chosen 
at random seven days after the initial assessment. The Pearson 
Correlation Coefficient of the two ratings was 0.99.
Two regions were rated by both the visual and computer- 
assisted method (the right and left sylvian fissure areas) which 
allowed for a cross validation of the techniques. The results 
are presented in Table 4.1 and show excellent agreement between 
the two methods.
There are several methodological difficulties associated 
with the interpretation of CT scans. These have been well 
summarised by Jacobson et al (1985).
Partial Volume Effect - each two-dimensional CT image 
actually represents a 3-dimensional structure (a voxel, the two 
dimensions of the image plus the slice thickness). Thus, in the 
two-dimensional representation (the pixel), areas at the 
CSF/brain interface will contain both structures and the 
resulting attenuation value (and hence the hue on the grey scale) 
will be a mixture of the two. While essentially an insoluable 
problem in the analysis of CT scans, the use of predetermined 
values to delineate CSF and brain help to reduce its effects.
Beam Hardening Effect - this situation obtains when X-rays 
are attenuated by passage through bone and so areas of tissue 
next to the skull will have falsely raised values. The effect is 
reduced by using pixels of predetermined density.
Visually Detectable Artefacts - these are due to a 
restless and uncooperative patient moving during the scan.
There were few of these in the present study and, where such an
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artefact significantly interfered with the interpretation of the 
scan, the scan was discarded.
Scanner Drift - This is due to differences in attenuation 
values secondary to changes which take place within the CT 
scanner over time. In this study, phantoms of predetermined 
density were scanned at each session and it was shown that the 
change in attenuation values over the period in which the study 
was performed was less than 5%.
Other Operating Factors - any changes in the software of the 
computer programs may affect the results. No such changes took 
place during the present study.
Timing of assessments - All the above assessments were performed 
at entry to the study, within 14 days of each other. The CAMCOG, 
GMSS, physical examination, behaviour rating scale and CT scan 
were repeated annually.
Neuropathology - as part of a full post-mortem examination, 
brains were removed, examined externally and either fixed in 
their entirety or sliced fresh, in which case individual slices 
were frozen or fixed in 10% formol saline. Following at least 
two weeks fixation, blocks of tissue were taken from standardised 
areas of frontal, parietal, temporal and occipital lobes, from 
basal forebrain, striatum, midbrain, pons, medulla and 
cerebellum, all according to the protocol of the Medical Research 
Council Alzheimer’s Disease Brain bank in the Department of 
Neuropathology, Institute of Psychiatry. Sections were stained 
with haematoxylin and eosin, luxol fast blue/cresyl violet and 
impregnated with silver according to Marsland and Glees. 
Immunohistochemistry for glial fibrillary acidic protein was
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carried out. In some instances, further investigations included 
the Galiyas silver method, Congo red and immunohistochemistry for 
A4 protein.
The histopathological diagnosis of AD may be approached in a 
number of ways. In this study, the diagnosis of AD was dependent 
upon finding widespread neocortical involvement with plaques 
and/or neurofibrillary tangles. Diffuse Lewy body disease was 
diagnosed when Lewy bodies were found not only in the substantia 
nigra and locus coeruleus but also in the cortex, particularly in 
the parahippocampal gyrus. Vascular damage, whether secondary to 
cerebral atherosclerosis, embolic disease or congophilic 
angiopathy, was considered to be significant when multiple and 
widespread macroscopic and/or microscopic lesions were 
identified. However, none of these diagnoses was considered to 
be mutually exclusive and when none was present and no other 
recognised neurodegenerative disease was identified, cases were 
placed into the "no diagnosis” group.
4.3 ANALYSIS OF DATA
This was performed using an IBM PC AT computer with the 
Statistical Package for the Social Sciences, personal computer 
version (SPSSPC+). Additional analyses were performed on the 
mainframe version of SPSS (SPSSX) using the Amdahl computer at 
the University of London Computing Centre. The survival analysis 
was performed using an EGRET programme on the IBM PC.
Standard statistical test were performed. Paired t-tests 
were used to compare changes in groups of individuals over 
time, unpaired t-tests were used to compare group means and one
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way anova was applied when the means of three or more groups were 
being compared. Chi-square tests (with Yates correction where 
appropriate) assessed the strength of the association of 
categorical variables. The strength of association of continuous 
variables was tested by a Pearson product moment correlation. 
Cluster analysis employed Ward’s method using squared Euclidean, 
distances on standardised scores. Other statistical tests used 
will be described in the appropriate results section.
With regard to the survival analysis (Chapter 9), the 
Standardised Mortality Ratios were calculated using the 
Camberwell Health Authority All Cause Mortality Rates. The rates 
were derived from the number of deaths reported for 1987 by the 
Office of Population Censuses and Surveys (OPCS, 1989). The 
population estimates were provided by the South East Thames 
Regional Health Authority (mid-year estimates, 1988). Confidence 
intervals were calculated using tables or the normal 
approximation to the Poisson distribution.
The survival times were analysed according to the 
proportional hazards model of Cox (Cox and Oakes, 1984). The 
study of survival times has considerable advantages over more 
simple analytic methods which, for instance, treat the 
outcome as a binary variable (dead or alive) at the end of 
the follow-up period. In brief, the model assumes that the 
hazard or risk of death for all individuals is proportional 
throughout the study. The second assumption of the model is that 
the effect of explanatory variables is multiplicative. The use of 
the proportional hazards model allows a multi-variate approach.
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The coefficients generated by the proportional hazards model are 
exponentiated and the hazard ratios can be interpreted as 
relative risks (a relative risk of greater than 1 indicates an 
increased death rate while a relative risk of less than 1 
corresponds to a reduced death rate, compared to the baseline). 
The final model for predictors of survival was determined by 
adding variables which were included if they were significant at 
the 5% level.
4.4 ETHICAL APPROVAL
All procedures were approved by the Ethics Committees of the 
Joint Hospital, Dulwich Hospital and Cane Hill Hospital.
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CHAPTER 5
GENERAL DESCRIPTION OF THE SAMPLE
In total, 186 patients satisfying the NINCDS/ADRDA criteria 
were approached for inclusion in the study. Eight relatives 
refused permission for patients to be included (the commonest 
reason being they felt the patients had been "through enough”). 
Therefore, 178 subjects were evaluated in the study (96% of those 
approached). Their demographic characteristics are shown in Table 
5.1. Due to lack of information, it was not possible to allocate 
a Clinical Dementia Rating (CDR) to three subjects.
The reasons for 40 of the patients being placed in the 
possible category were: diabetes (controlled with diet and oral 
hypoglycaemic drugs, nine patients, 22%); past or current 
hypertension (on antihypertensive medication, nine patients,
22%); evidence of cerebrovascular disease (temporally unrelated 
to the dementia syndrome, eight patients, 20%); heart disease 
(two patients, 5%); other physical illness (eg temporal 
arteritis, subacute bacterial endocarditis, epilepsy, vitamin Bi2 
deficiency and malignancy, seven patients, 18%); previous 
significant alcohol intake (two patients, 5%) and an atypical 
clinical picture (three patients, 8%).
Ninety-five percent of subjects had a Hachinski score 
(Hachinski et al, 1975) of four or less. Five patients had a 
score of five, two scored six and one patient had a score of 
seven. The score could not be calculated on two subjects due to
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TABLE 5.1
CHARACTERISTICS OF THE SAMPLE
Number (2) of total
ALL SUBJECTS 178
female 140 (79%)
male 38 (21%)
MEAN RANGE SD
AGE (years) 80.4, 56-99, 6.6
AGE OF ONSET (years) 75.2, 50-95, 7.4
DURATION OF ILLNESS (months) 63.0, 6-240, 42.6
Number (2) of total
’PROBABLE’ ALZHEIMER'S DISEASE 138 (78%)
’POSSIBLE’ " ” 40 (22%)
PLACEMENT: HOME 74 (41%)
HOSPITAL " —  —  ■ 78 (44%)
RESIDENTIAL CARE 26 (15%)
CLINICAL DEMENTIA RATING I 12 ( 7%)
(N=175) II 78 (45%)
III 85 (48%)
FAMILY HISTORY OF DEMENTIA OF
THE ALZHEIMER TYPE IN:
PARENTS 21 (12%)
SIBLINGS 31 (17%)
2ND DEGREE-‘RELATIVES 3 (2%)
EXISTING (’PREVALENT’) CASES 77 (44%)
NEW (’INCIDENT1) CASES 99 (56%)
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lack of information. ’’Existing” cases refer to those subjects who 
were already known to the services at the beginning of the study 
(1 October 1986). ’’New” cases consisted of those patients 
presenting for the first time to the hospital between 1 October 
1986 and 30 September 1988. As the study finished on 1 October
1989, recruitment ceased at the end of September 1988 to allow at
least 12 months follow-up on all cases. The mean follow up 
interval was 18.4 months (range 12-36 months).
Table 5.2 outlines the results of the cognitive testing and 
CT scan examinations for the whole sample at entry to the study. 
All patients received cognitive tests. CT scans were obtained on 
138 subjects (78%). The reasons for scan refusal were: the 
patient refusing the scan after discussion (5%), the relatives 
refusing permission for the patient to be scanned (10%), the
patient being too uncooperative due to aggression or
behaviour disturbance (58%) and the scan not possible for
physical reasons (eg arthritis preventing the subject lying 
flat, 27%).
Follow up of the patients was 100% complete. Details of the 
follow-up are presented in Chapter 7.
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TABLE 5.2
COGNITIVE FUNCTION AND COMPUTED TOMOGRAPHY FINDINGS 
IN THE SAMPLE (AT ENTRY TO THE STUDY)
MEAN RANGE STANDARD
DEVIATION
COGNITION
Mini-Mental State 8.0 0-24 6.7
Examination (Max=30)
Abbreviated Mental 2.5 o J i—
*
o 2.9
Test Score (Max=10)
CAMCOG:
Memory (Max=27) 3.3 0-16 3.8
Language (Max=30) .. .. . . 11.4 0-26 9-1
Praxis (Max=12) 4.0 " ' 0-12 3.8
Orientation (Max=10) 1.8 0-9 2.1
Attention (Max=7) 1.3 0-7 2.0
Calculation (Max=2) 0.7 0-2 0.8
Abstract Thinking (Max=8) 0.6 0-4 0.9
Perception (Max=ll) 3.6 0-4 3.2
Total (Max=107) 26.6 0-75 22.6
COMPUTED TOMOGRAPHY
Ventricular - Brain Ratio (%) 15.0 3.4 -. 34.4 5.4
III Ventricle ( c m 2 ) ______ 1.9 0.7 - 4.5 0.6
Total Cortical Store (Max=23) 6.5 1-16 2.8
% of Subjects with:
Basal Ganglia Calcification 25.1%
White Matter Changes
None 39.5%
Mild 36.6%
Moderate 20.1%
Severe 3.8%
Infarcts 2%
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CHAPTER 6
PSYCHIATRIC SYMPTOMS AND BEHAVIOUR DISTURBANCE 
6.1 RESULTS
Disorders of Thought Content
Table 6.1 outlines the proportion of subjects with 
delusions and persecutory ideas. No significant differences in 
the prevalence of symptoms were found between subjects with 
"probable” and those with "possible" AD. In view of this, and 
for the sake of clarity, the results are presented for the sample 
as a whole. 16% had experienced delusions since the onset of the 
illness and 11% in the 12 months prior to entry into the study. 
Delusions of theft were the commonest type of delusion followed 
by delusions of suspicion. Six subjects had "other" delusions. 
These consisted of: a conviction that a pet budgie had been
burnt; the idea that the patient had become a father at age 90; 
the belief that the patient was in Korea fighting a war; an idea 
held by one man that people came in at night and cut his throat; 
a woman who was convinced that people came into her house and 
added objects and a belief that someone was playing a tape 
machine in a local street which was giving the patient messages. 
20% of the sample had experienced persecutory ideas. One-third 
of the sample had some form of disorder of thought content. A 
greater proportion of men than women suffered delusions of theft.
Table 6.2 gives a summary of the main CT findings in 
relation to the symptoms. One hundred and thirty-eight patients 
had CT scans including only five of the six patients with "other" 
delusions. Subjects with simple delusions or persecutory ideation 
did not differ significantly from those without these features on
165
TABLE 6.1
DISORDERS OF THOUGHT IN SPAT
Disorder of Thought Present
1 OF % OF
SEX RATIO MALES FEMALES 
N(%) M:F AFFECTED AFFECTED
Any delusions 28(15.7) 13:15 *** 35% 11%
Any recent delusions 
(within previous 12 months)
19(10.7) 9:10 ■kick 24% 7%
Delusions of theft 16 (9.0) 7:9 ** 19% 6%
Delusions of Suspicion 10 (5.6) 4:6 11% 4%
Other Delusions 6 (3.4) 3:3 8% 2%
Persecutory Ideation 36(20.2) 9:27 24% 19%
Any Disorder of Thought 53(29.8) 16:37 * 43% 26%
KEY:
’Any disorder of thought' represents the total number of subjects 
with either delusions, persecutory ideation or both.
Statistics - Chi - square test, disorder more common in men - 
*: p<0.05
**: p<0.02
*** :p<.0.01
All others non-significant at p<0.05
1LE 6.2
"OTHER" DELUSIONS IN SDAT - CT FINDINGS
DELUSIONS
R. (Mean ± SD)
mber with Basal Ganglia 
lcification:
ft: Present
Absent
ght: Present
Absent
PRESENT 
(N = 5)
5.6 ± 3.0
ABSENT
(N = 133)
15.4 ± 5.3
125
9
124
Y: SD - standard deviation
VBR = ventricular-brain ratio 
Statistics - 1: students' 't' test 
2: Chi-square test.
SIGNIFICANCE 
p40.006 l
p<0.004 2 
p<0.007 2
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any of the CT variables assessed. However, those with "other” 
delusions differed from those without on two measures - they had 
significantly smaller VBR’s and more often had basal ganglia 
calcification. Neither cognitive score at entry to the study nor 
change in cognitive score over the succeeding 12 months differed 
for subjects with and without disorders of thought content. 
Disorders of Perception
Table 6.3 outlines the frequency for disorders of perception 
in the sample. Visual hallucinations (13%) were slightly more 
common than auditory hallucinations (10%). Misidentification
syndromes occurred more frequently with 30% of the sample having 
had one misidentification at some point in their illness and 19% 
having had the experience in the preceding 12 months.
Misidentification of other people and the belief that others were 
in the house were more common in men.
Table 6.4 shows a comparison of age, age of onset and 
duration of illness in those with misidentification syndromes.
No significant differences were seen in those with or without 
hallucinations but, as can be seen from Table 6.4, subjects with 
misidentifications involving mirror image and people in the house 
were significantly younger than those without. Their illnesses 
had started at a younger age but there was no relationship to 
duration of illness.
Table 6.5 outlines the results of neuropsychological 
testing. No differences were seen in either cognitive score at 
entry to the study or change in cognitive score over the 
succeeding 12 months between those with or without
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BLE 6.3
DISORDERS OF PERCEPTION IN SDAT
DISORDERS OF PERCEPTION PRESENT
N(%)
■Ilucinatlons: (N=177):
Ly hallucinations 
ly recent hallucinations 
rithin previous 12 months)
.sual hallucinations 
iditory Hallucinations
.sidentification Syndromes:(N=178)
Ly misidentification 
ty recent misidentification 
rithin previous 12 months) 
.sidentification of people 
sople in the home 
.sidentification of 
slevision
.sidentification of Mirror
Sex Ratio % OF % OF
M:F MALES FEMALES
AFFECTED AFFECTED
8:22 22% 16%
-6:14 16% 10%
6:17 16% 12%
3:14 8% 10%
19:35 ** 51% 25%
12:22 * 32% 16%
10:11.**' 27% 8%
12:19 ** 32% 13%
1:10 3% 7%
3:4 8% 3%
30(16.9)
20(11.3)
23(13.0)
17(9.6)
54(30.3)
34(19.1)
21(11.8)
31(17.4)
11(6.2)
7(3.9)
2/
:atistics -(Chi - square test), disorder more common in men -
*: p<0.02 
**: p<0.01
.1 others, non-significant at p<0.05
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misidentifications. Initial cognitive function was not 
significantly different in those with or without hallucinations. 
However, in those experiencing either visual or auditory 
hallucinations within 12 months of entry to the study, the 
deterioration in cognitive function over the succeeding year was 
significantly greater than in those not hallucinating.
Neuroleptic medication was prescribed for 34% of hallucinating 
subjects and 46% of those with misidentifications. 34% of non- 
hallucinators were taking these drugs as were 33% of those 
without misidentification syndromes - there was no statistically 
significant difference in these proportions.
After 36 months, 84 of the subjects had died but the only 
significant association between death and the presence of 
perceptual disorders was that 35.1% of those with
misidentification syndromes had died, compared to 52.4% of those 
without these symptoms (significant at p < 0.05, chi-square 
test). This difference remains significant after controlling for 
age. There was no difference in the proportion of subjects with 
or without perceptual disorders across the three levels of 
dementia rating.
Disorders of Affect
Table 6.6 outlines the rates for mood disturbances. 
Observations were recorded in 174 patients and relatives were 
able to give ratings in 163 patients. Seventy of the patients 
were unable to cooperate with the direct questioning involved in 
the GMSS and so they were excluded from this part of the 
analysis. Although nearly two-thirds of patients had at least one 
symptom of depression and nearly half were rated as depressed by
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BLE 6.6
DISORDERS OF MOOD IN SDAT
DISORDERS OF MOOD PRESENT
N(%) SEX RATIO
PRESSION
M:F
served by Rater 
=174)
ported by Patient 
=108)
ported by Relative 
=163)
evious history 
=178)
NIA
served by Rater 
=174)
ported by Patient 
=110)
41(23.5%) 6:35
68(63%) 12:56
70(42.9%) 14:56
17(9.5%) 1:16
6(3.5%) 0:6
1(0.6%) 0:1
Z of
MALES
AFFECTED
17% 25%
36% 66%
42% 43%
3% . 11%
0% 4%
0% 1%
% OF
FEMALES
AFFECTED
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their relatives. No patient satisfied DSM IIIR for major 
depressive disorder. Subjects on antidepressants were more 
likely to be rated as depressed by an observer (p < 0.002, chi- 
square test) but there was no relationship between antidepressant 
prescribing and either relatives* reports of depression or 
complaints by the patient. There was no association between a 
past history of depression and current depression as assessed by 
any of the three methods.
Signs and symptoms of mania were rare - only six patients 
had evidence of observed mania and only one patient reported 
manic symptoms.
Table 6.7 outlines the results of cognitive testing in those 
with and without depression. The main findings were: patients
who reported depression were less cognitively impaired than those 
who did not; observed depression was unrelated to either 
cognitive function or to deterioration in cognitive function; 
there was a tendency for subjects rated as depressed by their 
relatives to be less impaired and there was a tendency 
(statistically significant only for the MMSE) for those with a 
previous history of depression to deteriorate less quickly. Manic 
symptomatology was unrelated to cognitive function.
Table 6.8 summarises the main CT findings in relation to 
mood disorders. First, those patients in whom depression was 
reported by the relatives had smaller third ventricles and VBRs. 
Second, observed manic symptoms were strongly related to visual 
ratings of widening of the Interhemispheric Fissure (IHF) and 
depressive symptoms were inversely related to IHF widening.
174
year 
shows 
the 
mean 
change 
in 
score 
for 
the 
group 
over 
the 
12 
months 
- 
the 
negative 
s
i
g
n
 
♦-u,-,*- 
o 
in 
m
o
n
i
H
u
p
 
function 
has 
taken 
p
l
a
c
e
.
*• o *o
> 3”
L ' 3 *•300
> CO • •
> fl> ■ o  o
r O  to
rt rt 
A A  A
O 
O
1 to 
tn O' 
• *
VO O'
t-4 tO 
• •
O  tn
I
tO
to tn
o  to « .
tn -0
73 n r-t o o M r t o r t r* O M 'T' n  n M
co 3 j> o r 3 PO 3 ” 3 > zr 3 S >  O’ 3
K 3 H- 3 H* > 3 rt 2 3 r4- 2 K  3 r-4-
•• 3 rr o 3 rr p< 3 rt o 3 rr o O  3 rr
00 H* o OQ H- r t CTO r t G 00 r4* po O  00 t-4-
3 3 o 3 3 CO 3 3 f> 3 3 r< O  3 3
3 I -4 r t r t o I - 4 H 4
t—1 H- H H* rs r t cd r t r s r4*
I -4 3 3 O 3 3 21 3 3 3 3 3 3
O r t O O /—■. O > O
3 r-4 O r-4 O IX r t O 2 i-4 o P< r-4 o
rr rj P rj II rj !> If 1 rj
3 v< 3 •C 3 I - 1 V< 3 p < NC 3 t o V< 3
rr 3 /—\ 3 t o 3 ii 3 •^j 3
H* 3 3 3 t o 3 v - / 3
3 rj & rt rj O if rj
r r w
H* r t II r t r t r tl
O — H-4 "—^ —
3 C o C G G G
w "O
'_/
3 1
r r r - 4 t o 1 1 I—4 I 1
C O t o t—1 J> t o r - 4 4S O t o
Cl. • • • * • • • • • •
3 CO O O ' Ln O ' r - 4 00 O
3
r r
3
r r
1
I-4 t o 1 i r - 1 J 1
— t o t n I—1 t o O t o t o r -4 t o
• • • • • • • . • .
r r O ' O co CO *o I—1 r - 4 t o t o
3
3
r t
5
i - 1 4> I i r - 1 1 1
t n t o " J t n VO t o t n i"* 4>
. • • • • * • • • «
i—* *0 O o t—4 i—1 h-4 O '
J t o 1 1 i—1 1 1
VO CO r - 4 4> t o t o I—4 t o t - 4 t o
• . « . • . • • • •
00 • > t o r t t o Ln t n t o 00
X- X- X- X- X-
X- X- X- X- X-
X- X- X-
1
r - 4 t o 1 1 r t i 1
i—1 t - 1 t-> t o r - i—4t o
• • • • • • • • . .
- J O VO CO Ln VO o r - 4 o
1
r - 4 t o 5 s rt i 1
t o t o i - 1 t o o t o t o l - 4 t o
• • . • • • « . . •
4> co t o t o Co r - 4
to
.
VO
O  I—I ^  3-3 2;3 H* !> 3 n X 
CTO H* | (1/ O W 
t—1 O  h*. w  
3 CO O
r-4 O 
i-t
fl)n<
33
ft
rt
C
3
to vD 
• •
tn r-4
to -o 
.  #
CO O'
to VO 
• •
ON O
J
t o
o -o 
' • •
tn O'
h-4 t o 1 1 t—4 s 1 i
t o O ' t-4 J> 4 >  I -4 t o  t o I -4 t o t o CO. • .  . • • • • • • • •
CO O ' •^1 o O ' t o r - 4 t o r o 00 o
O  M 
3" 3 
3 r-4* 
3 rr 
DO r4* 
3 3
3
3H
rt
G
to O' 
to r-
O' 
4>- VO
vO 
'-J to
VO O'
VD tn 
O  03
& O
W 03
r a CO
po P3
C*3
t o <
t o PS
H a
O
2
&
rd
} t - 4 | r < O
4>  t o t n  O ' P3 pi
•  • I - 4 00 ( t o C3 H
r - 4 -f> K P3r tW
> a
H w
H rt
1 RJ St o  vo sa rt
• . t o H t o
t o r-4 O |c > co
•• -  — J
'
H
O
X- 2
grtrtoKJsrtrtrtrt► rtH rt
H rt< 2rtrtw rtrt
HO2
|ortrtg
rt<rt Hrt
grt
8rt
rtrtM HO rt2 HOsr<
>
CDf
R1
MOOD 
D
I
S
O
R
D
E
R
S
 
IN 
SDAT 
- 
C
O
G
N
I
T
I
V
E
 
F
U
N
C
T
I
O
N
co 7K Cfl >■ H
rr M  • • >•
p  ►< W
rr .. P- rr d > d o M o P> nd & d
P* P O' P O' P cr P o' O' p P p
CD P *d d rr P *d P P p rr p p p 'd •d
rr C/2 < CO cr r( p P rj P P p P p p p o p
P* d CO • p P 'O rf •o P P P p rt p p P p p
O pa Pj p P P P" P P rr P < P“ < rr P rr p
CD J • p P P P rr P rr p P p rr ■p p
1 I rr P P B P* P* CL B CL CL p*
1 CD rr P p- P < rs S~\ p- PN o
rr < CO P» p P P Z Z B p 3 z z O' p
C/2 D3 P> P p vs < no rr I It P *d p • I 1 vs
P- • • P p I—* Z Z P O' P r-* ON P zr P ^4 Ln CO
05 CL rr < II II P P vs LO v—' P* p p> NJ 4> sc VC
p P P P- LO CN CO rj P B O P p p s-/ p B
P* O CO P P* P NJ 4> VS p- cl -d p* r-* T5
t-T) O' rr CL O P V-/ B O rr n P p rr
P- P» P • C 'O p o p rt o
O J CL CL l-J t-h rr rn rr B Pi CL P* BP CD (P rp P P* O P- rt p p* < p
P .12 P < P CD B P O p P p
o ■c rr P- I CD P P •d p p rr ••
p p CD P a* c •• c zr P c Pp
p
rr
P-
O
P
P
P>
P
P
i-5
P
N<
o
*d
o
P
p
p
O
•d
zr
it­ rr
p
rr P P rn rrP vs
'd CD P CL o
A rr rr P rnO  • P rr o'
• CD H* •<
O  rr o
Ln •
*
it­ CO r3
M  cc
'd N  M
A NJ H-* cc sa
o • • d
« r- NJ Ln 3 O rs
o *>4 O  r-* O O  <
NJ P H- H- S rcP NJ Z
JS- o  o - H
Ji- • • PS
* O n Ln S M
00 UJ p  n
•d P G
A * P r*
O
• H- sa
o
o CO
I-1 d•
>
s ► r-* r-* r~N <o o rr O n 4> S  d
rr CL P • • p  sa
p* 1-* LO O n P O r-1 o p
P NJ Ln a  h  p *d P
P p z r H- *+•
p rr vs H-
P Ln 4>
P • • coo -«4 CD d
P *I
CDP* ' .:■ -- - r ■ -■ iOQ 
p
rnH»O
P  C/2
P Prr t-> <
O' NJ NJ Jr* P
p  a- p
rr *  «■ (t>
*
•d  *
AO
•
o
Ln
MOOD 
CHANGES 
IN 
SDAT 
- 
SUMMARY 
OF 
CT 
F
I
N
D
I
N
G
S
Depressive symptoms correlated negatively (Spearman correlation) 
with three indices on CT scanning - third ventricular size (- 
0.22, p < 0.05), right sylvian fissure size (- 0.23, p < 0.02) 
and VBR (- 0.20, p < 0.05). Observed depression did not 
correlate with any of the CT findings.
The following GMSS factors were more common in patients with 
severe dementia (CDR III, 3x2 Chi-square test) - retarded speech 
(p < 0.0001), nonsocial speech (p < 0.005), incomprehensibility 
(p < 0.0001), anxiety (p < 0.0001) and loss of insight 
(p < 0.05). Retarded speech, incomprehensibility and anxiety 
were more common in hospitalised patients (all p < 0.0001, 3x2 
Chi-square test).
Behavioural Disturbance
Table 6.9 outlines the frequency with which the main 
behavioural disturbances were seen (full data were not available 
on four patients). Three signs of the Kluver-Bucy syndrome were 
relatively uncommon (binge eating, hyperorality and sexual 
disinhibition). Incontinence occurred in nearly 50% of the 
sample. Subjects with aggression were more likely to be on 
neuroleptic medication but there was no association between 
binge eating and the prescribing of neuroleptics.
Table 6.10 shows the prevalence of behavioural abnormalities 
in relationship to the overall severity of dementia as assessed 
by the CDR. As would be expected, behavioural disturbances 
became more common as severity of dementia increased. The 
exceptions were binge eating, hypermetamorphosis and "rage” 
behaviour. There was a non-significant trend for aggression to 
increase with severity of dementia. 34% of hospitalised patients
177
TABLE 6.9
BEHAVIOURAL DISTURBANCE IN SDAT
BEHAVIOUR DISTURBANCE PRESENT
N(%)
AGGRESSION
(N=178)
WANDERING 
(N=178)
URINARY INCONTINENCE 
(N=174)
ELEMENTS OF * KLUVER BUCY 
SYNDROME':
BINGE EATING 
(N=174)
HYPERORALITY
(N=174)
SEXUAL DISINHIBITION 
(N=174)
MISRECOGNITION OF 
NURSES/RELATIVES
(N=174)
GOING INTO ’RAGES’ 
(N=I74) -
HYPERMETAMORPHOSIS 
(N=I74)
WITHDRAWAL/APATHY
(N=I74)
17(9.8%)
11(6.3%)
12(6.9%)
SEX RATIO
M:F
35(19.7%) 15:20 **
33(18.5%) 7:26
83(47.7%) 17.66
8:9 *
2:9
3:9
77(44.3%) 13:64
62(35.6%) 13:49
54(31%) 12:42
71(40.8%) 13:58
KEY: Statistics, Chi-square test
Behaviour more common in men, * p<0.01
** p<0.001
Z OF 
MALES
Z OF 
FEMALES
AFFECTED AFFECTED
40%
19%
47%
22%
6%
8%
36%
36%
33%
36%
14%
21%
48%
7%
7%
7%
46%
45%
30%
42%
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3LE 6.10
RELATIONSHIP OF BEHAVIOURAL DISTURBANCE TO OVERALL SEVERITY OF DEMENTIA
Clinical Dementia Rating
Mild Moderate Severe
(N=12) (N=77) (N=85)
(% with each behaviour)
IRESSION 8.3%
STD BRING 0%
ENARY INCONTINENCE 8.3%
5MENTS OF KLUVER-BUCY SYNDROME
SGE EATING 8.3%
PERORALITY 0%
XUAL DISINHIBITION 0%
3RECOGNITION OF NURSES/RELATIVES 8.3%
ENG INTO 'RAGES’ 25%
PERMETAMORPHOSIS 8.3%
rHDRAWAL/APATHY 50%
3JECTS WITH ANY FEATURES OF THE 
JVER-BUCY SYNDROME 75%
atistics - 3 x 2 Chi-square 
* p<0.05
** p<0.01
*** p<0.001
NS - not significant at p<0.05
16.7%
10.2%
2.6%
10.4%
0%
2.6%
26.0%
28.6%
28.6%
28.6%
66.2%
23.5% NS 
27.0% ** 
94% ***
9.4% NS 
13.0% ** 
11.8% * 
65.9% *** 
43.5% NS 
36.5% NS 
50.1% *
96.5% ***
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were aggressive compared to 11% of those at home and 4% in 
residential homes (p > 0.001, chi-square test). Of the 83 
subjects with incontinence 51 were dead at 36 month follow up, 
compared to 23 of those who were not incontinent (p > 0.001, chi- 
square test). Patients dead at follow-up had significantly higher 
scores on the communication failure, apathy and physical 
disability subscale of the Stockton Geriatric Rating Scale.
Table 6.11 shows the patterns of cognitive function in 
subjects with or without aggression, wandering and binge eating. 
Patients with aggression and wandering behaviour were 
significantly more cognitively impaired on all measures than 
those without these features. However, there was no significant 
difference in cognitive function in those with or without binge 
eating. Deterioration in cognitive function over the follow up 
showed no differential decline in any of the groups. (Cognitive 
function in patients without other behavioural disturbances 
showed a similar pattern to those with aggression and wandering 
and have not been detailed separately).
With regard to associations with CT findings, these have 
been summarised in Table 6.12. Aggression was associated with 
more temporal lobe atrophy, excess wandering behaviour with 
increased sylvian fissure size and hyperorality with third 
ventricular size. Hyperorality was also associated with 
frontal, parietal and occipital atrophy but was not 
associated with temporal lobe atrophy. There were no 
differences in the CT measures of those with or without 
sexual disinhibition. Patients with incontinence had
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BEHAVIOURAL DISTURBANCE IN SDAT - SUMMARY OF CT FINDINGS
jRESSION:
nporal Lobe Atrophy 
Absent 
Mild
Moderate
Severe
SDERING:
n
lvian Fissure Size
2 , Mean i S3) 
Right 
Left 
Total
Present
(N=22)
0
13
7
2
Present
(N=22)
8.8 ± 2.9. 
9.7 ± 2.9 
18.6 ± 5.4
Absent
(N=114)
U  1 953 ] *2
44 ]
1 3
Absent
(N=114)
7.1 ± 2.7
8.2 ± 2.9 *1 
15.3 ± 5.2 ***L
PERORALITY:
d ventricular size
i2 v mean ±
Present
(N=5)
2.55 ± .91
Absent
(N=132)
1.89 ± .61 **1
ontal Lobe Atrophy 
Absent 
Mild
Moderate 
Severe 
cipital Lobe Atrophy 
Absent 
Mild 
Moderate 
Severe
SD - Standard deviation1}
atistics 1: 
2:
Students test
Chi-square test 
* P<0.05
** P<0.02
*** p^O.Ol
34
73
19
1
53
65
14
0
*** 2
***2
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significantly more atrophy in all regions and more ventricular 
enlargement than continent patients (incontinent patients* mean 
VBR 16.9, Standard Deviation (SD) 6.0; continent patients* mean 
VBR 13.7, SD 4.4, p < 0.001, students* *t* test).
Subjects were divided into those who had at least one 
feature of the Kluver-Bucy syndrome (N = 142) and those who had 
no features (N = 32). Patients in the former group were more 
likely to have moderate or severe atrophy of the temporal lobes 
(chi-square test with Yates correction, p < 0.04).
The relationship between the seven elements of the Kluver- 
Bucy syndrome were analysed to see if they formed a discrete 
cluster which may have indicated a subtype. The findings were as 
follows:
1) 18.4% had none of the symptoms, 29.3% had only one symptom, 
24.7% had two, 17.2% had three and 8.6% had four. Only one 
patient had all seven;
2) a Spearman correlation showed significant correlations 
between disinhibited sexual behaviour and hyperorality 
(0.30, p < 0.001); hypermetamorphosis and apathy (0.23, p < 
0.001) and between binge eating and hyperorality (0.24, p < 
0 . 001 ) ;
3) a factor analysis using a Varimax Rotation revealed three 
factors accounting for 57.1 of the variance. These are showrt 
in Table 6.13 and
4) a Cronbach*s Alpha Coefficient to assess internal consistency 
was low (0.43) confirming that the scale was not assessing a 
unified construct.
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Therefore, the individual items on the scale were 
significantly associated with each other but the scale was 
assessing three different factors. Binge eating appeared to be 
least associated with the other items.
6.2 DISCUSSION 
Disorders of Thought Content 
The main findings were:
1) a significant proportion of subjects with SDAT suffered from 
associated delusions of persecutory ideas;
2) delusions of theft were relatively more common in men;
3) some types of delusion were associated with preservation of 
ventricular size and with basal ganglia calcification as seen 
on the CT scan and
4) cognitive function bore no direct relationship to the 
presence of these symptoms.
Frequency of Symptoms
Generally, this present work has found a lower frequency of 
delusions than other studies. For example, Cummings et al (1987) 
reported that 30% of DAT patients had evidence of current 
delusional ideas; Rubin et al (1988) found 31% to be deluded and 
Berrios and Brook (1985) reported delusions in 37%. Possible 
explanations for these differences need to be considered. The 
current study differs from these in two main respects. First, 
the current sample was an epidemiologically representative one 
from a catchment area rather than being made up of volunteers 
attending a research centre (Rubin et al , 1988) or consecutive
referrals to an acute service (Cummings et al 1987; Berrios and
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Brook, 1985). Both of these methods of selection may have led to 
a sample biased in favour of patients with more acute psychiatric 
disturbance. Second, the method of ascertainment of the symptoms 
in this study was similar to that used by Rubin et al (1988). 
However, only current symptomatology was investigated by Cummings 
et al (1987) and the high rate for delusions was attributed to 
the use of leading questions about their presence. Also, the 
group described by Cummings et al (1987) was less demented than 
the current sample and patients were able to co-operate more 
easily with an interview. Thus, the relatively high rate in 
other studies may be explained both in terms of the nature of the 
population and the method by which symptoms were ascertained. I 
believe the current study, by examining a representative sample, 
has revealed a more realistic frequency of delusions which 
accords with clinical experience. One other possibility for the 
differences is that some of the patients referred to in the 
present study as suffering from persecutory ideation may have 
been regarded as delusional by other authors.
Sex Difference
No other studies have commented on a differential sex 
distribution of delusions. In most papers insufficient 
information is given to enable this to be calculated. In the 20 
patients with organic delusions described by Cummings (1985), 16 
were male. This apparent high proportion was not commented on by 
the author and was most likely due to the sample being drawn from 
a Veterans’ Administration facility. In the present study, there 
is no reason to suppose that there was any systematic bias 
towards the overeporting of delusions in males. This finding of a
186
higher prevalence of delusions in males therefore remains 
unexplained and requires further investigation.
Relationship with CT Scan findings
The anatomical substrate of delusions has been investigated 
by a number of authors. Cummings (1985) postulated that 
pathological processes involving the limbic system and basal 
ganglia were particularly associated with the development of 
delusions. In this study, "other" delusions were found to be 
associated with less ventricular enlargement. Although some 
other studies of DAT subdivide delusions into different types (eg 
stealing and suspicious delusions, Rubin et al 1988; delusions 
of abandonment and impostering, Reisberg et al, 1987), no other 
studies have divided them according to the "simple" or "complex" 
categories proposed by Cutting (1987) and Cummings (1985). It 
seems logical that simple delusions (possibly based on an 
understandable psychological process eg mislaying of a handbag 
leading to a belief that it has been stolen) have a less complex 
pathophysiological substrate than more systematised and bizarre 
delusions. Other work has shown that delusions in dementia are 
inversely related to cortical atrophy in dementia (Jacoby and 
Levy, 1980a) or to impaired cortical perfusion (Gustafsson and 
Risberg, 1974). Patients with late paraphrenia (a condition 
characterised by delusions and hallucinations) have been shown to 
have no significant cortical atrophy when compared to normal age 
matched controls (Burns et al, 1989) and these findings have been 
interpreted as an indication that a relatively intact cortex may 
be a prerequisite for the development of delusional ideation.
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This hypothesis requires confirmation. However, this is the first 
study to show an inverse relationship between delusions and 
ventricular enlargement. The association between basal ganglia 
calcification and delusions has been noted previously (Cummings, 
1983, Frances, 1979). Although basal ganglia calcification is a 
recognised accompaniment of ageing (Murphy, 1979), no studies 
have looked systematically at its clinical correlates in DAT. The 
number of patients with basal ganglia calcification in this study 
was small, but nevertheless there appeared to be a significant 
relationship between this and "other” delusions.
Relationship with Cognitive Changes
There was no direct relationship between the presence of 
delusions and cognitive function. Although some studies have 
reported a significant decline in cognitive function in subjects 
with psychosis (Drevets and Rubin, 1989), this was not 
subcategorised in terms of delusions or hallucinations. The main 
methodological problem in this study was the means by which 
information about the phenomenology was obtained. The severity 
of illness in the population made reliance on relatives* and 
caregivers* reports essential. There are difficulties associated 
with the elucidation of phenomenology in demented patients and 
most other studies on this type of population have relied on 
reports of symptoms which might ideally be obtained through a 
direct interview with the patient (Rabins et al, 1982; Rubin et 
al, 1988; Reisberg et al, 1987; Merriam et al, 1988).
Disorders of Perception
The main findings were:
1) disorders of perception occurred commonly in SDAT;
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2) misidentification syndromes were more often found in men;
3) subjects with misidentification syndromes were younger and 
had a younger age of onset but a lower death rate and
4) hallucinations were associated with a more rapid cognitive 
decline.
Frequency of Symptoms
Hallucinations are a common accompaniment of SDAT. Their 
reported frequency varies from between 3% (Cummings et a l , 1987) 
and 49% (Rabins et al 1982). Of the smaller number of 
publications differentiating visual and auditory hallucinations, 
three have found a greater prevalence of visual hallucinations 
and two the reverse (Wragg and Jeste, 1989). There is a tendency 
for the number of patients with hallucinations to be higher in 
those studies describing acute referrals (eg Rabins et al 1982; 
Leuchter and Spar, 1985) compared to those reporting subjects who 
attend AD research centres (Rubin et al 1988). Results may vary 
according to the definitions used, ie the parsimonious definition 
used by Cummings et al (1987) resulted in a prevalence rate of 0% 
for visual hallucinations and 3% for auditory hallucinations 
while Rabins et al (1982), relying on care givers* accounts, 
found a rate of 49%. Cummings et al (1987) ignored questionable 
hallucinations while Rabins et al (1982) made no mention of such 
exclusions. The present study relied largely on caregivers* 
accounts and ephemeral visual and auditory hallucinations were 
excluded. This may explain why the rate in this study is between 
that of Cummings et al (1987) and Rabins et al (1982). Olfactory 
hallucinations have been described rarely (eg 2% in Rubin et al
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1988) but were not found in this study.
Berrios and Brook (1984), working with general hospital 
referrals, described visual hallucinations in 30% of 150 
referrals to a psychogeriatrician of whom 43% suffered from SDAT. 
Hallucinations were usually fleeting and were strongly associated 
with eye pathology and delusions. No association was found 
between visual hallucinations and either impairment of vision or 
delusions in the present study. Berrios and Brook (1984) also 
described "a new subtype of perceptual disorder" in seven 
patients who felt television images were real.
Perceptual disturbances, other than hallucinations, have 
also been described in DAT. Rubin et al (1988) examined these in 
detail and described them as misidentification syndromes, 
although they had been described separately in the early 
literature (Mayer-Gross et al, 1960). Three were documented: 
misidentification of television (originally described by Berrios 
and Brook, 1984); misidentification of mirror image and the 
conviction that someone else is in the house. This last syndrome 
is difficult to categorise unambiguously - it can be argued that 
it could also represent a delusion or visual hallucination. In 
agreement with Rubin et al (1988), but recognising that its exact 
nosology is debatable, I have chosen to include it as a 
misidentification. The justification for this is:
a) it often fails to fulfil the definition of a delusion;
b) it occurs frequently without definite evidence that the other 
person in the house has been seen;
c) it is associated with other misidentifications eg with 
misidentification of mirror reflection, p < 0.0001 and with
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misidentification of television, p 0.08, (both statistics 
chi-square tests) and
d) it is more systematised and iterative than confabulation.
Rubin et al (1988) described misidentification in 23% of 
their sample - 7% misidentified their mirror image, 12% 
misidentified images on the television and 12% felt that others 
were in the house. These figures are very similar to the rates 
in the current study. Merriam et al (1988) found extremely high 
rates of perceptual disturbances with 50% and 40% misidentifying 
people and places respectively. 17% of their sample displayed 
the Capgras syndrome, while this occurred in only one person in 
the present study. The population described by Merriam et al 
(1988) appears unusual and unrepresentative in view of the 
extremely high rates of psychiatric symptoms (eg 56% with 
persecutory ideas and 86% with depression). Misidentification of 
people occurred in 12% of the current sample which is almost 
identical to that described by Cutting (1987) in his 74 
patients with organic psychoses.
Sex Distribution
There was a significant excess of males with 
misidentification syndromes in this study. No other work has 
addressed this issue, although Teri et al (1989) found that men 
were reported to have more problems as described by relatives 
(which included behaviour such as aggression and symptoms such as 
loss of interest and muteness). In common with the situation for 
delusions, there seems no reason to suppose there was any 
systematic bias in the reporting of misidentifications in men.
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However, this merits further investigation as theoretically, 
altered sensitivity or tolerance on the part of their female 
carers may result in overeporting in males (Teri et al, 1989). 
Relationship to Age and Mortality
No previous studies have reported age and age of onset of 
illness in subjects with misidentification syndromes. Drevets 
and Rubin (1989) found no difference in age in subjects with or 
without psychoses but did not subdivide psychotic features into 
delusions, hallucinations or misidentification syndromes. The 
association between age and misidentification in this study may 
be due to involvement of the parietal lobe. Younger age of onset 
in DAT is associated with parietal lobe damage (Seltzer and 
Sherwin, 1983) as is agnosia (Lishman, 1987). The association 
between reduced mortality and misidentification in this study 
replicates a finding by Drevets and Rubin (1988). These authors 
found that ’psychotic* patients (those with delusions, 
misidentification or hallucinations) had a mortality rate of 20% 
at 66 months compared to 60% in non-psychotic patients (p <
0.05). On the other hand, parietal lobe involvement has been 
reported to be a predictor of rapid deterioration and higher 
mortality (McDonald, 1969, Naguib and Levy, 1982a). Since 
mortality was decreased in patients with misidentifications, 
there may be some intervening variable involved which was not 
identified in this study. Decreased mortality in patients with 
misidentifications may be a manifestation of different underlying 
cerebral pathology or an indication that a different pattern of 
care is given to patients with psychotic symptoms and that this 
in some way reduces mortality.
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Relationship to Cognitive Function
The relationship between psychotic symptoms and cognitive 
function has been investigated in several publications.
Generally speaking, psychotic features (including delusions) are 
said to occur early in the course of the disease while cognitive 
function is relatively intact (Rothschild, 1941; Cummings,
1985). However, there are conflicting reports about this issue 
in the literature. Merriam et al (1988) reported a significant 
association between the degree of cognitive impairment on the 
IMC and the presence of perceptual disturbances and 
hallucinations. On the other hand, Teri et al (1988) found no 
difference in the proportion with hallucinations across three 
levels of dementia severity, a finding which is in agreement with 
the present investigation.
Three studies have examined the rate of cognitive decline in 
DAT and have related this to the presence of psychotic features. 
Mayeux et al (1985a) found in a longitudinal study of 62 patients 
with DAT, that the 27 psychotic patients deteriorated much faster 
on neuropsychological and functional ratings. "Psychosis” was 
curiously defined as "persistent or recurrent thought disorder". 
Stern et al (1987), in an extension to the study by Mayeux et al 
(1985) presented information on 65 subjects examined over a 
follow up period of up to seven years. An association was noted 
between psychotic symptoms and myoclonus and extrapyramidal 
signs. Psychotic subjects deteriorated more quickly than non- 
psychotic subjects and reached a predetermined ’cognitive 
endpoint’ sooner than their non-psychotic counterparts.
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Drevets and Rubin (1989) compared ten subjects who had 
displayed psychotic symptoms early in the course of DAT with 15 
subjects who had never experienced psychosis. The two groups 
were followed up for 66 months. By 15 months, the previously 
’psychotic* group had deteriorated much faster on cognitive 
function and functional ability and in an overall rating of 
severity of dementia. The current work replicates the findings 
of increased cognitive deterioration in ’psychotic’ subjects but 
narrows this down to subjects specifically experiencing 
hallucinations and not delusions or misidentifications.
Disorders of Affect
The main findings were:
1) depressive symptoms occurred commonly in subjects with SDAT 
but objective signs of depression were much less common;
2) in contrast, symptoms and signs of mania were rare;
3) patients complaining of depressive symptoms were less 
cognitively impaired but their disease progressed at a 
similar rate to those without depression and
4) mood changes had neuroanatomical correlates - depression was 
associated with relative preservation of the third and 
lateral ventricles and with less widening of the IHF and 
widening of this region was more marked in subjects with 
manic symptomatology.
Frequency of Depression
Comparisons of the frequency of depression in this and other 
studies must be judged in the light of differing populations 
studied and assessment instruments employed. For example, some 
publications report only the mean number of symptoms (eg Burke et
19b
al 1988), while others give a categorical measure of whether the 
subject was depressed or not (eg Knesevich et al 1983). Some 
compare relatives* reports and patient’s complaints (eg Burke et 
al 1988). The present work reports three separate ratings of 
depression (from patient, relative and trained observer) carried 
out in a standardised way.
Reports of depressed mood in DAT vary from between 0% 
(Knesevich et al 1983) and 87% (Merriam et al 1988). Samples 
drawn from acute care settings tend to have higher rates than 
those obtained through research clinics. Symptoms tend to be 
more frequent when relatives* reports are used (Burke et al 1988; 
Merriam et al 1988) than when these are based on direct interview 
with the patients (Lazarus et al 1987). The findings of the 
present study are surprising in that the patients themselves 
reported more symptoms than the relatives. One possible 
explanation is the very low threshold used for diagnosing 
depressive symptoms on the GMSS (ie one symptom) and the 
comparative insensitivity of the question addressed to the 
relatives (ie a yes/no answer was required to the question "do 
you think your relative is depressed?"). The proportion of 
subjects regarded as depressed by the observer (23.5%) is similar 
to those regarded as suffering from depressive disorders in other 
studies (eg Reifler et al 1982; Birkett, 1972). 5.6% of
patients were taking antidepressant medication - no other reports 
are available with which to compare this. Theoretically, 
treatment with an antidepressant may have masked depressive 
features, but in view of the small number taking such a drug this
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would not significantly affect the results of the present study. 
The absence of any DSM IIIR cases of major depression is in 
agreement with reports by Cummings et al (1987) and Knesevich et 
al (1983). However, it should be noted that the diagnostic 
categories of primary degenerative dementia of the Alzheimer type 
and major depressive disorder are mutually exclusive in DSM IIIR. 
Mania
In contrast to the frequency of depressive symptomatology, 
elevated mood in DAT is less common. Bucht and Adolfsson (1983) 
described it in three out of 18 patients (17%) and Rothschild 
(1941) noted it in only one of 31 subjects (3%). No standardised 
instruments have been used to assess manic symptomatology in DAT 
before the use of the GMSS in the present study. However, the 
rates of elevated mood revealed are comparable to Rothschild 
(1941). Subjective evidence of elevated mood occurred in only one 
subject in the present study.
Relationship between Disorders of Mood and Cognitive Impairment
Subjects who complained of depression were less cognitively 
impaired than those who did not. This is in agreement with the 
observations by Reifler et al (1982) and Merriam et al (1988) who 
found that depressive symptoms were more common in DAT patients 
with less cognitive impairment. Cummings et al (1987) found 
little relationship between depression and cognitive function but 
noted that some features of depression (crying, diminished sleep) 
were discernible in subjects with all degrees of dementia but 
that certain symptoms (eg guilt, hopelessness and anxiety) were 
difficult to assess in those with severe dementia. Thus, the 
apparent paucity of depressive symptoms in patients with severe
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dementia may be an artefact due to the insensitivity of the 
assessment instruments employed or may be due to the inability to 
experience such complex integrated emotions and abstract ideas 
due to advanced brain disease. The present work suggests that 
patients with severe cognitive impairment have less complaints of 
depression but do not differ in terms of observed depression (by 
an interviewer or relative) or previous history of depression. 
Theoretically, the cholinergic deficit in DAT may protect 
patients from severe depressive episodes. The deterioration in 
cognitive function was similar in subjects with or without 
depression, suggesting that depressed subjects do not have a 
discrete biological subtype of DAT. However, those with a past 
history of depression had a tendency to deteriorate less quickly 
which may suggest that those patients, irrespective of current 
symptomatology, have a less severe form of the illness. The only 
other study to present information on the proportion of DAT 
patients with a past history of psychiatric morbidity is by 
Agbayewa (1986). In total, 18% of 188 subjects had a previous 
history of psychiatric problems. When only those with a history 
of depression are included, the figure is remarkably similar to 
the present study - 9.6% compared to 9.5% in the current sample. 
No additional information was given in the paper to allow 
comparisons with the present sample.
Anatomical Correlates of Affective Disorder
The CT scan changes seen in subjects complaining of 
depression concur with the cognitive findings in suggesting that 
these subjects, when compared cross sectionally to a group
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without depression, have a less severe form of dementia. Also, 
there was a negative correlation between the number of depressive 
symptoms and both third and lateral ventricle size. Patients 
whose relatives felt that they were depressed had smaller values 
for these same two indices. This is the first study, as far as I 
am aware, which has assessed CT findings in depressed and non­
depressed SDAT subjects, although Jacoby and Levy (1980a) found 
no correlation between depressive symptoms on the GMSS and CT 
variables in demented subjects. Several reports have appeared 
concerning CT changes in subjects with affective disorder alone 
(eg Jacoby and Levy, 1980b, Dolan et al 1986) and comparisons 
between depressives with and without cognitive impairment 
(eg Pearlson et al, 1989).
Two papers have described the neuropathological changes in 
AD patients with and without depression. Zubenko and Moossy 
(1988) examined degenerative neuropathological changes in the 
locus coeruleus and substantia nigra. In 14 out of 37 patients 
with AD, depression (based on DSM III criteria) had occurred 
during life. No differences were found between those with or 
without depression in terms of age, duration of dementia, brain 
weight or global rating of SP and NFT. However, degenerative 
changes in the locus coeruleus and substantia nigra were much 
greater in patients with depression and a combination of the 
findings in both nuclei was a better predictor of depression than 
those in each nucleus separately.
Zweig et al (1988) found evidence of depression during life 
in eight patients out of 21 with neuropathologically proven AD. 
They were characterised by having more neuronal loss in the
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nucleus coeruleus and. dorsal raphe nucleus than non-depressed 
subjects. Both Zubenko and Moossy (1988) and Zweig et al (1988) 
suggested that catecholamine depletion due to damage in these 
aminergic nuclei might be responsible for the clinical features 
of depression. Zweig et al (1988) suggested that this supports 
the hypothesis that the presence of depression in AD is 
representative of a biological subtype of the disorder. 
Behavioural Disturbance
The main results were:
1) behavioural disturbances occurred in a significant proportion 
of patients suffering from SDAT;
2) the majority were directly associated with more severe 
disease, as measured in terms of cognitive function and 
overall severity;
3) some had anatomical correlates as measured by changes in CT 
scan and
4) the complete ’Kluver-Bucy* syndrome, even in advanced 
dementia, was rare but individual items associated with the 
syndrome were common and tended to be interrelated with the 
exception of binge eating.
Proportion of Patients with Behavioural Disturbance
Aggression is the behaviour causing most distress to carers, 
both at home and in hospital. The proportion of patients 
exhibiting this behaviour varies according to the definition 
used. The one used in the present study (as behaviour liable to 
cause physical injury to others) is very similar to that used by 
Swearer et al (1988) and the percentage of subjects demonstrating
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aggression is almost identical (20% of the current study, 21% by 
Swearer et al). Likewise, Reisberg et al (1987) found "violence" 
to occur in 19% of their sample. Ryden (1988) found 65% of a 
community sample of 183 subjects to have at least one form of 
aggression (most commonly verbal aggression). Closer inspection 
of her results show that acts which would be deemed aggressive in 
other studies were much less frequent, eg pushing/shoving (21%); 
pinching/squeezing (15%) and hitting/punching (14%). Thus, it 
would appear that predominantly physical, as opposed to verbal, 
aggression showed a rate remarkably consistent at around 20%.
The neurophysiological basis for aggression is unknown, but 
human and animal studies have suggested circuits involving the 
medial nuclei of the hypothalamus (Moyer, 1971), the amygdala 
(Hitchcock and Cairns, 1973; Heath and Mickle, 1960) and 
hippocampus (Green et al, 1957). Two observations suggest that a 
link may exist between aggressive behaviour and neurochemical 
changes in DAT. First, there is evidence that the circuits 
mediating aggression are cholinergic (Smith et a l , 1970) and the 
cholinergic deficit in DAT is well recognised (Rossor et al 
1984). Second, serotonin metabolites have been shown to be 
reduced in aggressive patients with depression (Branchey et al , 
1984) and schizophrenia (Lemoine et al, 1984). A reduction in 
serotonin metabolites has also been demonstrated in DAT (eg 
Adolfsson et al, 1979).
Wandering has received less attention as a disruptive form 
of behaviour in DAT - it was not even included as an item in the 
original Stockton Behaviour Rating Scale (Meer and Baker, 1966). 
However, it has been cited by over 70% of families as being a
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problem (Rabins et al 1982). The only other study to offer a 
predetermined definition of wandering is that by Teri et al 
(1988) who found the behaviour in 26% of the 127 subjects. It 
was commoner (over 50%) in subjects with severe dementia 
(defined as an MMSE score of less than ten). Both the frequency 
of wandering and association with severe dementia have been 
replicated in the present study.
Urinary incontinence is another major problem both for 
relatives (Rabins et al, 1982) and care staff (Meer and Baker, 
1966). The prevalence rate in out-patients varies from between 
16% to 40% (Swearer et a l , 1988, Rabins et al , 1982). In one 
study (Teri et al, 1988), its presence was clearly related to the 
severity of dementia. This is in agreement with the present work 
in which the vast majority of those rated as "severe” were 
incontinent. The grave prognostic significance of the feature 
has also been shown with 47% of incontinent patients having died 
within 30 months of follow-up.
Binge eating is one of the features of the Kluver-Bucy 
syndrome (Sourander and Sjogren, 1952). Increased eating in 
dementia has been described (Hope et al, 1989) but was not 
considered to be associated with other signs of the Kluver-Bucy 
syndrome. A recent study by Morris et al (1989), found increased 
eating in 26% of 33 patients with dementia. However, the sample 
was mixed with 27 subjects suffering from DAT and six from other 
dementias. Swearer et al (1988) found "dietary change" (either 
decreased or increased eating) in 46% of his subjects. Binge 
eating differed from other behaviour described here in that the
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proportion of the subjects exhibiting this feature did not 
increase with the severity of dementia. There appeared to be no 
association with other features of the Kluver-Bucy syndrome, 
except with the related disorder of hyperorality, which is not 
surprising.
Sexual disinhibition was seen in 7% of the current sample. 
Like binge eating, this is considered by some an integral part of 
the Kluver-Bucy syndrome (Cummings and Duchen, 1981). An 
identical frequency of sexual disinhibition has been reported by 
Kumar et al (1989).
Association with Severity of Dementia
The majority of behavioural disturbances, unlike psychiatric 
symptoms (such as depression, delusions and hallucinations) were 
positively associated with the degree of dementia. Thus, such 
behaviour is likely to be a result of advanced cerebral pathology 
and so the neuropathological substrates may be qualitatively and 
quantitatively different from those of psychiatric symptoms. The 
distinction between disturbed behaviour and specific psychiatric 
symptoms in DAT is often not made (Reisberg et al, 1987, Teri et 
al, 1988). There was no evidence that disturbed behaviour was
the result of prescribed medication.
Relationship with CT Scan Findings
Many of the behavioural disturbances were associated with 
regional changes in the CT scans. More specifically, aggressive 
subjects had more atrophy of the temporal lobes. This confirms 
an earlier report of a similar relationship (Swigar et al, 1985). 
Hyperorality was associated with widening of the third ventricle 
and atrophy of the frontal lobe. The proximity of the
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hypothalamus to the third ventricle and its function as a 
regulator of dietary intake may suggest that hyperorality may 
result from damage leading to increased oral tendencies. Signs 
of the ’Kluver-Bucy syndrome’ were associated with temporal lobe 
atrophy.
The ’Kluver-Bucy Syndrome’
Sourander and Sjogren (1970) describe individual components 
of this syndrome as having frequencies of over 70% in 132 post 
mortem verified cases of AD. Abnormal sexual behaviour was the 
least frequent with a rate of 17%. However, the various features 
were not operationally defined and no indication was given of the 
proportion of cases exhibiting two or more of the components. It 
has been argued that the full syndrome is unlikely to occur in 
man as it is specific for other primates and that the abnormal 
sexual behaviour is the least likely to occur (Sourander and 
Sjogren, 1970; Pilleri, 1966). Both these observations have 
been confirmed by the present study. The seven features have 
been shown to have a degree of interrelationship but the 
association was not strong and three individual factors 
emerged with binge eating being isolated. This confirms the 
impression of Fairburn and Hope (1988,b) that binge eating is not 
associated with other features of the syndrome. It should also 
be noted that some of the symptoms were not exclusively related 
to temporal lobe damage.
One of the problems in the present assessment of the 
’Kluver-Bucy Syndrome’ involves the way in which behaviour seen 
in animals is assessed in humans using a rating scale. For
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example, it was very difficult to translate unequivocally 
abnormal sexual behaviour in the monkey (defined originally as 
increased sexual activity involving forms of heterosexual, 
homosexual and autosexual behaviour) to the sort of disturbance 
seen in the patients and to incorporate this into a rating scale. 
Nevertheless, an attempt to do this seemed worthwhile the 
questions asked did seem appropriate although there might 
obviously have been an overlap between this type of behaviour and 
that as seen in patients with frontal lobe damage.
6.3 SUMMARY
Delusions occurred in 16% of subjects since the onset of 
illness and had been present within the preceding 12 months in 
11%. Simple delusions of theft and suspicion were the most 
common types and a greater proportion of men suffered delusions 
of theft. Subjects with other types of delusion had relatively 
well preserved lateral ventricular size and basal ganglia 
calcification. 20% of the group had experienced persecutory 
ideation short of delusions since the onset of the illness. 
Cognitive function at entry to the study and cognitive 
deterioration over the succeeding 12 months were not influenced 
by the presence of disorders of thought content.
Visual hallucinations had been experienced by 13% and 
auditory hallucinations by 10%. 30% had misidentification
syndromes - these were associated with a younger age and younger 
age of onset of illness and proportionately more men than women 
were affected. There was a reduced 36 month mortality rate in 
this group. Subjects with hallucinations had a greater
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deterioration in cognitive function at 12 month follow up which 
could not be accounted for by neuroleptic medication.
At least one depressive symptom was reported by 63% of the 
sample, 24% were rated as depressed by a trained observer and 43% 
were considered depressed by their relatives. 10% had a previous 
history of depression. In contrast, elevated mood was rare, 
occurring in only six patients (3.5%). Subjects with depressive 
symptoms had less cognitive impairment and less ventricular 
enlargement on CT compared with those without symptoms. Widening 
of the IHF was associated with symptoms of mania but was 
inversely related to the presence of depressive symptoms.
Aggression was present in 20%, wandering behaviour in 19%, 
binge eating in 10%, hyperorality in 6%, urinary incontinence in 
48% and sexual disinhibition in 7%. Behavioural abnormalities 
were greater in those with more severe dementia. Temporal lobe 
atrophy correlated with aggression and widening of the third 
ventricle with hyperorality. Features of the Kluver-Bucy 
syndrome were commonly seen but the full syndrome occurred in 
only one subject. Patients with at least one feature of the 
Kluver-Bucy syndrome had greater temporal lobe atrophy than those 
without any of the features.
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CHAPTER 7
LONGITUDINAL CHANGES IN COGNITIVE FUNCTION 
AND COMPUTED TOMOGRAPHY
7.1 RESULTS 
Cognitive Function
Assessment of longitudinal changes in cognitive function was 
confined to those patients who scored above zero on the CAMCOG 
examination at entry to the study - 142 were eligible for 
inclusion. Of these, 34 died during the next 12 month follow up 
and so data are presented on the remaining 108. Table 7.1 
outlines the mean scores on the cognitive tests at entry to the 
study and 12 months later. There was a highly significant 
deterioration in cognitive function across the group. The 
relatively large sample size with an approximately normal 
distribution of scores justified the use of the paired t-test. 
Figure 7.1 shows the distribution of change in the MMSE score 
over 12 months. There were no significant differences between 
survivors and non-survivors in either cognitive tests or in age, 
age of onset or duration of illness. However, as would be 
expected, non-survivors were more likely to be in CDR III (Chi- 
square test, p<0.007) but no differences were seen in the two 
groups with regard to sex, family history of dementia, place of 
residence or CT variables.
Table 7.2 shows the effect on change in cognitive function 
of family history of dementia and initial cognitive score. A 
family history of dementia in parents was associated with a 
larger decline in cognition over one year, despite there being no 
difference in initial score. This was significant for the MMSE
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test with a strong trend (not quite statistically significant) 
for the other tests. A family history in either mother or father 
both contributed equally to this significant result but was not 
affected by the degree of certainty with which the judgement of 
the dementia syndrome in the relative was made (possible, 
probable or definite, see Chapter 4), The score on the CAMCOG at 
entry to the study was used to divide the sample into three 
subgroups according to the degree of cognitive impairment. 
Subjects with moderate impairment (CAMCOG scores of between 30 - 
50 out of 107) tended to have a greater decline in cognitive 
function than those with either mild or severe impairment. There 
was no significant correlation between duration of illness and 
decline. However, when the sample was divided into those with 
duration of illness above or below 24 months, there was a 
tendency for those with the shorter duration of illness to have a 
greater decline. This was significant for the memory subscale of 
the CAMCOG (-2.7 compared to -1.5 points per year, Students’ ’t ’ 
test, p<0.05).
Other factors which might have influenced the rate of 
cognitive decline were examined. Significant negative findings 
included no correlation between rate of cognitive deterioration 
and age at entry to the study, age of onset, years in 
education, sex, extrapyramidal signs, myoclonus and presence or 
absence of apraxia, aphasia or parietal lobe atrophy on CT scan.
To examine patterns of decline in more detail, a cluster 
analysis was performed using all the indices of change in 
cognition. Ward’s method was employed using squared Euclidean
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distances on standardised scores. Table 7.3 shows that three 
clusters resulted (N = 105 as incomplete data were present in 
three cases). The significant between the clusters using a one 
way ANOVA (Scheffe’s test), merely reflects the ability of the 
cluster analysis to separate the groups effectively. These 
results are shown graphically in Figure 7.2. The majority of the 
subjects showed mild or moderate decline. The nine subjects in 
the third cluster showed the most decline of the group. These 
nine were not significantly different from the others in their 
initial characteristics. The first cluster included six subjects 
whose MMSE actually increased over the follow-up period. The 
increase was small (two subjects each had an increase of 1, 2 and 
3 out of 30). Three of these subjects were hospitalised for 
continuing care; two had very mild dementia and lived at home 
and the sixth was in a nursing home. There was no significant 
difference between these six subjects and the others in terms of 
age, age of onset, duration of illness or initial cognitive 
performance. Unexpectedly, they had significantly more atrophy of 
the frontal lobe (p<0.04, Chi-square test), parietal lobe 
(p<0.002) and left Sylvian fissure region (p<0.001) than the 
others.
An attempt was made to quantify the rate of decline over 1 
year. To compare with other studies, it was necessary to convert 
the MMSE result into an IMC score using the formula of Thai et al
(1986), which is only valid when the MMSE is between 10 and 26.
23 patients had scores falling in this range on both occasions. 
The mean decline in Blessed Score was 2.80 (SD 3.21) per year (ie 
an increase of 2.80 errors per year).
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Computed Tomography
Of the original sample of 138 who had been scanned at entry 
to the study, 36 had died and could therefore not be rescanned. 
Two of the repeat scans were disgarded for technical reasons. It 
was not possible to rescan 37 patients who had been scanned at 
entry to the study and were still alive after one year. The 
reasons for scan failure in these 37 were: uncooperative,
aggressive behaviour - 16 patients (43%); too physically ill to 
be scanned - 10 patients (27%); moved too far out of the 
district making it impractical to perform a second scan - 8 
patients (22%) and relatives refusing permission for a second 
scan - 3 patients (8%).
Significant changes took place in the CT scan indices over 
the 12 month follow up period. The mean VBR increased from 15.1 
to 16.5 (9.3% increase, Student’s t test p < 0.0001), third 
ventricular size increased from 1.8 cm2 to 2.1 cm2 (16.6% 
increase, Student’s t test p < 0.001) and Total Cortical Score 
(tha summation of the regional atrophy scores) deteriorated from 
a mean of 5.9 out of 23 to 6.3 (6.8% increase, Student’s t test p 
< 0 .0001) .
It was found that measures of the sylvian fissure area often 
showed a decrease in size over time which was due to different 
positioning of the patient at the second scan. These results 
were therefore not included in the analysis. There was a wide 
variation in the changes in the CT scan - 14 out of the 63 showed 
either no change or an actual decrease in size of the third and 
lateral ventricles suggesting that no statistically significant
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overall change had taken place. A group of six patients, 
demonstrated a mean change in VBR of three or greater. A 
histogram of the distribution of changes in VBR suggested that 
these formed a subgroup and were not merely at one end of a 
normal distribution. Neither of these subgroups (those 
demonstrating large or negligible change in CT variables) showed 
any difference to the others in terms of demographic details or 
initial and follow-up cognitive or CT variables. The presence or 
absence of white matter changes did not affect the rate of 
increase in ventricular size. Changes in the CT indices were not 
related to initial severity of illness as assessed by the CDR.
The association between decline in cognition and change in 
CT scan variables was examined. A frequency distribution curve 
suggested that both the changes in cognitive function and in 
ventricular size were normally distributed, so a Pearson Product 
Moment Correlation was performed. The correlations between 
change in ventricular size and the cognitive tests were: total 
CAMCOG score -0.21 (p < 0.05); language -0.19 (p < 0.1); memory - 
0.24 (p < 0.05) and praxis -0.20 (p < 0.1). There was no 
significant correlation between age of onset of the disorder and 
increase in ventricular size (Pearson correlation, 0.0025).
7.2 DISCUSSION 
Cognitive Function
Assessments of the decline in cognitive function showed:
1) a highly significant decline in cognitive function occurred 
over 12 months in the group;
2) the rate of decline had a relatively normal distribution with 
some patients having marked decline and others only minimal
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deterioration;
3) initial cognitive function, duration of illness and family 
history of dementia in parents had some influence on rate of 
decline and
4) age, age of onset, parietal lobe atrophy, presence of aphasia 
and apraxia and previous educational attainment had no effect 
on rate of deterioration.
Rate of Cognitive Decline
Deterioration in cognitive function in SDAT has been 
documented previously and this is replicated by the present 
findings. It has also shown the ability of the CAMCOG scale to 
detect changes in cognitive function over one year. Other 
reports have demonstrated a non-significant decline when the 
follow-up period is three months or less (eg Cowan et a l , 1975), 
but a significant decline is apparent when the follow-up period 
is six months or more (eg Naguib and Levy, 1982a, Katzman et al , 
1988). Deterioration in SDAT and documentation of a variety of 
clinical stages has been reported by Reisberg et al (1982, 1986). 
The rate of decline was found to be relatively homogeneous as the 
histogram of the distribution of decline has shown (Figure 7.1). 
This is almost exactly the same shape as the distribution of 
decline in the IMC score in the paper by Ortof and Crystal 
(1989). At the extremes of this distribution were subjects whose 
decline was very rapid and others where the decline was 
negligible. This is in agreement with other studies (eg Dastoor 
et al, 1985; Botwinick et al, 1986). Botwinick et al (1986) 
described a subgroup of five out of 18 patients with mild DAT who
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progressed very little over a four year period. Four possible 
explanations for this lack of progression were given. First, that 
these patients were at one end of a normal spectrum. Second, that 
they were less severely demented to start with. Third, the 
duration of disease was less in this group and fourth, that they 
represented an identifiable subgroup of DAT, ie "slow or non­
progressive". In invoking the same explanations for the changes 
in the current population, it can be seen that the second and 
third explanations are not supported but both the first and last 
explanations remain possibilities.
The surprising finding of more atrophy in the frontal, 
parietal and left sylvian fissure region of the CT scans in the 
six patients who deteriorated most is difficult to interpret. 
Theoretically, if rate of decline of cognitive function (rather 
than actual degree of cognitive impairment) was related to 
cerebral atrophy (as suggested by Luxenberg et al, 1987), then 
one might argue that these patients had already reached a maximal 
level of cerebral atrophy ie a ’floor effect’. Thus, further 
deterioration in the atrophic process would be minimal and this 
is reflected in the relative non-progression of cognitive 
function. However, this is a theoretical explanation of a 
surprising finding and the question remains unresolved. Parietal 
lobe atrophy has been associated with a poor prognosis (McDonald, 
1969, Hare, 1978, Naguib and Levy, 1982a). However, the outcome 
variable used was death rather than decline in cognitive function 
and these two indices may not necessarily be related. Naguib and 
Levy (1982a) showed a significant association between an 
increased VBR and cognitive decline and a small but not
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statistically significant association between cognitive decline 
and radiodensity in the right parietal region on CT scan.
However, the number of patients was small (N=12), the follow-up 
period variable and the patients 3.6 years younger than in the 
present study. Further longitudinal studies of both cognitive 
decline and progression of cerebral atrophy are required to 
answer this question.
The finding of an association between initial cognition and 
decline concurs with that of Katzman et al (1988). These authors 
found that a ceiling effect occurred with an IMC score of 24 or 
above, which is equivalent to a floor effect (ie where a score is 
at, or sufficiently near zero, so that any further decline is not 
observed) seen with the MMSE (the IMC score is the number of 
errors while the MMSE and CAMCOG score is the number correct). In 
this study, patients with intermediate scores tended to 
deteriorate more quickly than those with either high or low 
scores. This may indicate that in the course of SDAT, there is a 
relatively small decline initially, followed by a more marked 
decline and then a slowing down later in the course of the 
disease. Alternatively, it may be due to a floor and ceiling 
effect on the MMSE and CAMCOG.
Quantification of Rate of Decline
Katzman et al (1988) quantified the annual rate of decline 
on the Blessed Scale in 161 patients drawn from four populations 
- a nursing home, an AD Research Centre, a private practice and 
an ageing study. The rate of decline in the present work (2.80 
IMC points per year) is almost identical to that in the Nursing
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Home and Research Centre subsamples. It is likely that these two 
populations had more in common with the present sample than those 
seen in the ageing study (who were all normal volunteers, some of 
whom developed dementia) or a private practice population. Ortof 
and Crystal (1989) found a mean decline of 4.1 Blessed points per 
year in a sample of 54 DAT patients. There are two possible 
explanations for this apparently high rate. First, the rate 
quoted was the mean for all 54 patients - when the group was 
split into those with an IMC score of 0-15 (similar to the 
present sample), the mean rate of decline was 2.70. Second, the 
average age of the group was 67, 13 years younger than this 
sample. The more rapid decline expected in younger patients 
(Becker et al, 1988) may therefore partly explain the differences
between the studies.
Factors Affecting Decline
The relationship between family history of dementia and rate 
of decline has been examined in several studies and found not to 
affect rate of cognitive decline (Thai et al, 1986; Ortof and 
Crystal 1989). In this study, there was a strong trend (just 
statistically significant) towards an increased decline in 
subjects whose parents suffered from dementia. The fact that the 
siblings of the patients may themselves not have completed the 
period at risk may have affected the findings and the numbers 
involved are small. The results should therefore be interpreted 
with caution and require replication. However, one possible 
explanation is that these patients have a genetic predisposition 
to a more severe form of the disease. Duration of illness of less 
than two years was associated with increased decline in the
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memory subtests of the CAMCOG, a result in agreement with that of 
Thai et al (1986).
In this work, several negative findings require explanation. 
Age of onset and age at examination were found not to be 
associated with more rapid rate of decline. This accords with 
other studies such as that of Thai et al (1986a), Becker et al 
(1988) and Ortof and Crystal (1989). Heyman et al (1987) and 
Christie and Wood (1988), found that a younger age of onset was 
predictive of death and institutionalisation. However, neither 
study used change in the cognitive score as the outcome variable 
and Heyman et al (1987) studied early onset cases. Huff et al
(1987) reported an association between age of onset and 
progression. Paradoxically, they found that onset over the age of 
65 was associated with more rapid progression. This was barely 
statistically significant and probably not clinically relevant. 
The lack of an association between age and decline in the present 
sample may have been due to the fact that all subjects were over 
65 years of age.
The presence of aphasia has been associated with more rapid 
progression in two studies (Faber-Langendoen et al, 1988, 
Knesevich et al, 1985). However, both used the CDR as a measure 
of progression and Knesevich et al (1985) used a cut-off point on 
the IMC score at the time of the second examination, regardless 
of initial score. The CDR is a global rating of dementia and 
includes no specific cognitive tests. Therefore, neither study is 
strictly comparable to the present results. The lack of influence 
on progression of sex or previous education is in keeping with
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the observations of Katzman et al (1988). With regard to 
neurological signs, all the subjects in the present study with 
either extrapyramidal signs or myoclonus were very demented and 
so a pronounced floor effect on the cognitive tests would explain 
the absence of an effect of these two physical signs on 
progression.
Four methodological drawbacks of the current work should be 
mentioned. First, many of the patients had advanced dementia and 
so a floor effect is seen on the cognitive tests, tending to 
underestimate cognitive changes. Second, the follow-up period 
was comparatively short (12 months). Although a longer follow-up 
period would be desirable, this would lead to an increase in the 
dropout rate and accentuate floor effects previously noted.
Third, the patients were over age 65 which may account for the 
lack of an association between age of onset and progression. 
Finally, patients who died during the follow up period could 
obviously not be included in the calculation of change in 
cognitive score which may have influenced the rate of decline in 
some way.
Computed Tomography
The main findings were:
1) statistically significant changes in the CT indices measured 
took place over the 12 month period;
2) there was wide variation in degree of the changes and
3) a relationship existed between deterioration in cognitive 
function and increasing ventricular size.
There are four criticisms which can be levelled at this part 
of the study. First, because of attrition the population
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examined was not unselected and the possibility of bias cannot be 
ruled out. Thus, only 63 of 100 patients could be re-scanned 
after one year. It is difficult therefore to be confident about 
extrapolating these results to a population of SDAT subjects. 
However, if serial scans are going to be of help in identifying 
subtypes of SDAT or to assess the natural history of the 
condition, it can obviously only be of use in those patients in 
whom it is possible to perform serial scans. SDAT is a 
progressive condition and deterioration in behaviour and 
therefore diminished ability to co-operate with investigations is 
to be expected over a 12 month period. It was decided, ab initio 
for ethical reasons, that no sedation for CT scans would be given 
in this research project.
Second, most of the patients suffered from moderate to 
severe dementia and as such the changes may be different than if 
the group had mild dementia (due to a CT ’floor* effect).
Third, is the problem of repositioning patients after 12 
months. Although the scanner employed was the same at both parts 
of the study, difficulty was experienced in positioning the 
patients correctly and, as was shown by the measures of the 
sylvian fissure, small changes in the position of the patients 
can produce misleading results. In three of the other studies 
assessing change in CT (Gado et al, 1983, Brinkman et al 1984, 
de Leon et al, 1989), the machines used were different at entry 
and follow up and in this regard the present study may be 
considered to be better. The effects of technical changes in the 
scanner itself were felt to be minimal, as shown by the lack of
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scanner ’drift’ over time (Jacobson et al, 1985). Also, the 
assessment of total cortical score by visual rating and the use 
of the mean of two slices to measure ventricular size probably 
help to minimise further these confounding factors. Finally, it 
was not possible in this study to rescan normal adults over 12 
months. However, these is sufficient information available from 
other studies to suggest that changes due to normal ageing are 
minimal and that changes in SDAT are as a result of the disease 
process and not a consequence of ageing (Brinkman et a l , 1984, 
Gado et al, 1983). Despite these drawbacks in method, useful 
results were obtained in this study.
First, it was shown that significant changes in CT scan 
appearance occurred in the SDAT group, as a whole, over 12 
months. Both ventricular enlargement was remarkably similar (9% 
per annum) to that described by de Leon et al (1989) who 
estimated total ventricular volume. Luxenberg et al (1987) 
assessed both third and lateral ventricular enlargement - the 
increases were of the order of 20-50%. However, the numbers 
studied were small (N=12).
The second finding, similar to that of Naguib and Levy 
(1982a), was that a significant minority of patients (14 out of 
63) showed no deterioration in the CT scan. Why is this? It may 
be that two subgroups do exist as suggested by Naguib and Levy, 
(1982a) - one with patients in whom minor or no change in CT 
indices takes place and another marked changes. A further 
possibility is that the patients who did not change had reached a 
predetermined level of brain atrophy and so the lack of 
continuing atrophy was due to a ’’floor effect”. However, it is
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noteworthy that the patients whose atrophy did not progress were 
no more cognitively impaired than those who did show further CT 
changes. The CT methods used in this study may also be 
criticised, but the same applies to other work in this field. I 
felt it is unlikely that any shortcomings in the CT method 
contributed significantly to the results of this study.
Test - retest, interrater and concurrent validity have been 
proven with the current technique and it has also been shown that 
there has been no significant alteration in the CT attenuation 
numbers over time. Also, this study had the advantage of using 
the same machine at entry and follow up while other studies (eg 
Brinkman et al, 1984, and de Leon et al 1989) used different 
machines.
The third finding was that there is a relationship between 
cognitive deterioration and increasing ventricular size. This 
accords with other studies which have shown an association 
between cognitive and radiological deterioration (Naguib and 
Levy, 1982a, Luxenberg et al 1987, de Leon et al 1989). The 
specific association between increasing ventricular size and 
apraxia just failed to reach statistical significance. McDonald 
(1969) and Hare (1978) stressed that parietal lobe involvement 
was a poor prognostic sign and Naguib and Levy (1982,b) provided 
radiological evidence to support this.
In conclusion, significant changes in CT scan indices take 
place over 12 months in patients with moderate to severe 
dementia. Although there is wide variation in the changes seen 
over time, the evidence for the presence of specific subgroups of
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SDAT is small as the changes were not related to other indices of 
the disease.
Special Problems encountered in Longitudinal Studies
There are currently several major studies being undertaken, 
mainly in the USA, investigating dementia of the Alzheimer type 
employing a longitudinal study design (La Rue, 1988). The 
rationale for utilising this method in the study of dementia is 
straightforward. It is irrational to attempt to characterise in 
a cross sectional fashion an entity which changes over time.
Thus, in longitudinal studies "the entity under investigation is 
observed repeatedly and evolves over time" (Baltez and 
Nesselroade, 1979). The natural of history of the disorder can 
thus be assessed. This has been defined as "biobehavioural 
changes over time in groups of individuals not subjected to a 
systematic intervention" (La Rue, 1988). The longitudinal method 
has its own drawbacks. Influences which may detract from the 
validity of such investigations have been outlined by La Rue
(1988) and are summarised below with a note on how the present 
study attempts to overcome them.
1) Reliability and Stability of Instruments: the measures
used require to possess reliability (interrater and internal 
consistency) in common with non-longitudinal designs. Measures 
must also be stable over short periods and yet be sensitive 
enough to assess any difference due to decline consequent on the 
natural history of the disorder. For the methods used in this 
study, test-retest and interrater reliability have been 
established (eg CAMDEX, Roth et al 1986, GMSS Copeland et a l , 
1976). For measures developed for this study (eg Kluver-Bucy
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symptoms on the behaviour rating scale and quantitative CT scan 
analysis), reliability statistics have been computed and appear 
in the relevant results section.
2) Instrument Bias: the most obvious way of introducing
such bias is by changing instruments partway through a study (eg 
by using updated versions of tests or by adding new tests or 
examinations). This is not an issue on the work reported here 
as the measures are the same throughout the study. The effects 
of instrumentation bias may appear in other ways. In the course 
of a study it is likely that subjects will become more demented. 
Thus, there is a risk of floor effects whereby the test is not 
sufficiently sensitive to measure changes in very demented 
patients. In the current study, the aim was to assess 
heterogeneity in SDAT and so subjects of varying degrees of 
dementia were included. Thus, some were still living 
independently in the community and suffered from mild dementia 
whereas others were suffering from extreme dementia and were 
often hospitalised and unable to speak. For the tests requiring 
co-operation from the patient, eg tests of cognitive function, no 
single test exists which would be as equally applicable to every 
patient in the study. Thus, tests spanning a variety of 
functional and organic domains were employed. The cognitive 
tests may show a floor effect and some of the behavioural 
assessments were too crude for the mild cases and so a ceiling 
effect was apparent. Another source of bias, slightly different 
to floor and ceiling effects, applies to the CT scan. Although 
equally applicable to all subjects, it did require a significant
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amount of co-operation. Some patients were too severely 
demented to co-operate in the scanner and some patients were 
sufficiently mildly affected to be able to say they did not wish 
to co-operate. Thus, the instrument is biased to those able to 
undergo the procedure but those excluded were not simply as a 
manifestation of a degree of dementia (this was unavoidable as it 
was considered unethical to sedate a patient for a research 
scan).
3) Repeated Testing: a practice effect may be apparent on 
testing normal subjects or mildly impaired subjects over a short 
time interval. These are not concerns of the present study 
because of the presence of amnesia which was inherent in the 
selection process. The time interval between testing (12 months) 
was considered sufficiently long to make a practice effect 
unlikely. Other effects such as a change of setting for the 
examination were unavoidable.
4) Subject Attrition: this can take two forms, refusal by 
a subject to participate in a follow-up or death of a subject. 
There is evidence that these can occur non-randomly, eg less able 
people are more likely to refuse repeated testing and are more 
likely to die than more able people. Thus, at each successive 
testing, there may be an underestimation of decline as less 
impaired people survive and take part in the follow-up.
Botwinick et al (1988) studied the question of subject 
attrition in research in great detail. They reported on their 
own data concerning patients with DAT and normal controls 
participating in a longitudinal study. Two main conclusions were 
drawn. First, subjects who opt out of the research were of
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similar cognitive impairment to those who remained. This was 
true both of the normal subjects and the demented patients. 
Second, the authors compared results from two groups of patients 
- those in a longitudinal study of SDAT and those in a cross- 
sectional study. Each was given a rating of dementia (mild, 
moderate or severe on the CDR) as well as more detailed 
neuropsychological tests. The results were similar for 
individuals assessed longitudinally at various levels of the 
global rating as for those assessed cross-sectionally. Thus, 
studying a group of patients cross-sectionally with dementia of 
varying severity gives no less information than studying a single 
group of patients longitudinally. However, as the authors 
mention, longitudinal studies are essential when assessing 
individual subject change or the rate of change.
In the current project, death was the only reason for 
subject attrition. This high follow-up success rate was 
obtained using two strategies - a willingness to travel 
considerable distances to examine patients and, most importantly, 
maintaining close contact with the patient and family providing 
support and advice and thus facilitating co-operation.
5) Cohort Effects and Sampling Bias: individuals born at
different times and in different areas have experienced 
influences which distinguish them from others. Thus, cohort 
effects (assessing patients over a wide age range, often 50 to 80 
years), and sampling bias (recruiting subjects for a study 
depending on volunteers who may be of a higher socioeconomic 
group and more willing to pursue research opportunities) may
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influence the results. The current study avoids sampling bias 
by investigating patients from a defined catchment area and was 
thus not dependent on volunteers (a very small number of people 
did refuse to take part in the study, less than 3%, but these did 
not differ significantly in major demographic variables from 
those included).
7.3 SUMMARY
A highly significant deterioration in cognitive function was 
observed in the group over the 12 month follow up period.
Decline in cognitive scores was relatively normally distributed. 
An increased rate of decline was seen in patients whose 
parents suffered from dementia, in subjects who had moderate 
dementia and who had been ill for less than 24 months. Age, age 
of onset and the presence or absence of aphasia and apraxia had 
no influence on rate of progression. A cluster analysis 
revealed three patterns of decline.
Significant deterioration occurred in the CT measures 
investigated (lateral ventricular size, third ventricular size 
and cortical atrophy) in 63 of the patients over one year. There 
was a wide variation in the size of the changes observed, 14 out 
of 63 patients showing no significant change while six showed a 
marked increase in ventricular size. However, neither group 
differed from the others in any demographic, cognitive or other 
CT variables which suggested, at least on the CT measures used in 
this study, that no clearly identifiable subgroups of SDAT were 
present. Changes in CT indices were not related to initial 
severity of disease. An increase in ventricular size was 
associated with cognitive deterioration.
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CHAPTER 8 
NEUROLOGICAL SIGNS
8.1 RESULTS
Table 8.1 shows the frequency with which each neurological 
sign was present. The number of subjects varies slightly as a 
small number were resistive to physical examination and it was 
not possible to examine them fully. There was no difference in 
the frequency of neurological signs in those with ’’possible" or 
"probable" AD (with the exception of an abnormal plantar 
response) and the results were essentially the same when the 
groups were analysed separately. Thus, for the sake of 
convenience, the findings are presented for the group as a whole.
Patients with a grasp reflex had a younger age of onset 
(69.7 cf. 75.1 years, p<0.01) and longer duration of 
illness (101.3 cf. 61.8 months, p<0.05) than those without 
this reflex. Subjects with increased tone had a longer duration 
of illness (86.5 cf. 62.2 months p,0.03) and a tendency towards a 
younger age of onset (71.6 cf. 75.2 years p=0.058) than those 
with normal tone. Similarly, subjects with myoclonus had a 
tendency towards a younger age of onset (70.4 cf. 75.4 years, 
p=0.064, all above statistics, students it i test).
Table 8.2 shows the scores on cognitive function for those 
with and without neurological signs. There was no difference in 
scores for subjects with and without abnormal reflexes, extensor 
plantars, snout reflex, palmomental reflex, tremor or epileptic 
fits. A grasp reflex, increased tone and myoclonus were found to 
be significantly more common in the CDR III category (severe 
dementia, Chi square test, p<0.0005, p<0.003 and p<0.03
230
TABLE 8.1
FREQUENCY OF NEUROLOGICAL SIGNS IN SPAT
Proportion
Affected
Sign N %
Unequal Reflexes (N = 165) 7 4.2
Extensor Plantars (N = 161)* 6 3.7
Snout Reflex (N - 159). 65 40.9
Palmo-Mental Reflex (N = 160) 4 2.5
Grasp Reflex (N = 161) 13 7.3
Any Primitive Reflexes (N = 158) 73 46.2
Tremor (N = 165) 9 5.5
Increased Tone (N =163) 17 10.4
Myoclonus (N = 173) 8 4.6
Epileptic Fits (N = 176) 5 2.8
Extrapyramidal Signs (N = 162) 19 11.7
Drug Induced ..
Extrapyramidal Signs (N = 162) 4 2.5
* More common in subjects with ’possible’ Alzheimer’s Disease 
(p<0.02, Chi-square test with Yates Correction)
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TABLE 8.2
COGNITIVE FUNCTION IN SUBJECTS WITH NEUROLOGICAL SIGNS
Mini-Mental CAMCOG
State examination
(MAX = 30) (MAX = 107)
Mean * SO Mean * SD
Grasp Reflex:
Present (N = 13) 0.1 * 0.3 0.3 * 1.1
Absent (N = 148) 9.1 * 6.5 *** 30.4 * 21.7 ***
Increased Tone:
Present (N - 17) 1.7 * 3.1 7.0 i 11.6
Absent (N = 146) 9.0 * 6.6 *** 29.9 ± 22.2 ***
Myoclonus:
Present (N = 8)  2.2 * 3.4 5 . 9 * 8 . 6
Absent (N = 165) 8.3 ± 6.7 * 27.8 * 22.5 ***
Extrapyramidal Signs 
Present (N = 19) 4.1 * 5.6 15.7 * 19.1
Absent (N = 143) 8.8 ± 6.6 ** 29.2 ± 22.4 *
Drug Induced 
Extrapyramidal Signs 
Present (N = 4) 1.8 * 2.2 6.0 ± 6.4
Absent (N = 158)    8.4 * 6.7 * 28.2 * 22.4 *
KEY: SD - Standard deviation statistics, students1 't' test.
Difference in cognitive function between those with and without 
physical signs, *p<0.05; ** p<0.01; *** p<0.001.
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respectively). Thus, there was a strong association between 
these signs and advanced dementia. A grasp reflex and increased 
tone were more common in patients who died within the three-year 
follow up (Chi square test, p < 0.02, p < 0.007 respectively). 
There was no sex difference in patients with and without 
neurological signs.
Table 8.3 shows the relationship with CT scan changes. 
Extrapyramidal signs were associated with increased third 
ventricular size and calcification of the right globus pallidus, 
a grasp reflex was more common in those with frontal lobe atrophy 
and those with a history of epileptic fits had more atrophy in 
the left sylvian fissure region.
Table 8.4 shows the incidence of new signs during the first 
12 month follow-up. The number at risk is smaller than the total 
number due to exclusion of those exhibiting the sign initially 
and due to attrition of the sample (because of death during 
follow-up or poor co-operation with physical examination).
There was no difference in the numbers developing signs in 
subjects with ’’possible" or "probable” AD with two exceptions - 
the development of an extensor plantar response and epileptic 
fits were more common in those with possible AD. The relationship 
between age, age of onset and duration of illness and the 
development of a grasp reflex, increased tone and myoclonus was 
the same as the relationship between these features at the start 
of the study. VBR was significantly greater in those developing 
a grasp reflex (19.5 cf. 15.0 p < 0.05) and an extensor plantar 
response (20.7 cf. 15.0, p < 0.02) and showed a tendency to be
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TABLE 8.3
NEUROLOGICAL SIGNS IN SPAT - SUMMARY OF CT FINDINGS 
EXTRAPYRAMIDAL SIGNS Present Absent
Size of third ventricle 
(cm^ Mean i SD)
Calcification in right 
globus pallidus 
Present 
Absent
GRASP REFLEX
Frontal Lobe Atrophy 
None 
Mild 
Moderate 
Severe
HISTORY OF FITS:
Size of left sylvian 
fissure area 
(cm^ Mean i SD)
(N = 13) (N = 116)
2.3 ± 0.73 1.9 0.58 a
4 7
9 109 b
Present Absent
1 33
3 72
1 17
1 •' v 1 c
Present Absent
(N = 3 )  (N = 134)
12.2 ± 2.7 -8.3 ± 2.9 d
KEY: a - students* ',7tv test, p<0.02
b - chi-square test, p<0.005 
c - chi-square test, p<0.03 
d - students1 *t* test, p<0.03
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TABLE 8.4
INCIDENCE OF NEUROLOGICAL SIGNS APPEARING IN SDAT 
OVER THE 12 MONTH FOLLOW UP
Proportion 
Developing 
the sign
Sign - N %
Unequal Reflexes (N = 119) 10 8.4
Extensor Plantars (N = 113)* 6 5.3
Snout Reflex (N = 68) 17 25.0
Palmo-Mental Reflex (N = 114) 3 2.6
Grasp Reflex (N = 114) 8 7.0
Tremor (N = 116) 5 4.3
Increased Tone (N = 114) 11 9.6
Myoclonus (N = 122) 7 5.7
Epileptic Fits (N = 127*) 4 3.1
Extrapyramidal Signs (N =»■ 109) 4 3.6
Drug Induced
Extrapyramidal Signs (N = 119) 3 2.5
* More common in subjects with ’possible* Alzheimer's Disease 
(p*0.02, Chi-square test with Yates Correction)
greater in subjects developing myoclonus (19.3 cf. 14.9 p=0.64, 
all above statistics students * t* test). The development of a 
snout reflex and extrapyramidal signs was associated with an 
increased death rate during the follow-up period (p < 0.02, p < 
0.005 respectively, Chi square test).
8.2 DISCUSSION
The main findings were:
1) a snout reflex and extrapyramidal signs were the commonest
neurological features in patients with SDAT;
2) a grasp reflex, increased tone and myoclonus were associated 
with younger age of onset, longer duration of the illness and 
more severe dementia;
3) some neurological signs had anatomical correlates as assessed 
by CT scan and
4) the incidence of neurological signs was surprisingly high 
and their occurrence was associated with an increased death 
rate and increased VBR.
The prevalence of neurological signs in DAT has been
documented previously. Mayeux et al (1985b) studied 121 patients
and found extrapyramidal signs in 28%, drug induced 
extrapyramidal signs in 10% and myoclonus in 10%. The population 
from which the sample was drawn was not stated in the paper but 
the report emanated from a department of neurology. In a later 
paper, the same group used a subsample of the first population 
(Stern et al, 1987) and found that subjects with extrapyramidal 
signs deteriorated more quickly (both functionally and 
cognitively) than those without. The proportion with myoclonus
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in the present sample was lower than that described previously 
(Mayeux et al, 1985b; Hauser et al, 1986). One reason for this 
may be that previous authors have depended on observations by 
others in addition to, or instead of, direct examination of the 
patient. Therefore, I may have under-estimated the number with 
myoclonus by limiting my assessment to the period of direct 
observation (which lasted on average 90 minutes). Subjects with 
extrapyramidal signs were less commonly seen in the present 
sample than that from the Department of Neurology sample 
previously described (Mayeux et al,1985b). It is possible that 
subjects referred to such a department may have extrapyramidal 
pathology overrepresented compared to the present catchment area 
sample of predominantly elderly psychiatric referrals.
Roller et al (1982) studied 52 subjects with DAT and found a 
snout reflex in 28 (54%) and a grasp reflex in only one subject. 
They found that the reflex was present in an equal proportion of 
normal (ie non-demented) elderly subjects and demonstrated a 
significant association between a snout reflex and increasing age 
in both groups. Tweedy et al (1982) found a snout reflex in 19%, 
a grasp reflex in 17% and a palmomental reflex in 47% of 32 
patients with DAT. Huff and Growdon (1986), reporting on 165 
patients, found these three reflexes in 18%, 10% and 10%
respectively. Paulson and Gottlieb (1968) described a snout 
reflex in 52%, a palmomental reflex in 21% and a grasp reflex in 
18% of 85 patients with senile and pre-senile dementia. The 
proportion with a snout reflex in the present study (41%) was 
greater than that described previously but the patients were on 
average ten years older than those in previous studies and an
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association between the snout reflex (but not other primitive 
reflexes) and age has been demonstrated (Roller et al,1982). The 
number with a grasp reflex was similar to those in other studies 
(Huff and Growdon, 1986; Tweedy et al, 1982; Paulson and 
Gottlieb, 1968). The lower number with a palmomental reflex may 
be due to the fact that other samples have been drawn from 
neurological sources where one might reasonably expect there to 
be an increased number of neurological abnormalities than those 
from a psychiatrically based population where behaviour 
disturbance and self neglect were the prominent reasons for 
referral. However, the significance of primitive reflexes is not 
certain and their presence has been demonstrated in subjects with 
non-organic psychiatric conditions (Keshevan et al,1979).
The association between neurological signs and other 
features of dementia has been examined. Stern et al (1987) found 
that extrapyramidal signs and myoclonus were associated with 
greater cognitive impairment. Mayeux et al (1985b) found that 
subjects with myoclonus had a younger age of onset than those 
without. Kaye et al (1988,a) found a younger age of onset and 
more severe cognitive impairment in their subgroup of DAT 
patients with myoclonus. As these authors suggested (and 
confirmed partially with neurochemical analysis) this may imply 
that the presence of myoclonus represents a subgroup of SDAT 
patients. The possible diagnostic confusion between myoclonic 
SDAT and Creutzfeld-Jakob disease has been discussed (Jacob,
1970; Fadden and Townsend, 1976). The observations that myoclonus 
is associated with a younger age of onset and more severe
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dementia has been replicated by the present study. The 
association between the presence of a grasp reflex and more 
severe cognitive impairment has been reported previously (Huff 
and Growdon, 1986; Tweedy et al, 1982) and the present study 
confirms this finding.
Two studies (Tweedy et al, 1982; Roller et al , 1982) have 
failed to find an association between a snout reflex and cortical 
atrophy as assessed by CT scan. However, the former group did 
find increased lateral ventricular size in DAT patients with the 
reflex. The present study has shown the association between 
extrapyramidal signs and basal ganglia abnormalities (as 
shown by increased third ventricular size and calcification in 
the right globus pallidus). Interestingly, patients with drug 
induced extrapyramidal signs did not show evidence of basal 
ganglia damage. Kaye et al (1988,b) found increased CSF volume 
in patients with extrapyramidal signs but did not differentiate 
between cortical and subcortical atrophy. The association 
shownin the current study between a grasp reflex and frontal lobe 
atrophy replicates a well known finding (Paulson, 1971). The 
association between epileptic fits and left sylvian fissure area 
atrophy may suggest that shrinkage or scarring of the left 
temporal lobe predisposes to epileptic fits. However, the 
numbers involved in these last two observations were small and 
the associations require replication.
The finding of an increased VBR in patients developing 
neurological signs (grasp reflex, myoclonus and extensor plantar 
response) may suggest that subcortical damage is the immediate 
precursor to their development, as has been shown with the snout
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reflex (Tweedy et al,1982). The lack of correlation between 
these neurological signs at entry to the study and VBR may be due 
to the different and often lengthy period between the development 
of the sign (which may have been some time prior to the beginning 
of the study) and the CT scan which would have masked such an 
association.
The incidence of neurological signs was surprisingly high 
and requires explanation. The proportion with signs 
traditionally associated with vascular disease (extensor plantar 
response and unequal reflexes) was very low at the beginning of 
the study because of their specific exclusion by the 
NINCDS/ADRDA criteria. Such patients may well have developed 
these signs in the follow up period as a manifestation of 
previously unrecognised vascular disease. Also, as these 
signs were generally associated with advanced disease, it is 
not surprising that they should develop them in the course of 
such a study. The high incidence in relation to the 
relatively low prevalence confirms the increase in mortality 
seen in patients with these signs.
8.3 SUMMARY
A snout reflex was present in 41%, extrapyramidal signs in 
12%, drug induced extrapyramidal signs in 3%, myoclonus in 5% and 
a history of epileptic fits in 3% of the patients. A grasp 
reflex and extrapyramidal signs were associated with severe 
cognitive impairment. Extrapyramidal signs were associated with 
increased third ventricular size and basal ganglia calcification. 
Patients with a grasp reflex had more frontal lobe atrophy and a
zho
history of epilepsy was related to left temporal lobe atrophy. 
Lateral ventricular size was greater in patients developing a 
grasp reflex during the 12 month follow up period. Extrapyramidal 
signs and primitive reflexes were associated with a higher 
subsequent mortality.
CHAPTER 9
SURVIVAL
9.1 RESULTS
Of the 178 patients in the study, 84 (47%) had died at the 
36 month follow-up. Their characteristics and the differences 
between survivors and non-survivors are shown in Table 9.1. There 
were incomplete data on four subjects and so the final analysis 
was confined to 174 patients. CT scans were available on 136 
subjects. Comparing mortality with the general population, the 
cohort had an increased mortality compared to rates for the 
Camberwell Health Authority. The Standard Mortality Ratio (SMR) 
for men was 2.825 (95% confidence interval (Cl) 1.615, 4.587) and 
for women 3.676 (95% Cl 2.584, 4.734). There was no statistical 
evidence for a difference between SMR’s for men and women 
(P=0.34) and the overall SMR for the whole sample was 3.457 (95% 
Cl 2.761, 4.329). There was a suggestion that younger subjects 
had a higher SMR than the older patients (Table 9.2). However, 
the heterogeneity test for an interaction with age was not 
statistically significant (Day and Breslow, 1987, p=0.25).
Factors affecting survival
Each of the factors was examined in turn to estimate the 
effect on survival using the proportional hazards model of Cox. 
The results are presented in Table 9.3. Subjects with higher 
scores on the MMSE survived longer and older subjects died 
sooner. Those with the highest cortical atrophy scores on CT 
scan and those with longer duration of illness died sooner. 
Subjects with misidentification syndromes survived for longer 
while whose with depressive symptomatology died more quickly. It
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TABLE 9.2
STANDARD MORTALITY RATIOS (SMR's) BY AGE GROUP
OBSERVED EXPECTED SMR
65-74 years 6 1.2 5.00
75-84 years 44 10.8 4.07
85+ years 30 10.7 2.80
84 of the original 178 patients died. There were 80 deaths in the 174 cases 
in whom complete data were available.
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TABLE 9.3
UNIVARIATE MODELS FOR THE EFFECT OF 
VARIOUS FACTORS ON SURVIVAL IN ALZHEIMER1S DISEASE
VARIABLES COMPARISON HAZARD RATIO SIGNIFICANCE
(p VALUE)
Increase in age by one year 1.06 0.002
Female vs male 0.76 0.32
Increase in duration of illness by one month 1.005 0.06
Incident vs prevalent cases " 0.82 0.38
Probable vs possible AD 0.80 0.41
Hallucinations: present vs absent 1.47 0.17
Thought disorder: present vs absent 0.94 0.80
Misidentification: present vs absent 0.55 0.02
Depression: present vs absent 1.70 0.04
Family history: present vs absent 0.64 0.08
Increase in MMSE Score by one point 0.95 0.001
Increase in CAMDEX praxis score by one point 0.90 0.001
Increase in CAMDEX language score by one point 0.96 0.005
Increase in CAMDEX memory score by one point 0.93 0.03
Increase in VBR by 1* 0.91 0.58
Cortical atrophy (1) vs 0* 0.72 0.36
Marked cortical atrophy (2) vs 0* 1.98 0.03
A hazard ratio of ^ 1 means that the first normal variable causes more rapid 
death and K 1 means the variable causes less rapid death, on comparison with 
the baseline.
* scores for VBR and cortical atrophy in the text
is noteworthy that in these univariate analyses, the reduced rate 
in women compared to men was not statistically significant. 
Furthermore, although the incident cases had a longer survival as 
one would expect, this was not significantly different from the 
survival of the prevalent cases. The individual scores on the 
CAMCOG subscales were all significantly associated with survival. 
Each of these scales was highly related to the MMSE and to each 
other. Further analysis of these is presented below.
Multivariate modelling
In order to adjust for possible confounding relationships 
between the factors examined above, the proportional hazards 
model was used in a multivariate manner. The whole sample was 
used so the CT scan data were excluded from this analysis. The 
final model is given in Table 9.4. The first point to note is 
that the effect of age of onset does not appear. This is because 
age and duration are associated and age of onset adds little to 
predicting survival once age and duration are included. Being 
female emerges as a factor prolonging survival. No particular 
confounder was identified here although other variables in the 
final model appeared to contribute to unmasking the effect of 
sex. The ’'probable” category also appears to be important in the 
final model. The importance of the "probable”/”possible” 
distinction was obscured by the association between the 
’’probables” and higher MMSE. The "possible” group had more 
physical illness and this presumably led to poorer survival.
If all the other variables (excluding the CAMCOG scores and 
CT scan data) were added to this model, it did not significantly
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Table 9.4
Multivariate model for predicting survival in Alzheimer Disease
Variables Hazard ratio Significance
" (p Value)
0.001 
0.008 
0.02 
0.03 
0.04 
0.06
95% Confidence Intervals in Parentheses
Increase in MMSE score by 1 0.93 (0.90,0.97)
Increase in age by 1 year 1.06 (1.02,1.10)
Depression: present vs absent 1.80 (1.11,2.89)
Female vs male 0.55 (0.32,0.95)
Probable vs possible AD 0-56 (0.32,0.97)
Misidentification: present vs absent 0.55 (0.33,1.02)
2k7
improve the fit of the model (Chi-square test = 2.78, 5df, p = 
0.73). The final point about this model is that the distinction 
between incident and prevalent cases was not associated with 
significant difference in survival. This suggests that the 
pooling of incident and prevalent cases had not distorted the 
results.
It has been suggested that low scores of measures of 
visuo-spatial ability are associated with poor survival. This 
was tested by including the memory, language and praxis CAMCOG 
subscales in a single model, the results of which are given in 
Table 9.5. Because of the high correlation between these 
subscales, none of the individual coefficients is statistically 
significant. However, the hazard ratio estimates indicate that 
the praxis subscale is a more powerful predictor of poor survival 
than the two other subscales. The memory and language subscales 
have a hazard ratio estimate of 1, indicating no effect on 
survival when the effects of the praxis scale are taken into 
account.
One further model was constructed using the 136 observations 
in which CT scan data were available. The cortical atrophy score 
variable was added to a model including all the variables listed 
in Table 9.2 (Chi-square = 5.091, 2df, P = 0.08). The estimates 
for the effect of cortical atrophy score in this model were 
similar in pattern to those for the unadjusted effect given in 
Table 9.2 (1 - 0.65, 95% Cl, 0.31, 1.38; 2 - 1.44, 95% Cl, 0.73,
2.82). The CT scan measure for VBR was unrelated to survival in 
a similar model. There was a significant departure from 
linearity for the cortical scores (p=0.026).
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Table 9.5
A MULTIVARIATE MODEL INCLUDING THE THREE CAMDEX SUBSGALES
Hazard ratio Significance
(P value)
Increase in praxis score by 1 0.90 (0.79,1.03) 0.13
Increase in language score by.1 ' 1.00 (0.95,1.06) 0.98
Increase in Memory score by 1 1.00 (0.91,1.10) 0.93
95% Confidence Intervals in Parentheses
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9.2 DISCUSSION
The main findings were:
1) the mortality rate for patients with SDAT was 3.5 times 
higher than would be expected for a population of similar 
age;
2) using a multivariate model, factors found to be significant 
in influencing survival included age, sex, presence of 
physical illness, depression, cognitive function and 
misidentification syndromes and
3) poor cognitive function was related to poor survival but 
there was some evidence that apraxia was particularly 
associated with early death.
Mortality rates
The finding of increased mortality in elderly patients with 
SDAT when compared to the normal population is not surprising. 
Indeed, the results would have been suspect had this not been 
shown. The standard mortality ratio (observed divided by 
expected deaths) of 3.5 is similar to that described by Kay 
(1962) who found a mortality rate of 4.8 for patients with 
dementia compared to a standard population. In the current 
study, 47% of subjects died within the three year follow-up. This 
three year cumulative mortality is lower than that described in 
other studies. Camargo and Preston (1945) documented a three 
year mortality of 70%, Shah et al (1969) found that 95% of 
subjects died during that time and Naguib and Levy (1982b) 
described a mortality rate of 69%. Goldfarb (1969) found that 
57% of subjects with moderate dementia and 75% of those with
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severe dementia were dead after three years. The main reason for 
the low mortality rate in this study is most likely due to the 
fact that patients in a variety of settings were studied - the 
majority of other reports have dealt exclusively with inpatients 
who will usually be more advanced in their disease and will 
therefore have a shorter survival time and a higher mortality 
rate. Two other explanations for the difference may be invoked. 
First, that the current sample was diagnosed using rigorous 
clinical criteria which have a proven high success rate with 
finding AD pathology at post mortem. It is possible that other 
studies used less stringent criteria and may have included 
subjects with physical illness which prompted early mortality. 
This is supported by the subgroup in the present sample who had 
’’possible" AD (ie the presence of physical illness such as heart 
disease, diabetes or hypertension). This group had a higher 
mortality. A second reason for the low rate in the present 
population may be that mortality in dementia is genuinely 
decreasing as has been suggested by Duckworth et al (1979) and 
Christie (1982). Obviously, some other unmeasured variable may 
be responsible.
Factors affecting survival
Age, duration of illness, and sex: increasing age was associated 
with a higher mortality. While it is acknowledged that younger 
patients have a more severe illness and deteriorate more rapidly 
(Seltzer and Sherwin, 1983), Kasniak et al (1978) found that age 
did not affect survival. Younger patients with DAT appear to 
spend longer in hospital in their terminal illness than older 
subjects (Christie and Wood, 1988).
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Patients with a longer illness died sooner which confirms a 
previous finding (Barclay et al 1985b) and makes clinical sense.
A new finding was that mortality did not differ between cases 
already known to the services (prevalent cases) and cases 
appearing over the subsequent two years (incident cases).
However, significantly more of the prevalent cases died during 
follow up.
The protective effect of being female also confirms previous 
work. Camargo and Preston (1945) were the first to document the 
fact that elderly male patients had an increased mortality 
compared to females. Kay (1962) looked specifically at subjects 
with dementia and found survival to be one third of that expected 
in females and less than a quarter of that expected in males.
Shah et al (1969), in a study of 38 patients with senile 
dementia, found only 30% of men to be alive three months after 
admission to hospital compared to nearly 72% of women. One 
obvious explanation for this is that males with dementia 
are looked after in their own homes longer than females and so on 
admission to hospital (taken as the point of entry to many 
survival studies), male patients are more advanced in their 
disease and so consequently, death is sooner. However, this 
would not explain the fact that sex differences are seen in 
community samples which measure mortality since the onset of the 
illness.
Physical Illness: Not surprisingly, the ’possible* group (as
defined by the NINCDS/ADRDA criteria) had a higher mortality 
which reflects the associated physical illness in these patients.
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Cognitive function: that poor cognitive function is a predictor
of early death accords with clinical experience and is documented 
by the present study. The majority of other studies have found 
poor cognitive function to indicate poor survival (Heyman et al, 
1977, Berg et al, 1984, Kasniak et al, 1978). An exception was 
Barclay et al (1985), who found that cognitive function was not a 
predictor of survival but that behavioural disturbance was. The 
association between subscales of the Stockton Behaviour Rating 
Scale and death in the current population has been noted in 
Chapter 6.
Aphasia has been specifically associated with a poor 
prognosis. Kasniak et al (1978) reported that in 47 hospitalised 
patients (with both presenile and senile dementia), an expressive 
language deficit was associated with mortality in the 12 months 
following the examination. Aphasia has been associated with 
dementia of more rapid progression (Knesevich et al 1985). The 
finding in this study of praxis as a particular factor leading to 
reduced survival agrees with earlier work. McDonald (1969) and 
Hare (1978) stressed that parietal lobe involvement was a poor 
prognostic sign in SDAT. Naguib and Levy (1982,b) studied 40 
patients with senile dementia and followed them for between 18 
months and three years. The 27 who died had lower 
radioattenuation density numbers in the right parietal lobe (as 
assessed by CT scan) compared with those who survived. Thus, 
radiological evidence of parietal lobe damage was a predictor of 
poor survival. This work has been replicated by Colgan (1985). 
The findings of the present study again confirm the poor 
prognosis in patients with apraxia.
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Psychiatric symptoms: It has been suggested that depression
indicates a good prognosis in SDAT (Naguib and Levy, 1982,a). In 
this study, observed depression was associated with an increased 
mortality rate. While this appears to contradict earlier work, 
there is one obvious explanation for this finding. The current 
study used the NINCDS/ADRDA criteria to diagnose DAT. Previous 
studies used criteria which have not been verified histologically 
which casts doubt on their validity. Thus, previous studies may 
have included patients with depressive pseudodementia who would 
have had a better prognosis than subjects with DAT. An 
alternative explanation is that the measure of depression used in 
the current study was that observed by a rater and not depression 
complained of directly by the patient. The poor prognosis in 
depressed DAT subjects may be a reflection of a more severe 
underlying histopathology (Zweig et al, 1988).
Psychotic symptoms (delusions, hallucinations and 
misidentification syndromes) have been associated with a more 
rapid cognitive decline (Drevets and Rubin, 1989, Stern et a l , 
1987). Paradoxically, misidentification syndromes are associated 
with a reduced mortality (Drevets and Rubin, 1989), a finding 
confirmed by the present work. The reasons for this are unclear 
but explanations vary from differing underlying neuropathology to 
differing patterns of care being provided for such patients.
In conclusion, SDAT is associated with greatly reduced 
survival and several features of the disease help to predict 
mortality. This has implications for the care of patients and 
also suggests clinical heterogeneity in SDAT.
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9.3 SUMMARY
The mortality rate of the sample was 3.5 times that expected 
of a population of similar age. The cumulative 36 month 
mortality was 47%. Factors shown to be associated with reduced 
survival included increasing age, longer duration of illness, 
male sex, presence of physical illness, poor cognitive function, 
observed depression and absence of misidentification syndromes. 
Apraxia was a stronger predictor of death than aphasia or 
amnesia.
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CHAPTER 10 
NEUROPATHOLOGICAL FINDINGS
10.1 RESULTS
Relatives were approached during the study and a request for 
a post mortem examination was made to all the relatives of 
patients, either before or immediately after death. Of the 84 
subjects who had died during the three year follow up, full post 
mortems were obtained on 48. In the remaining cases, I was not 
told of the death until several weeks after the event in seven 
patients and consent was refused in 29.
Table 10 details the neuropathological diagnoses in the 48 
cases. Thirty subjects satisfied the ’’probable” NINCDS/ADRDA 
criteria and 18 the ’’possible” criteria. The reasons 18 were 
placed in the "possible” category were - diabetes (five cases), 
evidence of vascular disease unrelated to the dementia syndrome 
(three cases), epilepsy prior to onset of dementia (two cases), 
episodes of delirium (two cases) and one case each of 
hypertension, vitamin B12 deficiency, carcinoma of lung, subacute 
bacterial endocarditis, temporal arteritis and lymphoma.
There were ten patients with ’’possible" AD in whom the 
diagnosis of "definite” AD was made at post mortem. Four of 
these had diabetes (all were on oral hypoglycaemic medication). 
The conditions in the other six which led to them being 
classified as "possible” AD were: hypertension; evidence of
peripheral vascular disease and atrial fibrillation associated 
with dementia which had a slightly atypical presentation; vitamin 
B12 deficiency, epilepsy (still on medication); a previous
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E 10
CLINICAL CRITERIA:
PROBABLE AD POSSIBLE AD TOTAL
CLINICAL CRITERIA VERSUS 
lOPATHOLOGICAL DIAGNOSIS
lOPATHOLOGICAL 
5N0SIS:
S AD
ED AD/VASCULAR 
ED AD/CLBD 
E VASCULAR 
E CL3D
d i a g n o s i s"
23
2
2
0
2
1
10
3
1
•2
0
2
33
5
3
2
2
3
69%
11%
6%
4%
4%
6%
ABILITY OF CLINICAL CRITERIA 
PREDICT AD PATHOLOGY:
iHEIMER PATHOLOGY PRESENT
:HEIMER PATHOLOGY ABSENT
30
27
3
18
14
4
48
41
7
100%
85%
15%
) ABILITY OF CLINICAL CRITERIA 
EXCLUDE VASCULAR PATHOLOGY
SCULAR PATHOLOGY ABSENT
SCULAR PATHOLOGY PRESENT
30
28
2
18
13
5
48
41
7
100%
85%
15%
30 18 48 100%
KEY: AD - Alzheimer's Disease
CLBD - Cortical Lewy Body Disease
257
history of sudden confusion allegedly diagnosed as a stroke and 
cancer of the lung. The neuropathological findings in the eight 
’possible’ subjects without ’definite’ AD are shown in Table 
10(a). Three subjects had neuropathological changes consistent 
with normal ageing but no evidence of disease responsible for 
their dementia. Two had associated physical disease (temporal 
arteritis and subacute bacterial endocarditis) while the other 
had features of depression, in addition to being demented.
Table 10(b) breaks down the neuropathological diagnoses as 
to whether AD changes were present or not. The sensitivity with 
which the criteria were able to predict AD was 90% and 77.8% for 
the ’probable’ and ’possible’ criteria respectively. Specificity 
could not be assessed as the sample did not include patients who 
did not satisfy the NINCDS/ADRDA criteria. (However, two 
additional patients were assessed and found not to satisfy the 
NINCDS/ADRDA criteria and so were not recruited into the study.
As both were inpatients in the Joint Hospital, post mortems were 
performed when they died and neither had AD.)
Table 10(c) shows the ability of the criteria to exclude 
patients with vascular disease. Only two patients who satisfied 
the "probable” criteria had evidence of vascular disease, both of 
whom also had AD changes. Two subjects had evidence of vascular 
disease only - one was a centenarian who developed a stroke after 
the onset of dementia and the other was a woman who had been in 
hospital for many years and who had a lymphoma diagnosed earlier 
in life. Both were placed in the "possible" category. The 
"probable" criteria were therefore correct in excluding vascular 
disease in 93.3% of cases, the "possible" criteria excluded such
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changes in 72.2%.
10.2 DISCUSSION
The main findings of were:
1) AD can be diagnosed accurately during life by applying 
NINCDS/ADRDA criteria, without the need for extensive 
investigation and resources;
2) significant vascular disease can be almost entirely excluded 
by the strict use of these criteria;
3) in some patients AD can be confidently diagnosed even when 
accompanying physical illness such as diabetes, epilepsy or 
cancer is present and
4) cortical Lewy bodies are a common neuropathological finding 
in elderly demented patients.
There have been several studies which have evaluated the 
agreement between clinical and pathological findings in dementia. 
The rate of agreement between clinical and histological diagnoses 
of AD varies from about 50% (Homer et al, 1988, Alafuzoff et a l , 
1987) to 95% and above (Martin et al, 1987, Boiler et a l , 1989). 
Alafuzoff et al (1987) were correct in only 53% of cases.
However, they examined only the frontal lobe and almost certainly 
underdiagnosed the condition. Homer et al (1988) did not use any 
standardised criteria for their clinical diagnosis which probably 
accounted for their success rate of only 46%. They were, however, 
trying to predict neuropathological findings in dementias with a 
variety of aetiologies whereas the present study confined itself 
to the clinical diagnosis of AD. Studies where agreement has been 
90% or above have all employed the NINCDS/ADRDA criteria.
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The current findings of three patients in whom no 
neuropathological diagnosis could be reached is in accord with 
other studies. Homer et al (1988) found one such patient out of 
27, Perl et al (1984) one case out of 26 and Wade et al (1987) 
one out of 65. Three explanations are possible. First, the 
clinical diagnosis was wrong and a condition, not resulting from 
structural brain disease (eg physical disease in another organ or 
pseudodementia) was responsible for the patient’s symptoms and 
behaviour. Second, that a metabolic disturbance in the brain, 
not associated with structural abnormalities, was responsible. 
Third, that standard neuropathological techniques may be missing 
cases in which changes not hitherto recognised as pathognomonic 
of AD (eg A4 protein deposition) are present. It can be seen from 
Table 10 that the NINCDS/ADRDA criteria are consistent with a 
successful neuropathological diagnosis of AD in 90% of cases. Ten 
patients were classified as having "possible" AD because of 
associated physical illness which may have indicated either the 
presence of vascular disease or another disorder which may have 
accounted for the dementia. Despite this, all had AD proven at 
post-mortem.
The paucity of significant vascular disease in this sample 
was expected as patients with the widely recognised features of 
vascular dementia (eg sudden onset, stepwise deterioration 
etc.) were specifically excluded. All subjects in the sample 
had a low Hachinski score which is in keeping with the dearth of 
vascular disease seen. The original Hachinski score (Hachinski 
et al,1975) was developed on the basis of blood flow studies and 
the loadings given to each item were arbitrary. Subsequent
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studies (Rosen et al, 1980, Loeb and Gandolfo, 1983) have shown 
that only some of the original items do in fact predict the 
presence of infarcts. By employing the "probable’'
NINCDS/ADRDA criteria in this sample, all cases in this study 
with pure vascular disease were excluded.
Finally, cortical Lewy body disease (CLBD) was found in five 
cases. Patients with CLBD have features of a Parkinson syndrome 
and it has been suggested that they represent a variant of AD 
(Hansen et al, 1990). No such distinguishing features were found 
in this sample. The frequency of CLBD (10.4%) was very similar to 
that of Perry et al (1989) and appears to constitute the second 
commonest neuropathological finding in neurodegenerative dementia 
in old age.
10.3 SUMMARY
The NINCDS/ADRDA were able to predict Alzheimer pathology at 
post mortem in 85% of cases. Only two patients out of 48 had 
pure vascular pathology, both of whom were in the "possible" AD 
category. Cortical Lewy body disease was found in 10.4% of 
cases, of which half also had sufficient Alzheimer changes for 
that diagnosis to be made in addition. Three subjects had 
cerebral changes consistent with ageing alone - no cause for 
their dementia syndrome was found.
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CHAPTER 11 
CONCLUSIONS AND FUTURE STRATEGIES
The main conclusions of this study will be summarised in 
relation to the hypotheses outlined in the Introduction. 
Hypothesis 1 - there is considerable clinical heterogeneity in 
Senile Dementia of the Alzheimer Type (SDAT) and that features of 
the disease will be identified which predict future cognitive 
decline and survival - the study has confirmed, in view of the 
diverse nature of psychiatric symptoms, behaviour disturbance and 
neurological signs found, that clinical heterogeneity does exist 
in SDAT. The features related to cognitive decline and mortality 
included age, sex, cognitive performance, hallucinations, 
misidentification syndromes, observed depression, behaviour 
disturbance, family history of dementia in parents, duration of 
illness of less than two years and neurological signs.
Hypothesis 2 - specifically, apraxia and ventricular 
enlargement will be related to a poor outcome and depression will 
be associated with a good outcome - apraxia appeared to be 
related to reduced survival, ventricular enlargement was 
not and depression (observed by a rater) was associated 
with poor survival.
Hypothesis 3 - the proportion of patients with specific 
psychiatric symptoms and behaviour disturbance will be lower than 
other studies because of the representative nature of the 
population under investigation - generally speaking, this has 
been found, particularly for the psychiatric symptoms.
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Hypothesis 4 - specific psychiatric symptoms and behaviours will
have structural correlates as assessed by Computed Tomography 
(CT) scan - this has been shown in the case of depression, some 
types of delusion, mania, wandering behaviour, hyperorality and 
aggression.
Hypothesis 5 - subgroups will be identified by longitudinal 
changes in cognition and CT scans - longitudinal changes in 
both measures were disappointing in elucidating subtypes but, 
apart from the obvious conclusion that subtypes assessed on these 
measures did not exist, this may be due to inherent problems in 
longitudinal investigations.
Hypothesis 6 - by the use of appropriate clinical criteria, 
it will be possible to predict during life which patients will 
have Alzheimer’s disease changes at post mortem - it has 
been shown, by applying the NINCDS/ADRDA criteria, that 
histopathological changes of Alzheimer’s disease at post mortem 
can be predicted with nearly 90% accuracy.
The major problem surrounding clinical heterogeneity in SDAT 
is one of definition, both of the clinical syndrome and of the 
method of establishing heterogeneity. The syndrome consists of 
two parts - a clinical picture (defined as dementia) and a 
histopathological pattern (defined in terms of plaques and 
tangles in the neocortex and hippocampus). While there is 
overwhelming evidence that the two are causally linked and are 
distinct from the changes which occur during normal ageing, much 
is unknown. The aetiology of the condition is unknown, the 
pathogenesis unclear, specific diagnostic tests unavailable and
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no effective treatment is possible. Also, neither the clinical 
features nor the neuropathological findings are specific to SDAT. 
Given these uncertainties, the finding of clinical heterogeneity 
in SDAT is not surprising.
Another problem when discussing heterogeneity is the 
definition of subtypes (or subgroups). So far, no definite 
criteria have been developed though suggestions have been 
proposed along the lines of qualitative and quantitative subtypes 
(Jorm, 1985). These categories remain theoretical and depend on 
the elucidation of causal factors. The latter depends on the 
discovery of the responsible gene or genes and the identification 
of environmental agents modifying the genotype. The uncertainties 
surrounding the nosological status of SDAT should provoke a more 
cautious approach to the elucidation of subtypes.
There are four reasons why clinical heterogeneity may be 
discovered in SDAT. First, it may be due to erroneous diagnosis 
ie patients with conditions other than SDAT may have been 
studied. Second, true subtypes of the disorder may be present as 
is the case in Duchenne and Becker muscular dystrophy (ie 
qualitative subtypes). Third, there may be differential 
expression of the same underlying disorder, perhaps with 
different genetic or environmental causes (eg a single or double 
dose of a responsible gene as is the case in Thallassaemia minor 
and major). Fourth, clinical heterogeneity may be due to 
differences in severity of the same underlying condition ie that 
all patients will develop the same symptoms if they have the 
disease for a sufficient length of time.
A review of the literature shows that there are clinically
2 6k
distinct groups of patients who have dementia (and senile 
dementia) of the Alzheimer Type. These groups have been 
variously defined in terms of familial aggregation, age of onset, 
neuropsychological profile, clinical symptomatology, survival and 
neurochemical and neuropathological features. A weak point in 
existing studies is that the populations under study consist of 
unrepresentative groups of patients who, with the exception of 
neuropathological studies, lack precise diagnostic criteria. The 
patients studied in the present work were from a defined 
catchment area of Health District and all satisfied stringent 
criteria for the clinical diagnosis of Alzheimer’s disease.
Another important factor in the work presented in this 
thesis is that all the patients examined were elderly and the 
vast majority had been referred to psychiatrists. It is likely 
that elderly subjects presenting to their General Practitioners 
(from whom most of the patients in the study were originally 
referred) would require more severe (and/or additional) symptoms 
to merit referral to a specialist than would younger patients. It 
is probable that, in many elderly patients, early symptoms of 
dementia are put down to "normal ageing" and so referral for 
specialist investigation is not made until a relatively later 
stage of the disease. Also, the reason for referring a 
particular patient to a psychiatrist rather than to a neurologist 
may be influenced by factors such as symptomatology and age but 
also may be entirely arbitrary. Common sense dictates that 
patients with troublesome behavioural disturbance or prominent 
psychiatric symptomatology should be referred to psychiatrists.
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It is possible that any differences in clinical heterogeneity 
between this and other studies may be, in part, explained by the 
selection process of the sample, particularly in the case of 
neurological signs, psychiatric symptoms and behavioural 
disturbance.
As all the patients were 65 years or over on admission to 
the study, age and age of onset of the disease were not important 
variables. However, some associations were found. Subjects with 
misidentification syndromes and myoclonus were younger than those 
without these features. The presence of misidentification and 
young age was associated with increased survival suggesting that, 
within the elderly group, relative youth predicts longer 
survival. The most likely explanation for this was that, as age 
increased, its deleterious effect on survival outweighed the 
effect of a more severe illness said to occur in early onset 
cases,
Family history of dementia is notoriously difficult to 
evaluate and is particularly so in the relatives of elderly 
subjects. The only positive finding in relation to family 
history was that deterioration in cognitive function was greater 
in those with a positive history in parents. It would be 
tempting to conclude that this finding indicates a genetic 
contribution to a more severe disease. However, no other 
evidence emerged to support this conclusion. With this 
exception, there was no indication in the study that a family 
history of dementia bore any relationship to other features. One 
may conclude that genetic factors play a less important role in 
dementia in the elderly than in younger patients and subtypes,
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based on this, do not exist.
Although relatively neglected as symptoms of DAT, non- 
cognitive abnormalities (psychiatric symptoms and behavioural 
disturbance) are important - they are usually apparent, 
potentially treatable, may shed light on the pathophysiology of 
the functional psychoses and, most importantly, their presence or 
absence may indicate subtypes. The presence of possible subtypes 
based on these symptoms was suggested by the association of 
misidentification syndromes, younger age of onset of disease and 
prolonged survival. Depressive symptoms were associated with a 
milder form of the disease (as indicated by less severe cognitive 
and CT scan changes) but this might simply reflect those less 
severely impaired being unable to express depressive ideation 
which required relatively intact cerebral function. A trend 
emerged for those with a previous history of depression to have a 
less rapid progression of the disease but, similar to the reverse 
finding with regard to family history of the illness, the 
significance of this solitary finding is debatable. A somewhat 
surprising finding was that subjects who appeared depressed had a 
significantly shorter survival time. Previous neuropathological 
studies have suggested a different neuropathology in depressed 
compared to non-depressed subjects and this, although untested in 
the present study, may be reflected in the clinical picture.
Other psychiatric symptoms such as hallucinations, were 
associated with more rapid cognitive decline over the follow-up 
period which did suggest some subgrouping.
Most of the behaviours assessed in the study were associated
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with advanced dementia and so it is reasonable to 
postulate that their presence results from structural brain 
damage. The assumption implicit in this statement is that all 
patients will develop these behaviours which is patently not 
true and so some additional factor, genetic, environmental or 
related to pre-morbid personality must exert some influence 
on these particular clinical features. The exception was 
binge eating which was equally common across all ranges of 
severity but there was no other evidence to suggest that this 
represented a qualitative subtype.
Neurological signs were present in a surprising number of 
patients and myoclonus and a grasp reflex were associated with a 
younger age of onset and thence may represent a subtype.
However, these appeared to be present in the more advanced stages 
of the disorder which, as with behavioural disturbance, probably 
reflects structural brain damage rather than a particular 
subtype. Other studies have used neurological signs to describe 
clinical subtypes of DAT, both cross-sectionally and 
longitudinally. As most of these studies have come from 
neurological clinics consisting predominantly of younger 
patients, sample bias may be present.
It is difficult to make valid interpretations of results 
based on cross-sectional assessments of a progressive disorder 
such as DAT. Longitudinal changes must be measured - cognitive 
function and CT scans were examined in this thesis. There are 
many problems associated with longitudinal studies, the most 
outstanding in this work being the actual instruments used for 
analysis and the presence of "floor effects" (ie the fact that
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many of the patients were moderately to severely demented at the 
time of entry to the study and that the scope for further 
deterioration was therefore limited). With regard to the first 
point, no instruments exist which are exclusively sensitive to 
changes in cognitive function and so the measures used, although 
not ideal, were as good as any. The assessment of longitudinal 
CT changes faced the inherent problem of positioning the patient 
in the same CT plane at both points in time when, by definition, 
he/she will have deteriorated and therefore may be less able to 
co-operate. A relatively normal distribution of change in 
cognitive function was found, suggesting but by no means proving, 
that clinical subtypes as assessed on this index were not 
present. Similarly, the range of changes seen on the CT measures 
was very wide and did not suggest discrete subtypes. One can say 
only that the case for clinical subtypes utilising the 
longitudinal measures is unproven. However, patients were 
examined only at two points in time and prolonged longitudinal 
assessment may reveal additional information.
The neuropathological findings presented may appear somewhat 
out of place but were included to justify the clinical criteria 
used in the study. As mentioned in the first paragraph, research 
on psychiatric disorders in general and DAT in particular, is 
bedevilled by problems of definition. The data presented proved 
(in conjunction with the review of the associated literature) 
that a reliable diagnosis of AD was possible during life with the 
careful application of appropriate clinical criteria. It will be 
important to continue the follow-up of the survivors in the
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current work and obtain post mortems on as many as possible. 
Neuropathological heterogeneity was not within the remit of this 
thesis and so has not been addressed.
Future strategies in the investigation of subtypes of DAT in 
general and SDAT in particular can be divided into two broad 
categories. First, the definitive answer will be obtained only 
when the aetiology and pathogenesis of the condition are 
understood. This may be genetic or environmental but probably 
involves a combination of these two. Second, longitudinal 
studies with clinico-pathological correlations are essential as 
validation of particular clinical subtypes against longitudinal 
changes and neuropathological findings will help to document the 
presence of subtypes. Both these aims will be facilitated by 
more detailed and prolonged longitudinal studies investigating 
patients earlier in the course of the disease. Neuroimaging 
modalities such as Magnetic Resonance Imaging and Single Photon 
Emission Tomography may be used to follow patients longitudinally 
in parallel with neuropsychological testing. Biological markers 
may be developed to identify subtypes of the disorder.
Correlation of clinical and histopathological features is 
essential and post mortems should be obtained routinely on all 
suitable patients.
The work here has suggested some disease characteristics 
which may be of help to future researchers in identifying 
clinical features most strongly indicative of subtypes - 
psychiatric symptoms, behaviour disturbance and neurological 
signs. Ultimately, the elucidation of subtypes will depend on 
finding the aetiology and pathogenesis of the condition.
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APPENDIX 1 THE HINT—MENTAL STATE EXAMINATION (MMSE, Folstein et al., 1975)
ORIENTATION
Points
1. What is the Year?
Season?
Date?
Day?
Month?
2. Where are we? Country?
County?
Town?
Hospital?
Floor?
REGISTRATION
3. Name three objects (Apple, Table, Penny), taking one second to say each. 
Then ask the patient all three after you have said them.
Give one point for each correct answer. Repeat the answers 
until the patient learns all three.
ATTENTION & CALCULATION
4. Serial sevens. Give one point for each correct answer.
Stop after five answers. 5
RECALL
5. Ask for names of three objects learned in Question 3.
Give one point for each correct answer. 3
LANGUAGE
6. Point to a pencil and a watch. Have the patient name them 
as you point. 2
7. Have the patient repeat "No ifs, ands, or buts." 1
8. Have the patient follow a 3-stage command: "Take the paper in
your right hand. Fold the paper in half. Put the paper on the 
floor." 3
9. Have the patient read and obey the following: "CLOSE YOUR
EYES" (Write it in large letters) 1
10. Have the patient write a sentence of his or her own choice.
(The sentence should contain a subject and an object and should make 
sense. Ignore spelling errors when scoring.) 1
11. Draw the design printed below to 1.5 cm per side and have the 
patient copy it. Give one point if all sides and angles are 
preserved and if the intersection sides form a quadrangle.) 1
Maximum score = 30
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APPENDIX 2
ABBREVIATED MENTAL TEST SCORE (AMIS, Thompson and Blessed, 1987)
Points
1. How old are you? (exact year) 1
2. What time is it? (to nearest hour) 1
"I would like you to remember this address:
42 Church Street*'
3. What year is it? (exact year) 1
4. What is the name of this part of London? 1
5. Recognition of two persons (e.g. neighbours, 1
relatives, name photographs in room)
6. What is your date of birth? 1
7. In what year did the First World War begin? 1
8. Who is on the throne at the moment? 1
9. Can you count backwards from 20 to 1? 1
10. Can you tell me the address I asked you to remember 
a few minutes ago?
42 Church Street 1
Maximum score = 10
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ENDIX 3 PHYSICAL EXAMINATION
E DATE STUDY
SE RATE BEATS PER MINUTE
RHYTHM: REGULAR = 0, IRREGULAR = 1
SYSTOLIC
DIASTOLIC
GUE: 0 = NORMAL; I = ATROPHIC
TH: 0 = OWN 1 = FALSE
SIGHT: GLASSES WORN 0 = NO; 1 = YES;
ISION WITH GLASSES 0 = NORMAL;
1 = SLIGHTLY IMPAIRED
2 = VERY IMPAIRED
RING:HEARING AID WORN 0 = NO; 1 = YES
HEARING WITH AID 0 = NORMAL
1 = SLIGHTLY IMPAIRED
2 = VERY IMPAIRED
ILITY: 0 = NORMAL, UNAIDED
1 = WITH WALKING AID
2 = WITH HUMAN ASSISTANCE
3 = CHAIR/BED BOUND
PIRATION: 0 = NORMAL; 1 = ABNORMAL
IL RESPONSE TO LIGHT; 0 = NORMAL; 1 = ABNORMAL
EL EQUALITY; 0 = NORMAL; 1 = ABNORMAL
MOVEMENTS; 0 = NORMAL; 1 = ABNORMAL
2 SYMMETRY; 0 = NORMAL;"~1 ABNORMAL
2NGTH: 0 = NORMAL; 1 = ABNORMAL OR ASYMMETRICAL
? TENDON REFLEXES:
0 = NORMAL; 1 = ABNORMAL OR ASYMMETRICAL
3ATI0N: 0 = NORMAL; 1 = ABNORMAL OR ASYMMETRICAL
E: 0 = NORMAL; 1 = ABNORMAL
TTARS: 0 = FLEXOR; 1 = EXTENSOR
JT REFLEX: 0 = ABSENT; 1 = PRESENT
REFLEX: 0 = ABSENT; 1 = PRESENT
>P REFLEX: 0 = ABSENT; 1 = PRESENT
IOR: 0 = ABSENT; 1 = PRESENT
)EDNESS: 0 = RIGHT HANDED; 1 = LEFT HANDED
:C FUNDI: 0 = NORMAL; 1 = ABNORMAL
: IN LIMBS: 0 = NORMAL; 1 = ABNORMAL
LONUS: 0 = ABSENT; 1 =  PRESENT
>ENDIX 4 STOCKTON GERIATRIC RATING SCALE (Meer and Baker, 1966)
IE'  ......................  DATE:.................... STUDY NO............
The Patient will fall from his bed or chair unless protected by side rails or 
soft ties (day or night):
0 - never
1 - sometimes
2 - frequently
The patient helps out on the ward (other than a regular work assignment):
0. - often helps out
1 - sometimes helps out
2 - never helps out
The patients understands what you communicate to him (you may use speaking, 
writing, or gesturing):
0 - understands almost everything you communicate
1 - understands some of what you communicate
2 - understands almost nothing you communicate
The patient is objectionable to other patients during the day (loud or 
constant talking, pilfering, soiling furniture, interfering in affairs of 
others):
0 - rarely or never
1 - sometimes
2 - frequently
Close supervision is necessary to protect the patient, due to feebleness, from 
other patients:
0 - rarely or never needs protection
1 - sometimes needs protection
2 - frequently needs protection
The patient keeps self occupied in constructive or useful activity (works, 
•reads, play games, has hobbies, etc.):
0 - almost always occupied
1 - sometimes occupied
2 - almost never occupied
The patient communicates in any manner (by speaking, writing, or gesturing):
0 - well enough
1 - can be understood sometimes or with some difficulty
2 - can rarely or never be understood for whatever reason
The patient engages in repetitive vocal sounds (yelling, moaning, talking, etc.) 
which are directed to no one in particular or to everyone:
0 - never
1 - sometimes
2 - frequently
When bathing or dressing, the patient requires:
0 - no assistance
1 - some assistance
2 - maximum assistance
The patient socializes with other patients:
0 - does establish a good relationship with one or more patients
1 - has some difficulty establishing a good relationship with one or more
patients
2 - has a great deal of difficulty establishing a good relationship with one or
more patients.
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ENDIX 4 (CONT.)
The Patient knows his own name:
0 - almost always responds to his name
1 - sometimes responds to his name
2 - almost never responds to his name
The patient threatens to harm other patients, staff, or people outside the 
hospital either verbally (e.g., "I’ll get him") or physically (e.g. raising of 
fist):
0 - never
1 - sometimes
2 - frequently
With regard to walking the patient:
0 - shows no sign of weakness
1 - walks slowly without aid, or uses cane
2 - is unable to walk, or if able to walk, needs walker, crutches, or someone by
his side
The patient, without being asked, physically helps one or more patients in
various situations (pushing wheel chair, helping with food tray, assisting in
shower, etc. ):
0 - often helps without being asked
1 - sometimes helps without being asked
2 - never helps without being asked
The patient wants to go home or leave the hospital:
0 - expresses great eagerness in leaving
1 - expresses some interest in leaving
2 - expresses almost no interest in leaving
The patient is objectionable to other patients during the night (loud or 
constant talking, pilfering, soiling furniture, interfering in affairs of others 
wandering about, getting into some other patient’s bed, etc.):
0 - rarely or never
1 - sometimes
2 - frequently
The patient is incontinent of urine and/or faeces (day or night):
0 - never
1 - sometimes (once or twice per week)
2 - frequently (three times per week or more often)
The patient takes the initiative to start conversations with others (exclude
side remarks not intended to open conversations):
0 - often takes the initiative
1 - sometimes takes the initiative
2 - never takes the initiative
The patient accuses others (patients, staff, or people outside the hospital) of
doing him bodily harm or stealing his personal possessions (if you are sure the
accusations are true, rate zero: otherwise rate one or two):
0 - never
1 - sometimes
2 - frequently
When eating, the patient requires
0 - no assistance (feeds himself)
1 - a little assistance (needs encouragement to eat, needs food cut up for
him/her)
2 - considerable assistance (spoon feeding, etc.)
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The patient has a regular work assignment:
0 - away from the ward
1 - on the ward
2 - no regular assignment
The patient is destructive of materials around him (breaks furniture, tears up 
magazines, sheets, clothes, etc.):
0 - never
1 - sometimes
2 - frequently
The patient is confused (unable to find his way around the ward, loses his 
possesions, etc.):
0 - almost never confused
1 - sometimes confused
2 - almost always confused
The patient knows the staff by name:
0 - knows names of more than one member of the staff
1 - knows name of only one member of the staff
2 - knows name of none of the staff
The patient engages in apparently useless repetitive movements (pacing, rocking, 
wringing of hands, making random movements, etc.):
1 - never - -v . ... . ■ > ■ ,
2 - sometimes
3 - frequently
The patient is in bed during the day (bed does not include couch, settee, etc.):
0 - never
1 - sometimes
2 - almost always
The patient is allowed to leave the ward
0 - whenever he/she wants.
1 - sometimes
2 - never _____ ..
The patient hoards apparently meaningless items (wads of paper, string, scraps 
of food, etc.):
0 - never
1 - sometimes
2 - frequently
When left to his own devices, the patient’s appearance (clothes and/or hair, 
including beard for males) is:
0 - almost never disorderly
1 - sometimes disorderly
2 - almost always disorderly
If patient were allowed the freedom of the grounds alone, he would be able to 
protect himself from the weather or from getting lost:
0 - would never need supervision outdoors
1 - would sometimes need supervision outdoors
2 - would always need supervision outdoors
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?ENDIX 4 (CQNT.)
The patient’s sleep pattern at night is:
0 - almost never awake
1 ~ sometimes awake
2 - often awake
The patient’s meals consist of:
0 - a regular solid diet, no limitations, "will eat anything"
1 - a normal diet with modification e.g. avoidance of particular food
2 - a special diet (diabetic, low salt, pureed, etc.)
The patient is willing to do things suggested to or asked of him:
0 - often goes along
1 - sometimes goes along
2 - almost never goes along
following four factors were derived from the scale (Meer and Baker, 1966) 
tor Question
sical Disability 1, 5, 9, 13, 17, 20, 23, 26, 29, 32.
:hy 2, 6, 10, 14, 18, 21, 24, 27, 30, 33.
lunication" failure 3, 7, 11, 15.
.ally Irritating Behaviour 4, 8, 12, 16, 19, 22, 25, 28, 31.
question about wandering behaviour was worded thus:
patient wanders aimlessly around the ward:
rarely or never
sometimes
frequently.
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APPENDIX 5
QUESTIONS RELATED TO BEHAVIOUR ASSOCIATED WITH THE ’KLUVER-BUCY SYNDROME’.
.) The patients sexual behaviour (exposing self, obscene sex language, 
masturbation, propositioning others, ) is:
0 - never inappropriate,
1 - sometimes inappropriate,
2 - often inappropriate.
,) The patient recognises well known nurses and relatives:
0 - almost ..always, . ... '
1 - sometimes,
2 - almost never.
) The patient goes into rages:
0 - never or rarely,
1 - sometimes,
2 - frequently.
) The patient is distractable and immediately explores things around him/her when 
they happen (e.g. always going up to the door when someone comes in):
0 - never or rarely,
1 - sometimes,
2 - often or always.
>) The patient tends to "binge" with food (i.e. eating very quickly and stuffing 
food in his/her mouth):
0 - never or rarely,
1 - sometimes,
2 - often or always.
) The patient tries to put objects (other than food) in his/her mouth:
0 - never or rarely,
1 - sometimes,
2 - frequently.
) The patient seems withdrawn and apathetic:
0 - never or rarely,
1 - sometimes,
2 - a lot of the time.
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